Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,29172,-0.187713310335358,0.00429573948968457,-0.19613295973514,-0.179293660935576,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28612,-0.232253933919633,0.00585005647240177,-0.24372004460554,-0.220787823233725,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,24699,0.209378755112525,0.00465786621850756,0.20024933732425,0.2185081729008,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,29470,-0.200044580174621,0.00359501163581083,-0.207090802980811,-0.192998357368432,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,24683,0.0710868586552377,0.00174286649123996,0.0676708403324074,0.074502876978068,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,28908,-0.0909967747851833,0.0020680480609899,-0.0950501489847235,-0.086943400585643,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,24683,0.173429132559341,0.00367935642653844,0.166217593963326,0.180640671155356,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,28986,-0.238042427542104,0.00521485947475858,-0.248263552112631,-0.227821302971577,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,29180,-0.273123335690113,0.00558124155338828,-0.284062569134754,-0.262184102245472,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,29273,-0.102558409997595,0.00238601772092591,-0.10723500473061,-0.0978818152645806,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,29359,-0.333848642668712,0.00827439226812313,-0.350066451514233,-0.31763083382319,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29256,0.0968509690023746,0.00228044575698399,0.092381295318686,0.101320642686063,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FURIN,Furin,29256,-0.10270155433365,0.00232754571596533,-0.107263543936942,-0.098139564730358,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,28491,-0.536683654364747,0.00834180220965291,-0.553033586695667,-0.520333722033827,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,24119,-0.0791645786710253,0.00200348089403747,-0.0830914012233387,-0.0752377561187118,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,28612,-0.186773929419135,0.00462559279992548,-0.195840091306989,-0.177707767531281,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29449,0.400421350265234,0.00844542197660226,0.383868323191094,0.416974377339375,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,24653,-0.33822930962214,0.00557786636343659,-0.349161927694476,-0.327296691549804,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,29132,-0.121546839256258,0.00286583913255029,-0.127163883956057,-0.11592979455646,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,29193,-0.218645987569965,0.00353234859427112,-0.225569390814736,-0.211722584325194,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,29172,0.146550449338655,0.00325945217932097,0.140161923067186,0.152938975610124,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24529,-0.173782536075197,0.00384646839121546,-0.181321614121979,-0.166243458028415,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,29132,-0.217597762611918,0.00287832263033168,-0.223239274967368,-0.211956250256468,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,29409,-0.265529793517651,0.00445064700225619,-0.274253061642073,-0.256806525393228,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,29381,-0.386644939831278,0.00971872128429899,-0.405693633548504,-0.367596246114052,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29271,0.0938186850177483,0.00196395401660463,0.0899693351452033,0.0976680348902934,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,24669,-0.167522412209528,0.0027383545261306,-0.172889587080744,-0.162155237338313,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,29038,-0.147968604066665,0.00281351886270313,-0.153483101037563,-0.142454107095767,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,23848,-0.316003946630761,0.00670850403624125,-0.329152614541793,-0.302855278719728,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,29122,-0.156540096879515,0.00372073822338043,-0.163832743797341,-0.14924744996169,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,29034,-0.322206744376604,0.00620571595158134,-0.334369947641703,-0.310043541111505,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,24653,-0.246889275692807,0.00640357525467309,-0.259440283191966,-0.234338268193647,1.1125369694455e-308
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,28727,0.142179229369233,0.0037668215032738,0.134796259222816,0.14956219951565,2.49385918674485e-304
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,28631,-0.209529490693272,0.00558305129689723,-0.220472271235191,-0.198586710151353,6.03970452679535e-301
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,23940,-0.212906834236941,0.00567364363039659,-0.224027175752518,-0.201786492721364,1.65836715667071e-299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29314,-0.123515830982191,0.00331171840978094,-0.130006799065362,-0.117024862899021,1.70383902616681e-297
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,29132,0.0702800588808945,0.00188983265942873,0.0665759868684141,0.0739841308933748,8.78168450735336e-296
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29445,0.160632554424256,0.00436988972875989,0.152067570555887,0.169197538292625,2.94067748015693e-289
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,29091,-0.262442001012351,0.00714729076117223,-0.276450690904249,-0.248433311120454,1.42561616167397e-288
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,29120,-0.216151665127997,0.00592215418485857,-0.22775908733032,-0.204544242925675,3.14744537537327e-285
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24119,0.0778456299740505,0.00214891670381974,0.0736337532345638,0.0820575067135371,7.59377942228223e-280
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,27142,-0.102614664206499,0.00285820984171051,-0.108216755496251,-0.0970125729167459,8.20204412788023e-276
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,24683,0.128747416471508,0.00362607774508107,0.121640304091149,0.135854528851867,2.37428719729299e-269
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24538,-0.212531810477207,0.00598948232552239,-0.224271195835231,-0.200792425119183,5.42250391017501e-269
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28612,-0.128708203933879,0.00364016924515693,-0.135842935654386,-0.121573472213371,4.54521916060171e-268
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24579,-0.18598872844977,0.00536135850355091,-0.19649699111673,-0.17548046578281,1.77027994381225e-257
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,29230,-0.0742486959373121,0.00215883999786426,-0.0784800223331261,-0.0700173695414982,3.80529773519109e-254
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,23979,-0.124318297846079,0.00360919000480422,-0.131392310255495,-0.117244285436663,8.2108802767816e-254
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,29314,0.0672119241409797,0.00195629441924514,0.0633775870792593,0.0710462612027002,1.21589450189545e-253
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23567,-0.0778426450100422,0.0022609327115283,-0.0822740731246377,-0.0734112168954467,1.73723025322815e-253
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24315,-0.062256911397238,0.00184051474357774,-0.0658643202946504,-0.0586495024998257,3.95659311158241e-245
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,29507,-0.123750145571011,0.00368161034680125,-0.130966101850741,-0.11653418929128,4.21590330808863e-243
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29034,-0.18858553502717,0.00561029097608738,-0.199581705340301,-0.177589364714039,4.80181556215721e-243
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,29231,-0.0428795724670171,0.0012837997368211,-0.0453958199511865,-0.0403633249828478,4.44750988720693e-240
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29034,-0.160394667471406,0.00480312483122352,-0.169808792140605,-0.150980542802208,5.91125701531439e-240
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,29172,-0.144035802820515,0.00432142895636489,-0.15250580357499,-0.13556580206604,4.30337578121925e-239
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,28491,-0.180027702423166,0.00540106783044145,-0.190613795370831,-0.169441609475501,5.25640648234642e-239
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,24669,0.138814785110142,0.00416598862058703,0.130649447413791,0.146980122806493,3.66078925574492e-238
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,29034,-0.131681100602056,0.00396472481229349,-0.139451961234151,-0.12391023996996,1.951937655584e-237
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFM,Afamin,24699,-0.0456595810524078,0.00137273540110831,-0.0483501424385801,-0.0429690196662355,2.38520202874885e-237
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,29226,-0.0773818168052383,0.00234196558112685,-0.081972069344247,-0.0727915642662297,4.42574625648985e-235
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,28725,-0.342988669734409,0.010384182622184,-0.36334166767389,-0.322635671794929,7.56061458363635e-235
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,29409,-0.0782236880477259,0.00238604327368428,-0.0829003328641471,-0.0735470432313047,1.49079003236044e-231
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,29034,-0.185738679149627,0.00567407087464695,-0.196859858063935,-0.174617500235319,7.97667915963627e-231
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29409,-0.0752091703610898,0.00231259937188958,-0.0797418651299934,-0.0706764755921862,5.84932390721816e-228
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,29293,-0.1365558395469,0.00421782910861053,-0.144822784599776,-0.128288894494023,5.82935085141772e-226
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29346,-0.0715627836243125,0.0022182999021016,-0.0759106514324316,-0.0672149158161933,2.12661116898855e-224
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,29071,-0.0675349236382896,0.00210048628955581,-0.071651876765819,-0.0634179705107602,6.69791678264094e-223
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29132,0.0719314760744607,0.00223885442196158,0.067543321407416,0.0763196307415054,1.35811174345057e-222
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,29317,-0.109855373291523,0.00342058518795101,-0.116559720259907,-0.103151026323139,1.90884508244217e-222
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28491,-0.1857927633349,0.005803773130312,-0.197168158670311,-0.174417367999488,6.06940357046624e-221
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,28467,-0.115600044291846,0.00364128215985707,-0.122736957325166,-0.108463131258526,2.17181376871463e-217
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29034,-0.193920003797054,0.00613296126617599,-0.205940607878759,-0.181899399715349,9.23072304541148e-216
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28491,-0.132258013644163,0.00418337102322415,-0.140457420849682,-0.124058606438643,1.22570882826102e-215
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29280,0.0851213947945341,0.00269534038655472,0.0798385276368869,0.0904042619521813,2.78472685954727e-215
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29409,-0.0822354024222897,0.00261288968814188,-0.0873566662110478,-0.0771141386335316,7.25620432883155e-214
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,24067,-0.0836224082567734,0.00266128544194063,-0.088838527722977,-0.0784062887905697,1.99719467632998e-212
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,29409,0.0788549888092488,0.00251819553511269,0.0739193255604279,0.0837906520580697,9.09538848543359e-212
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,24653,-0.0626709844489424,0.00200363672833942,-0.0665981124364877,-0.0587438564613971,1.19597027196928e-210
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29070,-0.119012774217716,0.0038131439539883,-0.126486536367533,-0.111539012067899,2.24618965792166e-210
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28491,-0.138822810167711,0.00448435742226074,-0.147612150715342,-0.13003346962008,5.51153268649801e-207
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,29132,0.0817402135608144,0.00264170920867259,0.0765624635118161,0.0869179636098127,7.28021103314609e-207
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29409,-0.0749452459731725,0.00242293813150263,-0.0796942047109177,-0.0701962872354274,9.32122679486825e-207
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,24539,-0.157557395984616,0.00509160484659774,-0.167536941483947,-0.147577850485284,2.77516990555336e-206
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,29390,0.0777689658613255,0.00253833945603045,0.0727938205275059,0.0827441111951452,6.04093889919774e-203
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,24441,-0.0545712778267974,0.00178951159862594,-0.0580787205601042,-0.0510638350934905,1.73183112973309e-200
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,28458,-0.128050120884298,0.00421008813475796,-0.136301893628424,-0.119798348140173,5.55831116126046e-200
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29507,0.0733440008421197,0.00241227512076824,0.0686159416054139,0.0780720600788254,5.87317340985623e-200
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29359,-0.09061712274747,0.00298095242976037,-0.0964597895098003,-0.0847744559851397,7.21382688575136e-200
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29172,-0.0654689373297399,0.00215388608280214,-0.0696905540520321,-0.0612473206074477,8.23940410836321e-200
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29034,-0.225881811505609,0.00748655775021271,-0.240555464696026,-0.211208158315192,6.17054372169583e-197
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,29245,-0.0694122788091514,0.00231008134645911,-0.0739400382482112,-0.0648845193700915,2.21080236813779e-195
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,28790,-0.100171931004328,0.0033587477061142,-0.106755076508312,-0.0935887855003445,1.62143598604669e-192
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28631,-0.115598402082047,0.00389727080369154,-0.123237052857282,-0.107959751306811,1.85451808584083e-190
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29034,-0.170477039565109,0.00576269311887816,-0.181771918078111,-0.159182161052108,1.62282439321339e-189
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,29132,-0.0672935913261325,0.00228014760068272,-0.0717626806234706,-0.0628245020287943,1.18788871150099e-188
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,24602,-0.0922379353391835,0.00313655063820857,-0.0983855745900723,-0.0860902960882947,7.56833626740612e-187
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,23979,-0.133681130694642,0.00454644224148708,-0.142592157487956,-0.124770103901327,1.02395757949457e-186
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,29470,-0.0580748806174481,0.00201026874420497,-0.0620150073560898,-0.0541347538788064,5.49161569680292e-181
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,29470,-0.0921821597373373,0.00321481429402291,-0.0984831957536222,-0.0858811237210524,2.26971610316272e-178
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,29367,-0.0406103885730729,0.00142562299704737,-0.0434046096472857,-0.03781616749886,4.35399659309408e-176
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,29145,-0.110063109665472,0.00386438192641666,-0.117637298241249,-0.102488921089696,5.16077570487075e-176
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,29423,-0.101172442684916,0.00356121554005283,-0.108152425143419,-0.0941924602264121,3.59612842476922e-175
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,29130,0.0906271518625063,0.00319493136389986,0.0843650863892625,0.09688921733575,1.26780263686813e-174
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28629,-0.157799830608014,0.00557116955191597,-0.16871932292977,-0.146880338286259,4.38586902523683e-174
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29122,-0.0556218735381247,0.00196401341357784,-0.0594713398287373,-0.0517724072475121,4.44825381630268e-174
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,29127,0.355670494092633,0.012568138031506,0.331036943550882,0.380304044634385,7.96211106517084e-174
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,23979,-0.108375672962829,0.00383157365768754,-0.115885557331896,-0.100865788593761,3.70074579571333e-173
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29079,-0.100230301427858,0.00356462137860526,-0.107216959329924,-0.0932436435257916,1.173445348432e-171
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,24539,-0.221386506971571,0.00786781835273935,-0.23680743094294,-0.205965583000202,1.76762109340782e-171
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,29507,-0.100385596687119,0.00357354251372368,-0.107389740014017,-0.0933814533602205,2.26425168167008e-171
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23979,-0.114317341988049,0.00406916126807886,-0.122292898073484,-0.106341785902615,6.88763629324331e-171
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29256,-0.0711088202787001,0.00254272127611259,-0.0760925539798808,-0.0661250865775194,7.34439976597578e-170
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,29132,-0.11107941451112,0.00397890570177002,-0.118878069686589,-0.103280759335651,2.81795648919675e-169
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,28908,-0.0648332293098804,0.00232643283034605,-0.0693930376573586,-0.0602734209624021,1.11060842376943e-168
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24103,-0.0935148908151728,0.00335892059423343,-0.10009837517987,-0.0869314064504753,6.34204163809972e-168
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28467,-0.104111401209421,0.00374682881985665,-0.11145518569634,-0.096767616722502,1.096969912127e-167
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,24648,-0.0551482464515078,0.00199832893132385,-0.0590649711569026,-0.0512315217461131,3.90685531178695e-165
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,29280,-0.132945117807172,0.00483072690367124,-0.142413342538368,-0.123476893075977,1.24203503919828e-164
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24378,-0.0620084526831137,0.00225601017608267,-0.0664302326282357,-0.0575866727379916,8.16109146904794e-164
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24119,-0.0731115815654965,0.00266484171791616,-0.0783346713326122,-0.0678884917983808,3.3127936373842e-163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,28853,-0.140936317394987,0.00514964251987557,-0.151029616733943,-0.130843018056031,7.92491614784436e-163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29034,-0.076863909349234,0.00281122011201099,-0.0823739007687755,-0.0713539179296924,1.55496389820607e-162
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,29409,-0.0553388580111257,0.00202873687711852,-0.059315182290278,-0.0513625337319734,8.14810224406747e-162
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,29470,-0.066292872045276,0.00243967353937873,-0.0710746321824583,-0.0615111119080936,1.30478642327168e-160
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29280,0.0640901193155574,0.00236064142669265,0.0594632621192398,0.068716976511875,2.49879089755387e-160
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24119,-0.095544604053754,0.00351777845548075,-0.102439449826496,-0.0886497582810118,4.8788705901727e-160
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,29198,0.0378632038429587,0.0014056971225868,0.0351080374826886,0.0406183702032288,7.20227956502856e-158
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24529,-0.100402462506996,0.00372391000616325,-0.107701326119076,-0.0931035988949158,8.35511823378198e-158
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29256,-0.042054293532975,0.00156719422895005,-0.0451259942217171,-0.0389825928442329,1.0250196476106e-156
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28337,-0.104840249031248,0.00391272931907604,-0.112509198496637,-0.0971712995658587,3.31307263344636e-156
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,29409,-0.24315676416415,0.00908799875711078,-0.260969241728087,-0.225344286600213,7.79678869335127e-156
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,24293,-0.0452364247452464,0.00169465027077558,-0.0485579392759665,-0.0419149102145262,9.54164810152284e-155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,28908,-0.0682270708464086,0.00256999587949332,-0.0732642627702155,-0.0631898789226016,1.90495315950157e-153
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,29132,-0.0441709819451136,0.00166843592829408,-0.04744111636457,-0.0409008475256572,1.2257897211355e-152
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28612,-0.102632086555776,0.00389763444789466,-0.110271450073649,-0.094992723037902,5.2387385258277e-151
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29381,-0.0973840829826823,0.00370708946035851,-0.104649978324985,-0.0901181876403797,2.33312093179452e-150
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28612,-0.171311083281079,0.00652291298803251,-0.184095992737623,-0.158526173824536,3.08220815976307e-150
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,29470,-0.142782604706914,0.00545371414546683,-0.153471884432029,-0.132093324981799,2.25670705265232e-149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,29470,-0.056274403815072,0.00215328408147967,-0.0604948406147721,-0.0520539670153718,7.4363360812356e-149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,23979,-0.112100362519114,0.00428888013206934,-0.12050656757797,-0.103694157460258,1.65064929897272e-148
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24602,-0.107270756950871,0.00411773689511448,-0.115341521265295,-0.0991999926364463,1.32309847967973e-147
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24653,-0.1220051010084,0.00469540745855718,-0.131208099627172,-0.112802102389628,7.16444087323737e-147
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,29271,-0.0762172982684574,0.0029486806817038,-0.0819967124045968,-0.0704378841323179,1.11182524907473e-145
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,28986,-0.0474882011899401,0.00183724573713684,-0.0510892028347284,-0.0438871995451519,1.16597834048263e-145
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,23535,0.0795434823091186,0.00308038808583641,0.0735059216608793,0.085581042957358,5.18915069108797e-145
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,24653,-0.103685281961714,0.00402328510312627,-0.111570920763841,-0.0957996431595864,1.53103843816465e-144
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,29122,-0.0874702485896922,0.00340144969766157,-0.0941370899971088,-0.0808034071822755,3.2012320213755e-144
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24683,-0.0406413588211877,0.001579113021991,-0.0437364203442901,-0.0375462972980854,3.62014595756884e-144
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,29264,-0.119074304616815,0.00463308785031839,-0.128155156803439,-0.109993452430191,4.55664798822925e-144
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24669,-0.0599597793489974,0.00233785390914185,-0.0645419730109154,-0.0553775856870793,3.41587047948504e-143
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29231,0.0535281289181714,0.00209460757582903,0.0494226980695465,0.0576335597667963,1.77110034339847e-142
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,29172,-0.114580738448295,0.00451617123253803,-0.12343243406407,-0.10572904283252,1.75740385093112e-140
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,29034,-0.130784956499925,0.00515542195374969,-0.140889583529275,-0.120680329470576,1.91453751342206e-140
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,29470,-0.0589173683162227,0.00233024734832931,-0.0634846531189481,-0.0543500835134972,1.48858548502232e-139
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28297,-0.0350405834840024,0.001395345220599,-0.0377754601163764,-0.0323057068516284,1.1735363159263e-137
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,29409,-0.0818168180947732,0.00327718912171137,-0.0882401087733275,-0.0753935274162189,3.80328431600384e-136
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,24699,-0.0354084763822685,0.00141710856835537,-0.038186009176245,-0.032630943588292,4.21991157979319e-136
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEP,Leptin,29172,-0.119018815101531,0.00476893484140484,-0.128365927390685,-0.109671702812378,4.80020569880201e-136
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29280,-0.0753985610244858,0.00302451978546516,-0.0813266198039975,-0.0694705022449741,9.4099924014402e-136
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29034,-0.063600303908378,0.00255503502168916,-0.0686081725508887,-0.0585924352658672,2.38508690053933e-135
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24119,-0.13415262201838,0.00538924190337381,-0.144715536148993,-0.123589707887767,4.53753652844698e-135
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,28908,-0.129972323235689,0.00523258397101266,-0.140228187818873,-0.119716458652504,8.83223173871932e-135
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,29381,0.0382146888260388,0.00154091750483705,0.0351944905165582,0.0412348871355195,2.17167608689309e-134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29034,-0.0554386351460289,0.00226143883824869,-0.0598710552689963,-0.0510062150230615,2.2355012803055e-131
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23848,-0.119159658974026,0.00485806488192456,-0.128681466142598,-0.109637851805454,3.13042219899927e-131
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,29122,-0.0695246759914031,0.00285906537210364,-0.0751284441207262,-0.0639209078620799,2.51710988754669e-129
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,24119,-0.0472258220216407,0.00194278017709297,-0.051033671168743,-0.0434179728745385,5.70839977975585e-129
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,29289,-0.102810575959627,0.00425715904279906,-0.111154607683513,-0.0944665442357404,1.32426084945184e-127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,24390,-0.0466189312769802,0.00194566336043903,-0.0504324314634407,-0.0428054310905197,2.02968008808385e-125
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29423,-0.0345947393170567,0.00145773917667269,-0.0374519081033352,-0.0317375705307782,2.45203250198162e-123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28491,-0.114426844959876,0.00482649383767478,-0.123886772881718,-0.104966917038033,4.64436743262505e-123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,29034,-0.0600576530329703,0.00253655222390175,-0.0650292953918177,-0.0550860106741229,9.12480614247241e-123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24529,-0.117024521393439,0.0049495309783463,-0.126725602110998,-0.10732344067588,3.21000342912777e-122
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,24669,-0.189599269181883,0.0080364615522563,-0.205350733824305,-0.173847804539461,1.03056247971598e-121
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28491,-0.184907176871668,0.00784348948972577,-0.20028041627153,-0.169533937471805,1.03095252003721e-121
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,29173,-0.0528666253641943,0.00225198683836898,-0.0572805195673975,-0.0484527311609911,9.5782791545273e-121
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,29438,0.0900123169538171,0.00384408673584193,0.082477906951567,0.0975467269560673,3.71316781251883e-120
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29122,-0.106373077314599,0.0045516539363148,-0.115294319029776,-0.0974518355994215,1.08874491913654e-119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29034,-0.0723675929397833,0.00310228569738899,-0.0784480729066658,-0.0662871129729009,2.94564286102337e-119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,28908,-0.0933344379143382,0.00400113869396814,-0.101176669754516,-0.0854922060741606,2.9927084909287e-119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29507,-0.0654040761605595,0.00280876811084565,-0.0709092616578169,-0.059898890663302,7.32902799545357e-119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,29172,-0.0436425048824404,0.00187699207997359,-0.0473214093591887,-0.0399636004056922,1.65558439245489e-118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,29470,-0.0433950993259241,0.00186701414955746,-0.0470544470590567,-0.0397357515927915,1.95040424409417e-118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,24683,-0.0457291617172274,0.00196682439896931,-0.0495841375392073,-0.0418741858952476,2.64765828816454e-118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,24119,-0.105640220109147,0.00454635361542769,-0.114551073195385,-0.0967293670229089,3.89640443719665e-118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29132,-0.0878126578087531,0.00378438193687624,-0.0952300464050306,-0.0803952692124757,4.8990134736116e-118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,29122,-0.0648894600262268,0.00279896152439918,-0.0703754246140492,-0.0594034954384045,7.83723876542523e-118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,29381,-0.0396251775956499,0.00170983742303657,-0.0429764589448016,-0.0362738962464982,9.32968250393951e-118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28491,-0.135696603515177,0.00587369576883552,-0.147209047222095,-0.12418415980826,5.22332740893158e-117
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24653,-0.119335915249329,0.00517449196101183,-0.129477919492912,-0.109193911005746,1.89361166374994e-116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29247,-0.0382903201476544,0.00166497028509793,-0.0415536619064463,-0.0350269783888624,5.28406810175176e-116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29034,-0.203400193370086,0.00884525171332329,-0.2207368867282,-0.186063500011972,5.64878932710572e-116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,24262,-0.0455647653321422,0.00199689753501705,-0.0494786845007756,-0.0416508461635087,4.8551282372679e-114
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,29256,-0.0869331509766277,0.00381843031842219,-0.0944172744007351,-0.0794490275525202,9.57036605676156e-114
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELN,Elastin,24653,-0.0570619943959234,0.00250575357277836,-0.061973271398569,-0.0521507173932778,1.28324939096124e-113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29023,0.102116653383493,0.00448828066349064,0.0933196232830515,0.110913683483935,1.36013429908619e-113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,23974,-0.135615245622156,0.00595860683793906,-0.147294115024517,-0.123936376219796,1.84297328883221e-113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,24669,0.0613953786436502,0.00270200711298016,0.0560994447022091,0.0666913125850913,3.93295201834587e-113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,29507,-0.0953559935621893,0.00420597951898847,-0.103599713419407,-0.0871122737049719,7.89744627256245e-113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,29034,-0.112384128399638,0.00497129404825529,-0.122127864734218,-0.102640392065057,3.47883698751976e-112
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,29089,-0.147102555932597,0.00653760960153842,-0.159916270751613,-0.134288841113582,3.61917207623832e-111
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29172,-0.0542596725085704,0.0024167303232551,-0.0589964639421504,-0.0495228810749904,1.07088381288737e-110
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29034,-0.0951998102275416,0.00424841211498434,-0.103526697972911,-0.0868729224821723,2.81938683370498e-110
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,24119,-0.0644104110201147,0.00287390075929052,-0.0700432565083241,-0.0587775655319053,3.99541915703767e-110
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29256,-0.145347426070039,0.00650202719262303,-0.15809139936758,-0.132603452772498,9.15581296465823e-110
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,29034,-0.180547818757224,0.0081084660591873,-0.196440412233232,-0.164655225281217,6.37814867858779e-109
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,28908,-0.0663406556473121,0.00298158786716086,-0.0721845678669474,-0.0604967434276769,9.23617527672546e-109
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,29169,0.0831071601468533,0.00373964954125563,0.0757774470459922,0.0904368732477143,1.63301340586825e-108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,28908,-0.139855262801695,0.00630685500723964,-0.152216698615885,-0.127493826987505,4.76644875085035e-108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,29040,-0.04866974871998,0.00219675842158977,-0.0529753952262959,-0.044364102213664,7.28670103881121e-108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,29470,-0.0652428531066999,0.00294537250443241,-0.0710157832153874,-0.0594699229980124,7.7675452063274e-108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,23979,-0.0955322388129637,0.00431168372759565,-0.103983138919051,-0.0870813387068763,1.08722178375373e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29034,-0.0695915903242485,0.00314616587198604,-0.0757580754333412,-0.0634251052151559,1.59055182026348e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,28882,-0.0583024877071104,0.00263823029939913,-0.0634734190939327,-0.0531315563202881,2.50732199865632e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29095,-0.0313429381610451,0.00141986831350773,-0.0341258800555203,-0.02855999626657,4.21542768231274e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29034,-0.106468644346044,0.00482922776449199,-0.115933930764448,-0.0970033579276398,7.7502399964719e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28248,-0.158840598906135,0.00720392571609622,-0.172960293309684,-0.144720904502586,7.7690382390717e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29381,-0.104820553759973,0.0047582429362517,-0.114146709915026,-0.0954943976049198,1.10621928510462e-106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29132,0.0423323766073312,0.00192226532182317,0.0385647365765578,0.0461000166381046,1.31324438893041e-106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29445,-0.0601187158642603,0.00273305991189555,-0.0654755132915756,-0.054761918436945,2.22523245578605e-106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,29122,-0.0850418528424427,0.00388018968200847,-0.0926470246191793,-0.0774366810657061,1.28241023477506e-105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,24551,-0.170954219619735,0.00779498367566705,-0.186232387624043,-0.155676051615428,1.35103188649935e-105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,23974,-0.133541274906525,0.00608911018306753,-0.145475930865337,-0.121606618947713,1.43272957602631e-105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,23979,0.0950768810026306,0.00434941921472338,0.0865520193417728,0.103601742663488,6.66526147043766e-105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,28860,-0.138762899108356,0.00636548849040105,-0.151239256549542,-0.12628654166717,1.6477666691799e-104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,24653,-0.106580388477639,0.00488615715230308,-0.116157256496153,-0.0970035204591248,1.71331447308801e-104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29122,-0.0794318506767409,0.00364662826534053,-0.0865792420768083,-0.0722844592766735,2.33256582971425e-104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24579,-0.0735708922552289,0.00338173062724589,-0.0801990842846309,-0.066942700225827,5.88780228021377e-104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24529,-0.0883949870007971,0.00406934253920846,-0.0963708983776457,-0.0804190756239485,1.20298285652386e-103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29034,-0.150577963334602,0.00694415900729241,-0.164188514988895,-0.136967411680308,1.92248372773682e-103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,29280,-0.0826273311022098,0.00381442839121721,-0.0901036107489955,-0.0751510514554241,3.0503206875349e-103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,23848,-0.0965755605705365,0.00445523069304294,-0.105307812728901,-0.0878433084121723,3.36683348961299e-103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,28467,-0.0794716047977479,0.00367688969514344,-0.0866783086002291,-0.0722649009952668,8.948391707523e-103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28467,-0.0796727015446653,0.00369088889858956,-0.0869068437859008,-0.0724385593034297,1.60711240758933e-102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,24653,-0.14062727450577,0.00652504140270176,-0.153416355655065,-0.127838193356474,4.45305656973809e-102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29122,-0.149573992784514,0.00695009564180365,-0.163196180242449,-0.135951805326579,6.15908245667334e-102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,29409,-0.0995006740527135,0.00462695191711669,-0.108569499810262,-0.0904318482951648,8.59930429358269e-102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29507,0.037754896314692,0.00175689839080723,0.0343113754687098,0.0411984171606741,1.17673804844124e-101
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,29381,-0.0567445228646969,0.00264065490661641,-0.0619202064816651,-0.0515688392477288,1.2037205343777e-101
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,29231,-0.0504489415295827,0.0023479568275983,-0.0550509369116753,-0.04584694614749,1.28068027285829e-101
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,29409,-0.0406704735513422,0.00189541502899238,-0.0443854870081673,-0.0369554600945172,2.34297823584517e-101
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,29271,0.0657817603861412,0.003075487259097,0.0597538053583111,0.0718097154139714,9.99637978736045e-101
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29034,-0.105582879906228,0.0049466239038101,-0.115278262757696,-0.0958874970547606,2.59785123953767e-100
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,29122,-0.135041682274163,0.00634463377294672,-0.147477164469139,-0.122606200079188,9.13539140973872e-100
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29289,-0.0878967041617144,0.00413354587820528,-0.0959984540829967,-0.079794954240432,1.38108415056712e-99
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,24539,-0.161957115025856,0.00763941331434601,-0.176930365121974,-0.146983864929738,7.33764721402249e-99
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28491,-0.107755118358954,0.00509514882507402,-0.117741610056099,-0.097768626661809,1.62988536903633e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29507,-0.100685662754622,0.00477588485545127,-0.110046397071306,-0.0913249284379371,6.13986370865982e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28664,-0.0658567387809804,0.00312535614911963,-0.0719824368332549,-0.0597310407287059,7.99177587266259e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,28776,-0.0570925860842074,0.00271035908193089,-0.0624048898847919,-0.0517802822836228,9.21598194158348e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,29172,-0.0530097308802578,0.00252717524234863,-0.0579629943552611,-0.0480564674052544,5.67632654820766e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24539,-0.1218345102202,0.00580926396316267,-0.133220667587999,-0.110448352852402,8.29228018441141e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,29122,-0.110157259846884,0.00525643263607504,-0.120459867813591,-0.0998546518801771,8.47469564701312e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28291,-0.129253732083756,0.00617381099876133,-0.141354401641328,-0.117153062526184,1.36809181165988e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24119,-0.0327421974523074,0.00156476681883942,-0.0358091404172327,-0.0296752544873821,2.29827892235005e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28491,-0.0952164842491606,0.0045613739846265,-0.104156777259029,-0.0862761912392927,4.78981684047585e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23979,-0.12627239615278,0.0060489165022166,-0.138128272497124,-0.114416519808435,6.42806041631568e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,24119,-0.0683856261559489,0.00327776282282409,-0.0748100412886841,-0.0619612110232137,8.08349435214264e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,29381,-0.0903306974790642,0.00433609596596398,-0.0988294455723536,-0.0818319493857747,1.08809150797545e-95
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,24602,-0.0649657264919299,0.00313710338668244,-0.0711144491298275,-0.0588170038540323,1.84736971404062e-94
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28631,-0.103548391398603,0.00500817242773576,-0.113364409356965,-0.0937323734402408,2.79552895336357e-94
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,29507,-0.0648954857304653,0.00314407219250701,-0.071057867227779,-0.0587331042331515,5.48385977534644e-94
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,29369,-0.0847545961530018,0.00411679685292891,-0.0928235179847425,-0.0766856743212612,1.6279723391858e-93
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,29381,-0.0635966500616143,0.00310094420425369,-0.0696745007019515,-0.057518799421277,8.04347432532159e-93
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,29507,-0.088555810261711,0.00433829142362743,-0.0970588614520208,-0.0800527590714012,5.59201946539779e-92
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29122,-0.154483178715304,0.00757093309872021,-0.169322207588796,-0.139644149841812,6.67513300316932e-92
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28491,-0.0720693585029501,0.00353234683646531,-0.0789927583024221,-0.0651459587034781,7.19241193938989e-92
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23974,-0.0650686957888045,0.00319323724275383,-0.071327440784602,-0.058809950793007,1.5967144176981e-91
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,28487,-0.0720556000121426,0.00353884324696755,-0.078991732776199,-0.0651194672480862,1.65393382849275e-91
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24539,-0.202903277963239,0.00999260372362136,-0.222488781261537,-0.183317774664941,6.45372236516683e-91
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,29256,-0.0580079145953674,0.00285968532021289,-0.0636128978229847,-0.0524029313677502,7.41314852396649e-91
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,29256,-0.11980999059107,0.00590700235351026,-0.13138771520395,-0.108232265978189,7.71859556451371e-91
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24529,-0.115413836834822,0.0056906552176713,-0.126567521061458,-0.104260152608187,1.0449960614549e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,23432,-0.033857539792421,0.00167102941074186,-0.037132757437475,-0.030582322147367,1.68020329066343e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24119,-0.0562661249364726,0.00277908687732381,-0.0617131352160273,-0.0508191146569179,2.16507136917303e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24539,-0.0397589911496563,0.0019656730783992,-0.0436117103833188,-0.0359062719159939,3.10918779395297e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,29132,0.0413625695041223,0.00204749150054239,0.0373494861630593,0.0453756528451854,3.93680145533639e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29059,-0.0280542264552493,0.00139045788837916,-0.0307795239164725,-0.0253289289940262,6.55026930157907e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29507,-0.0718211907138627,0.00356463196521788,-0.0788078693656897,-0.0648345120620356,1.11991564216182e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24539,-0.0860238023177412,0.00426672330459631,-0.09438657999475,-0.0776610246407324,1.13649082768627e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,24653,-0.117634200025853,0.00583661079707235,-0.129073957188115,-0.106194442863591,1.29677166206264e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29064,-0.0290829165686381,0.00144391108441261,-0.0319129822940868,-0.0262528508431894,1.30209339731154e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29256,-0.0356280380516232,0.0017710999023519,-0.0390993938602329,-0.0321566822430135,2.1402401125444e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,23940,-0.174096526275755,0.0086578449493089,-0.1910659023764,-0.157127150175109,3.39389551897503e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,24653,-0.0377719418236553,0.00188065566534502,-0.0414580269277315,-0.0340858567195791,5.209976855674e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24620,0.0702744434235942,0.00349936024479889,0.0634156973437884,0.0771331895034,5.47236567232324e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,29122,-0.131127497260197,0.00653898233708624,-0.143943902640886,-0.118311091879508,7.54693256069635e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",28992,-0.150113384196011,0.00748671198484818,-0.164787339686313,-0.135439428705708,7.98790079027686e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29381,-0.136443140926751,0.00683904738738252,-0.149847673806021,-0.123038608047482,5.67416830020769e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29132,-0.0333459725463522,0.00167230291189944,-0.0366236862536751,-0.0300682588390293,7.05364401417501e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,29127,-0.0426219871382573,0.00214069619831608,-0.0468177516869568,-0.0384262225895578,1.26956733841736e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,29122,-0.135155871811745,0.00679133322138726,-0.148466884925664,-0.121844858697826,1.5193439852915e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28491,-0.0909304387060801,0.00457131764403705,-0.0998902212883927,-0.0819706561237675,1.89421349511185e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,24529,-0.141191953428547,0.00709865749188078,-0.155105322112633,-0.12727858474446,2.43115208045236e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,28908,-0.0738053917410047,0.00371831527593278,-0.081093289681833,-0.0665174938001765,4.27093823322872e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29122,-0.0608239880634048,0.00306741774531552,-0.0668361268442232,-0.0548118492825864,6.2741794070212e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,29127,-0.0527665688606048,0.002661214975782,-0.0579825502131375,-0.047550587508072,6.40370681404488e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,29122,-0.078986365297942,0.00400170353536704,-0.0868297042272614,-0.0711430263686226,3.71434995771514e-86
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,24669,-0.0396563590301098,0.00201053436595119,-0.0435970063873742,-0.0357157116728455,6.14090969407194e-86
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24653,-0.0416632357699766,0.00211245246847345,-0.0458036426081846,-0.0375228289317687,6.34171849013517e-86
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29122,-0.053146343751671,0.00269845005084487,-0.0584353058513269,-0.047857381652015,8.60139615502884e-86
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29256,-0.0490061381789986,0.00248872434819881,-0.0538840379014682,-0.0441282384565289,9.22084203400116e-86
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28631,-0.119465495061757,0.00607189496202541,-0.131366409187327,-0.107564580936187,1.29726687878837e-85
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,24579,-0.183551806222952,0.00933220707623473,-0.201842932092372,-0.165260680353531,1.8216646651294e-85
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24539,-0.04212917026967,0.00214574308579074,-0.0463348267178198,-0.0379235138215201,3.58664265680225e-85
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29145,0.0477327561366305,0.00244279749518083,0.0429448730460761,0.0525206392271849,1.73904829720306e-84
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24602,-0.0873174597986233,0.00447255942657651,-0.0960836762747132,-0.0785512433225333,3.04783258939885e-84
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29172,-0.120601951904042,0.00620361717409515,-0.132761041565268,-0.108442862242815,1.18674410121339e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,23848,-0.103624703639913,0.00532657847355724,-0.114064797448086,-0.0931846098317412,1.19524273002062e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,23974,-0.110774463682266,0.00569571148261735,-0.121938058188196,-0.0996108691763358,1.31863520720654e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28467,-0.0389157373595057,0.00200293571137926,-0.042841491353809,-0.0349899833652023,1.51783123672598e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,24653,-0.0624069672725592,0.0032117721101887,-0.068702040608529,-0.0561118939365893,1.79075949794652e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24119,-0.115265445485816,0.00594498695996925,-0.126917619927356,-0.103613271044276,4.13421513361179e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28631,-0.0603235090513387,0.00313154138451661,-0.0664613301649912,-0.0541856879376861,3.62880824384978e-82
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,29034,-0.0720493522118567,0.0037415032320096,-0.0793826985465955,-0.0647160058771179,4.0332532839929e-82
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29271,-0.0398867726185164,0.00207197848095756,-0.0439478504411932,-0.0358256947958396,4.49812973076975e-82
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29145,-0.03812536059145,0.00198211659388915,-0.0420103091154727,-0.0342404120674273,6.12049605387682e-82
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24579,-0.0560262282431237,0.00291473761749182,-0.0617391139734076,-0.0503133425128397,9.71273872756479e-82
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,29122,-0.111875892714722,0.00582487283428478,-0.12329264346992,-0.100459141959524,1.04555672084326e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29122,-0.078375849172416,0.0040840927771324,-0.0863806710155955,-0.0703710273292365,1.41897610364402e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,28908,-0.0731175653645339,0.0038163619617676,-0.0805976348095984,-0.0656374959194694,2.60483218764274e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29470,-0.0518546902068234,0.00271255178646989,-0.0571712917083044,-0.0465380887053424,5.6916658265109e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,29271,-0.0468701687844392,0.00245187295138054,-0.0516758397691451,-0.0420644977997334,5.79021994446801e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24653,-0.102703517532046,0.00537040796381966,-0.113229517141132,-0.0921775179229594,6.15995314839851e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28491,-0.0908320500209875,0.00475946256590052,-0.100160596650152,-0.0815035033918224,1.08446571514322e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24185,-0.154121178057757,0.00807990328260182,-0.169957788491656,-0.138284567623857,1.6035592825497e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,24119,-0.0714161469935879,0.00374582609953401,-0.0787579661486745,-0.0640743278385012,1.91064478342558e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29034,-0.115079744181605,0.00604014991672474,-0.126918438018385,-0.103241050344824,1.94417525811047e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28491,-0.0693180520528114,0.00363988579416275,-0.0764522282093704,-0.0621838758962525,2.32924167801757e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,28908,-0.071873035686436,0.00377427667641744,-0.0792706179722142,-0.0644754534006578,2.34162156816146e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,29256,-0.0772916632114506,0.00406368330081173,-0.0852564824810416,-0.0693268439418596,3.5485813194761e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,24699,-0.0281119349035885,0.00147910122604037,-0.0310109733066277,-0.0252128965005494,5.66192276939617e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24475,-0.148291306922261,0.00780575223806972,-0.163590581308878,-0.132992032535645,6.70842819856662e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29388,-0.110815871299857,0.0058432738827881,-0.122268688110122,-0.0993630544895924,1.00148150910742e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28467,-0.106795405953534,0.00564707939944272,-0.117863681576442,-0.0957271303306266,2.80679333076194e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,23979,-0.0982862070848726,0.00519885522467188,-0.108475963325229,-0.0880964508445157,3.88400150211597e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,29337,-0.0502617716064028,0.00266334609902133,-0.0554819299604846,-0.045041613252321,5.7365261653807e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29034,-0.0376480487160806,0.0019965755746036,-0.0415613368423036,-0.0337347605898575,7.72869270942359e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,29377,-0.0762466864320358,0.00405417452509284,-0.0841928685012178,-0.0683005043628538,1.91679038235833e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,28459,-0.0531303355471124,0.00282676414765468,-0.0586707932765155,-0.0475898778177092,2.45653745272934e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,29231,0.0371021065844378,0.0019815490459246,0.0332182704544255,0.04098594271445,9.04638725563288e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,28467,-0.0864074172755594,0.00461521945062905,-0.0954532473987923,-0.0773615871523265,9.56736236799555e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29172,-0.103129562895673,0.00550956647489931,-0.113928313186476,-0.0923308126048707,1.00424913330896e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,29470,-0.101051270242571,0.00539992184092327,-0.111635117050781,-0.0904674234343614,1.08630604983725e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29172,-0.0569281149458902,0.00304216242948854,-0.0628907533076877,-0.0509654765840927,1.10652270634067e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29381,0.0612065827721008,0.00327218625432696,0.05479309771362,0.0676200678305817,1.27253855845838e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29122,-0.114755593969519,0.00613790118129832,-0.126785880284864,-0.102725307654174,1.51389474352519e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,24653,-0.0399025667569325,0.0021342360185733,-0.0440856693533362,-0.0357194641605288,1.82086238295535e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,29122,-0.108292738858209,0.00580223109762428,-0.119665111809553,-0.0969203659068654,2.74994285269662e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29228,0.0412923596804267,0.00221536275886454,0.0369502486730522,0.0456344706878012,4.33989352975641e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,28860,-0.068245861545548,0.00366210774702621,-0.0754235927297193,-0.0610681303613766,4.68337715833092e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29381,-0.0461623043808045,0.00247776971784146,-0.0510187330277737,-0.0413058757338352,5.05150078924258e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,28491,-0.0987881244318082,0.00530947953702353,-0.109194704324374,-0.0883815445392421,8.20838337192227e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29470,-0.0515724633839767,0.00277265155044141,-0.0570068604228418,-0.0461380663451115,8.78799822207623e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24602,-0.130115593068432,0.00699283249202217,-0.143821544752795,-0.116409641384068,9.49884461576556e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29172,0.035985223481601,0.00193969324525729,0.0321834247208967,0.0397870222423053,2.16436002397913e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,23848,-0.0898976342701671,0.00484707654107692,-0.0993979042906779,-0.0803973642496564,2.98185338604299e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,29122,-0.120705853363527,0.00654333427769679,-0.133530788547813,-0.107880918179241,1.4834131047631e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23848,-0.074280723040568,0.00402533507272368,-0.0821703797831064,-0.0663910662980296,1.64818503249957e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,29186,-0.0614316378569551,0.00333351968173154,-0.0679653364331489,-0.0548979392807613,2.08287597463776e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,23878,-0.0662772110063829,0.00359617868532444,-0.0733257212296188,-0.059228700783147,2.52167987788056e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29226,-0.113274173580532,0.00616044613861532,-0.125348648012218,-0.101199699148846,4.40618254556305e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,24539,-0.128810928674867,0.00700244311474768,-0.142535717179773,-0.115086140169962,4.59916140156164e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29280,0.0574720290163986,0.00312623375624192,0.0513446108541645,0.0635994471786328,4.69162526067193e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24579,-0.113824218643534,0.00619011460676439,-0.125956843272793,-0.101691594014276,5.22146809717332e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,24119,0.0299019132325644,0.00162751741952747,0.0267119790902905,0.0330918473748382,7.05500289896473e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23979,-0.0913541542454944,0.0049730455873454,-0.101101323596691,-0.0816069848942974,7.48133474145284e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29122,0.0513000353349403,0.00279587959691641,0.0458201113249842,0.0567799593448965,8.9773502571727e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28491,-0.0797559276460342,0.00434702933584078,-0.0882761051442821,-0.0712357501477863,9.37642148688372e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,29381,-0.0775199312523223,0.00423192036551315,-0.085814495168728,-0.0692253673359165,1.55067777351157e-74
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,29217,-0.0369382715685247,0.00202419974795903,-0.0409057030745244,-0.032970840062525,5.50373693887385e-74
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24579,-0.0905726321445549,0.00496277711530775,-0.100299675290558,-0.0808455889985517,6.3318136798631e-74
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29122,-0.135208074795058,0.00741495292726892,-0.149741382532505,-0.120674767057611,7.08830828730685e-74
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,29381,-0.0753317746211661,0.00413290073319273,-0.0834322600582239,-0.0672312891841084,8.00400670516245e-74
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,29470,-0.0489248265897431,0.00268788539910047,-0.05419308197198,-0.0436565712075062,1.26200577511314e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,24669,-0.0975569758972707,0.0053589643494554,-0.108060546022203,-0.0870534057723382,1.44449956190529e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29172,-0.0364602476657467,0.00200866374216658,-0.0403972286003932,-0.0325232667311002,3.165130345507e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,29122,-0.108814097427928,0.00599660656768484,-0.12056744630059,-0.0970607485552652,3.50308690290886e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29339,-0.0395506821892736,0.00218262106242701,-0.0438286194716306,-0.0352727449069167,5.47611700464668e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,29231,-0.0334642305900388,0.00184892666144209,-0.0370881268464653,-0.0298403343336123,8.07797281894794e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24579,-0.114560668732851,0.00633124512003168,-0.126969909168113,-0.102151428297589,1.0453329949143e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,29507,-0.0574337189434922,0.00317721481148691,-0.0636610599740066,-0.0512063779129779,1.19985771687236e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29127,-0.147470743474454,0.00815993636375604,-0.163464218747416,-0.131477268201492,1.30927312364407e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,24579,-0.0816185533050607,0.00452209166076445,-0.090481852960159,-0.0727552536499624,2.36513205439783e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,29127,-0.0384213157240122,0.00213134410031407,-0.0425987501606277,-0.0342438812873966,2.96931141380783e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24529,-0.0490135983446427,0.00271825508113109,-0.0543413783036597,-0.0436858183856258,3.24432477179801e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,23979,-0.0963323694159465,0.00534366031422749,-0.106805943631832,-0.0858587952000606,3.56168061725379e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,29470,-0.121243395099294,0.0067379638505575,-0.134449804246387,-0.108036985952202,5.27362844687435e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,29280,-0.0730887793761898,0.00406239646378842,-0.0810510764452151,-0.0651264823071645,5.54871147505638e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24653,-0.0993857321510813,0.00552451603642532,-0.110213783582475,-0.0885576807196877,6.74284203779376e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,23974,-0.0574781973933377,0.0031958142443158,-0.0637419933121966,-0.0512144014744787,7.52349149423449e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,29034,-0.131074904407658,0.0073216909059669,-0.145425418583353,-0.116724390231962,2.739930627457e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24539,-0.0655595994249639,0.0036632745342342,-0.072739617512063,-0.0583795813378649,3.5671909572779e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,23974,-0.0892613980098759,0.00499500753260663,-0.0990516127737849,-0.0794711832459669,5.82506568681279e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29120,-0.0782863571880033,0.00438379747871358,-0.086878600246282,-0.0696941141297247,5.98191125932895e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29507,0.0406235760975747,0.00227559986145671,0.0361634003691196,0.0450837518260298,6.61329596758822e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,28403,-0.088757418375777,0.00498070553684908,-0.0985196012280012,-0.0789952355235528,1.19494444262738e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,24653,-0.0954242631927162,0.00535595149125242,-0.105921928115571,-0.0849265982698615,1.45978826454983e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,29470,-0.0534307824910742,0.00300114858581256,-0.0593130337192668,-0.0475485312628815,1.55779542525563e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",28986,-0.0959791621646933,0.00541328542568102,-0.106589201599028,-0.0853691227303585,5.73754976899815e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29172,-0.0457357614616742,0.00257958722745539,-0.0507917524274867,-0.0406797704958616,5.74918301733651e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,29367,-0.0435590545573537,0.002457818832394,-0.0483763794688459,-0.0387417296458615,6.49262026826479e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28631,-0.0878744728572774,0.00496082900609553,-0.0975976977092246,-0.0781512480053302,7.76772919926973e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,28631,-0.059931777948002,0.00339046617620793,-0.0665770916533696,-0.0532864642426345,1.49027918657811e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29122,0.0442049863077222,0.00250155620556599,0.0393019361448128,0.0491080364706315,1.61981552907841e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,24539,-0.13188557806062,0.007460553656074,-0.146508263226525,-0.117262892894715,1.68142488274174e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,28467,-0.0776854324654203,0.0043989426874217,-0.0863073601327669,-0.0690635047980738,2.00120871846817e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24579,-0.079922012124923,0.00452452273985068,-0.0887900766950303,-0.0710539475548157,2.12748605357927e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29132,0.050514171041303,0.0028665658567127,0.0448957019621461,0.0561326401204598,3.83033765459868e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24539,-0.107664279084674,0.00611233366129878,-0.119644453060819,-0.095684105108528,5.09783563997965e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29034,0.0249045214193286,0.00141489060925147,0.0221313358251957,0.0276777070134615,5.45934074530027e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29317,-0.0912731516101337,0.00518905582477827,-0.101443701026699,-0.0811026021935683,6.70036566785367e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29470,-0.12428938839321,0.0070679490133399,-0.138142568459356,-0.110436208327064,7.23262320778073e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,23974,-0.154937248559714,0.00880568930743505,-0.172196399602287,-0.137678097517142,7.28183622460449e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,29122,-0.107430439475252,0.00611262299287512,-0.119411180541287,-0.0954496984092166,8.65735416390619e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,29216,0.0486805774444323,0.00278372919769958,0.0432244682169412,0.0541366866719235,3.96905386747963e-68
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,28491,-0.0787520142480349,0.0045129104634053,-0.0875973187563093,-0.0699067097397605,7.71432585173322e-68
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,29256,-0.0330827000408033,0.00189619008985988,-0.0367992326169287,-0.029366167464678,8.01823267276504e-68
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,24579,-0.0472286000693688,0.00270989620657999,-0.0525399966342656,-0.0419172035044721,1.28718302472652e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29132,-0.0573035913096582,0.00329337878002159,-0.0637586137185005,-0.0508485689008159,1.82340902475094e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24529,-0.142009782035318,0.00816910568811453,-0.158021229184023,-0.125998334886614,2.77550898209529e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,29132,-0.0555432236681457,0.00320082902752212,-0.0618168485620891,-0.0492695987742024,4.09387956849001e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,24602,-0.130054495789502,0.00750607527844999,-0.144766403335264,-0.11534258824374,7.40368742381891e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,28808,-0.044724497785417,0.00258506211698653,-0.0497912195347106,-0.0396577760361234,1.00391866156629e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28467,-0.0758653610420767,0.00438626092063539,-0.0844624324465221,-0.0672682896376313,1.10403532629145e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,29042,-0.0533147456246237,0.00308376755860459,-0.0593589300394887,-0.0472705612097587,1.23230421012896e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29034,-0.0747762388630381,0.00433097059620776,-0.0832649412316053,-0.0662875364944709,1.84042539774454e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,24651,-0.0693536550594308,0.00401801447058051,-0.0772289634217685,-0.061478346697093,2.28660714322294e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29143,-0.0615744992320704,0.00357216160541007,-0.0685759359786741,-0.0545730624854667,2.97256230329721e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28467,-0.104974601185437,0.00608975302970137,-0.116910517123651,-0.093038685247222,2.99597967991524e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,28908,-0.0709076608240175,0.00412950164466582,-0.0790014840475626,-0.0628138376004725,9.28895241220414e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24653,-0.0784732173240841,0.00456824728240637,-0.0874269819976006,-0.0695194526505676,9.38344595227935e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,29122,-0.0413969640903133,0.00241149378919449,-0.0461234919171345,-0.0366704362634921,9.97049878076047e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29034,-0.168551212299973,0.00982942988089824,-0.187816894866534,-0.149285529733413,1.37939312590368e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,28908,-0.053930816162291,0.00314794462051611,-0.0601007876185026,-0.0477608447060794,1.80282804793079e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,28467,-0.0426731339418299,0.00249774314025743,-0.0475687104967344,-0.0377775573869253,4.08028839210773e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24529,-0.0590992535658526,0.00345786146230084,-0.0658766620319623,-0.052321845099743,4.11117496982725e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,24538,-0.0718654980680202,0.00421255911236345,-0.0801221139282526,-0.0636088822077879,7.00043431942233e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29122,-0.068868208809208,0.00404009352257289,-0.0767867921134508,-0.0609496255049651,7.70529443522422e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,28168,-0.0490609807346062,0.00287900516913593,-0.0547038308661126,-0.0434181306030998,8.62840987760889e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNST,Consortin,29172,-0.131960155057281,0.00774777923667686,-0.147145802361167,-0.116774507753394,9.78613930522344e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28612,-0.116729032603172,0.00685587361573355,-0.13016654489001,-0.103291520316335,1.0959026587667e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,29409,0.0561550516468695,0.00330284720038001,0.0496814711341247,0.0626286321596144,1.61542209919295e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29132,-0.0621428253693116,0.00365817533831705,-0.0693128490324131,-0.0549728017062102,2.08205635536124e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29187,-0.0370676092643505,0.00218217857816447,-0.0413446792775529,-0.0327905392511482,2.10995211940912e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,29034,-0.0554314050830113,0.00326530457887534,-0.061831402057607,-0.0490314081084157,2.53427763771177e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24529,-0.0878793664353593,0.00517455619574615,-0.0980214965790217,-0.0777372362916968,2.56210555270999e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,28612,-0.0651343791962448,0.00384042021529737,-0.0726616028182276,-0.0576071555742619,3.33433935996883e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,29445,-0.063804136695713,0.00376475379572019,-0.0711830541353245,-0.0564252192561014,4.03061846841477e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,28853,-0.0749550562139288,0.00442804766345778,-0.0836340296343061,-0.0662760827935516,5.76540400785575e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,29007,-0.046881636637289,0.00277026103035056,-0.0523113482567761,-0.0414519250178019,6.15934098853332e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,24185,-0.156277333070391,0.00924140319642981,-0.174390483335394,-0.138164182805389,8.75611670227154e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,29314,-0.0820827879567085,0.00485975591470262,-0.0916079095495256,-0.0725576663638914,1.06219451682558e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,28908,-0.114170545387843,0.00676645379742364,-0.127432794830794,-0.100908295944893,1.4333340487361e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29034,-0.0926018057366817,0.00549263775265425,-0.103367375731884,-0.0818362357414793,1.79984040060227e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,29034,-0.0394376442152166,0.00233959494295787,-0.044023250303414,-0.0348520381270191,1.8814681664264e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,24669,0.0485795051830174,0.00288229991465945,0.0429301973502849,0.0542288130157499,2.20539346448509e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24579,-0.130320305016711,0.00773920888832202,-0.145489154437822,-0.1151514555956,2.86382899152932e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29034,-0.0651882419228358,0.00387345026923962,-0.0727802044505454,-0.0575962793951261,2.96186108302878e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29181,-0.047697571676021,0.00284401231117129,-0.0532718358059167,-0.0421233075461253,7.81044802785287e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28631,-0.0716675184727285,0.00427696098381626,-0.0800503620010083,-0.0632846749444486,1.00877065643588e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,29359,-0.0687422191169724,0.00410876698601217,-0.0767954024095563,-0.0606890358243886,1.52944964071022e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,23934,-0.0331105020423588,0.00197823195831363,-0.0369878366806535,-0.029233167404064,1.58779894050222e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,29168,-0.0681444831500837,0.00407680118580822,-0.0761350134742678,-0.0601539528258996,1.98544247438136e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,24529,-0.0532183022268286,0.00318559351578061,-0.0594620655177586,-0.0469745389358986,2.62506262940815e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28467,-0.0800484645137686,0.00480048911686164,-0.0894574231828174,-0.0706395058447198,3.92714824340233e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,24683,-0.087026916953443,0.00521854956211391,-0.0972552740951863,-0.0767985598116998,4.25615317890575e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,28908,-0.0795842153025099,0.00477539101294689,-0.0889439816878858,-0.070224448917134,4.55538024028721e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,24119,-0.138441273288735,0.00830425700720471,-0.154717617022856,-0.122164929554613,4.73427883225915e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,24636,0.0409414683217675,0.00247343425743234,0.0360935371772001,0.0457893994663349,3.29228945490922e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,28853,-0.131985537973589,0.0079789849569037,-0.147624348489121,-0.116346727458058,3.52212810480004e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29293,-0.121853477753763,0.00737122672562764,-0.136301082135994,-0.107405873371533,4.15787237950993e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29271,-0.147864580022689,0.00894720778474444,-0.165401107280788,-0.13032805276459,4.48840240771013e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,29034,-0.0645949044996668,0.00391579866535723,-0.072269869883767,-0.0569199391155667,7.42756979977939e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,24546,-0.087946483512327,0.00534258535257454,-0.0984179508033731,-0.0774750162212809,1.4680853657916e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,28908,-0.0458175246932966,0.0027893494659464,-0.0512846496465516,-0.0403503997400417,2.34572866708455e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24119,-0.0920403052862344,0.00560148611451644,-0.103019218070687,-0.0810613925017822,2.42744479677238e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,29381,-0.0762393328682465,0.00464257024115819,-0.0853387705409166,-0.0671398951955765,2.48250891694894e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,29172,0.0604791114015992,0.00368488821208854,0.0532567305059056,0.0677014922972927,2.89074657381082e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,29271,-0.0555840196824296,0.00339222030178549,-0.0622327714739292,-0.04893526789093,4.48114797307538e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,29470,-0.0581079581225815,0.00354700335467768,-0.0650600846977498,-0.0511558315474133,4.72197330214397e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,29359,-0.0331251280760739,0.00202292680889611,-0.0370900646215103,-0.0291601915306375,5.3405165043777e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,28908,-0.0715028705398686,0.0043696521647474,-0.0800673887827735,-0.0629383522969637,6.4843518920435e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,29507,0.031923037207723,0.00195200213004133,0.028097113032842,0.035748961382604,7.47625259333305e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,24699,-0.0200414521195434,0.00122541070059015,-0.0224432570927001,-0.0176396471463867,8.28728331516814e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,23848,-0.042777816854287,0.0026187520879448,-0.0479105709466588,-0.0376450627619152,1.17039750884504e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24653,-0.0855109639118301,0.00523854816537192,-0.095778518315959,-0.0752434095077011,1.38287582659193e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28467,-0.059495488007753,0.00364680812105132,-0.0666432319250136,-0.0523477440904924,1.45405812823107e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,29381,-0.0707632427427842,0.00433939701029262,-0.0792684608829577,-0.0622580246026107,1.60407263472409e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24653,-0.0696377250805148,0.00426932594690164,-0.078005603936442,-0.0612698462245875,1.68604031544493e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,29172,-0.141823730426915,0.00870697909879325,-0.15888940946055,-0.12475805139328,2.17963180986502e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,24119,-0.0817744482191129,0.00502550259379491,-0.0916244333029509,-0.0719244631352749,3.23338177682535e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29187,0.0392349321067052,0.00241528621929494,0.0345009711168872,0.0439688930965233,4.44698313360286e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,29122,0.0398458783425159,0.00245550789685018,0.0350330828646895,0.0446586738203422,5.88636946944848e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,29470,-0.0402064354270734,0.00248234422281519,-0.0450718301037912,-0.0353410407503557,9.51087272260642e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,28860,-0.060784740839028,0.00375545956437617,-0.0681454415852053,-0.0534240400928508,1.15435832343607e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,24579,-0.0442638070007185,0.00273660586002929,-0.049627554486376,-0.0389000595150611,1.52690015716645e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28467,-0.065910909820803,0.0040784367738577,-0.0739046458975641,-0.0579171737440419,1.73646140512562e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,28908,0.0393166566707745,0.0024336607178684,0.0345466816637525,0.0440866316777966,1.87887014911795e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29172,-0.0733050101976726,0.00453937794603755,-0.0822021909719062,-0.064407829423439,2.08022565826479e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24168,-0.0510082806024918,0.00315765698440455,-0.0571972882919248,-0.0448192729130589,2.15987606999455e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24602,-0.0732334496465703,0.00453575043327267,-0.0821235204957848,-0.0643433787973559,2.42583578314839e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,29388,-0.0306050192972226,0.00190230674709237,-0.0343335405215236,-0.0268764980729215,5.44994759074982e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29256,-0.109469159611071,0.0068049637498767,-0.122806888560829,-0.0961314306613124,5.61549533921508e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,28978,-0.0527270835797598,0.00328204453716801,-0.0591598908726091,-0.0462942762869105,7.94422693631531e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,24460,-0.0398154341255461,0.00247826154085246,-0.0446728267456169,-0.0349580415054753,8.7519748496742e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29226,-0.0597208650650419,0.00371997444656336,-0.0670120149803061,-0.0524297151497777,9.45671320573623e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,24301,-0.126249681824693,0.00786160545185395,-0.141658428510327,-0.110840935139059,9.8064205277535e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,29271,-0.121024179210715,0.00755116559331383,-0.13582446377361,-0.10622389464782,1.45129865524505e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),24220,0.204990690874271,0.0128143322192479,0.179874599724545,0.230106782023997,2.63893787621013e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,28491,-0.111920382158363,0.00701027239626585,-0.125660516055045,-0.0981802482616824,3.95475040143541e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,24529,-0.0948856873979698,0.00595002200872571,-0.106547730535072,-0.0832236442608674,5.77362370589267e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,23974,-0.0598493516615065,0.00375725482362083,-0.0672135711158033,-0.0524851322072096,7.80784145783079e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23948,-0.0912234470236929,0.00573442271949245,-0.102462915553898,-0.0799839784934877,1.0885285184477e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",24699,-0.0189346471227908,0.00119078250839744,-0.0212685808392498,-0.0166007134063318,1.19211439958459e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,29507,-0.0634048455687665,0.00398940337301783,-0.0712240761798814,-0.0555856149576515,1.21222776979432e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24185,-0.0607808917473566,0.00382703015695242,-0.0682818708549833,-0.0532799126397298,1.63166924860202e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24539,-0.123533420020504,0.00777897318390382,-0.138780207460956,-0.108286632580053,1.65693715927518e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,28865,-0.0322916257112686,0.0020345737177125,-0.0362793901979851,-0.0283038612245521,1.73349708352999e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24579,-0.0455393588168729,0.00286880653524444,-0.051162219625952,-0.0399164980077937,1.83263022747144e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29271,0.0232229666358718,0.00146467207356073,0.0203522093716927,0.0260937239000508,2.21630893620736e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28431,-0.0662475306771552,0.00418447735989956,-0.0744491063025583,-0.0580459550517521,3.27052037887008e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,24653,-0.0932398274595396,0.00589097091561077,-0.104786130454137,-0.0816935244649425,3.79851025151175e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,24653,-0.0523744601234972,0.00331814875671584,-0.0588780316866603,-0.0458708885603342,7.50427927627678e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,24602,-0.0626391342594625,0.00396901809619185,-0.0704184097279985,-0.0548598587909265,7.7801163715594e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,28853,-0.0719076406313932,0.00456824088586816,-0.0808613927676947,-0.0629538884950916,1.35473454448154e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29256,-0.0284983888890827,0.00181369274917175,-0.0320532266774594,-0.0249435511007061,2.08042036510109e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29226,0.0506800362151892,0.00322694386888655,0.0443552262321715,0.0570048461982068,2.34555181302283e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,29280,-0.112740416244506,0.00718642406171485,-0.126825807405468,-0.0986550250835453,3.07087644814968e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29247,0.0350933697214757,0.00223931878230871,0.0307043049081507,0.0394824345348008,3.97686037944114e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24539,-0.0450577629792881,0.00287500443355555,-0.0506927716690569,-0.0394227542895192,4.33518411712989e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,28908,-0.0798072254370847,0.00509690166923071,-0.0897971527087768,-0.0698172981653925,4.9355038438366e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24119,-0.0256841207554505,0.00164102719705534,-0.028900534061679,-0.022467707449222,6.07538015296007e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29280,-0.0472015638687289,0.00301720872751119,-0.0531152929746508,-0.0412878347628069,6.08631828556786e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,23974,-0.0508466018005366,0.00324983061163128,-0.0572162697993339,-0.0444769338017393,6.6244818045151e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,23979,-0.1154385683969,0.00737936045670224,-0.129902114892037,-0.100975021901764,6.88463428106104e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,23974,-0.104471230944116,0.00667901050471399,-0.117562091533355,-0.0913803703548766,7.07161890683122e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,28914,-0.0810147915218919,0.00518206982896409,-0.0911716483866615,-0.0708579346571223,7.20727205516779e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24579,-0.0891312650023097,0.00570351336383724,-0.100310151195431,-0.0779523788091887,8.69649706732864e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,29034,-0.0616922948593728,0.00394982231746615,-0.0694339466016065,-0.0539506431171392,9.03581296014835e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,24619,-0.0498541635795467,0.00319119242106088,-0.0561089007248261,-0.0435994264342674,9.3906618075599e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,24577,0.0213669500955015,0.00136908683406032,0.0186835399007433,0.0240503602902597,1.19963300704014e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,23848,-0.0482315412405315,0.00309033750710312,-0.0542886027544536,-0.0421744797266093,1.2125918997898e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,29388,-0.0266295583229959,0.00170958384222317,-0.0299803426537533,-0.0232787739922385,1.73433074147063e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,28491,-0.062347466168632,0.00400833837261313,-0.0702038093789537,-0.0544911229583103,2.48493556320676e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,23974,-0.0370175475908733,0.00238009588025659,-0.0416825355161763,-0.0323525596655704,2.79984747546323e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,23979,-0.0527651083849821,0.00339634288738037,-0.0594219404442477,-0.0461082763257166,3.64642100101553e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,29122,-0.066976004137991,0.00432296735341253,-0.0754490201506796,-0.0585029881253024,6.34736708392845e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29034,0.02662414087608,0.00171911587238218,0.023254673766211,0.0299936079859491,6.96799668397981e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29122,-0.0557917217823224,0.00360531077564974,-0.0628581309025959,-0.0487253126620489,8.40278079249317e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,24539,-0.0785237348735427,0.00507329336734944,-0.0884673898735476,-0.0685800798735378,8.79557394330976e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,29154,0.0428491054296876,0.00277027774148061,0.0374193610563856,0.0482788498029896,9.41715103966283e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24119,-0.0645724106012014,0.00417515384479647,-0.0727557121370025,-0.0563891090654003,1.06843632912636e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29470,-0.0613910523751915,0.00397799467006211,-0.0691879219285132,-0.0535941828218697,1.59982386318869e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29271,-0.114886022053746,0.00744933222947059,-0.129486713223509,-0.100285330883984,1.88142190940991e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24539,-0.0522107491361259,0.00338731022294562,-0.0588498771730993,-0.0455716210991525,2.35912254864872e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24137,-0.0719601799509763,0.00467005932929067,-0.081113496236386,-0.0628068636655666,2.56333125141625e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24539,-0.0845623670148146,0.00549611822856744,-0.0953347587428068,-0.0737899752868224,3.61110569739614e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,23979,-0.0677734584355798,0.00440519112189142,-0.076407633034487,-0.0591392838366727,3.71168646108027e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,28853,-0.0880631292154133,0.00573605120688998,-0.0993057895809177,-0.076820468849909,5.51836194233575e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,29042,-0.0349941786658235,0.00228063868685373,-0.0394642304920568,-0.0305241268395902,6.26882544194341e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29034,-0.049172839927437,0.00320692494241848,-0.0554584128145772,-0.0428872670402967,7.38268842101687e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29367,-0.0691265685811718,0.00450858374465183,-0.0779633927206894,-0.0602897444416543,7.46935954704105e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28612,-0.0800976806730332,0.005227006006447,-0.0903426124456693,-0.0698527489003971,8.59694026133064e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,28523,-0.0424684698815518,0.00277183804668557,-0.0479012724530555,-0.037035667310048,8.93181005354361e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24602,-0.0851717823515174,0.00555938044048209,-0.0960681680148623,-0.0742753966881725,9.79862050495771e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28491,-0.0392766012863318,0.00256454942122734,-0.0443031181519374,-0.0342500844207263,9.8241183065537e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24579,-0.0992003281481223,0.0064803341853747,-0.111901783151457,-0.0864988731447879,1.1854690033318e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,24579,-0.0677782869273981,0.00443007554382178,-0.0764612349932888,-0.0590953388615074,1.34564517046771e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,23979,-0.0586578073732717,0.00383921347878473,-0.0661826657916898,-0.0511329489548536,1.87715843837197e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,29122,-0.0828660783836727,0.00542748656764776,-0.0935039520562623,-0.0722282047110831,1.99999529774738e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,28860,-0.0335207789839411,0.00219954954133897,-0.0378318960849655,-0.0292096618829167,3.07445543604217e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29076,-0.0705885007439348,0.0046325224959831,-0.0796682448360616,-0.0615087566518079,3.16996210732271e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,24529,-0.0232923046312505,0.00152918755206323,-0.0262895122332944,-0.0202950970292066,3.76990314909172e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,24669,-0.0444783158895675,0.00292429497853987,-0.0502099340475056,-0.0387466977316293,5.23529405220475e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23649,-0.0584336383264737,0.00384204516573503,-0.0659640468513144,-0.0509032298016331,5.43515655893317e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,28117,-0.0997394967119368,0.00656977426676167,-0.11261625427479,-0.0868627391490839,7.52528567063745e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29122,-0.0834941961346425,0.00550502203072862,-0.0942840393148706,-0.0727043529544144,9.24057391190357e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,29122,-0.0356278926117002,0.00235087869573919,-0.040235614855349,-0.0310201703680513,1.10396864417454e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28491,-0.0605240470069753,0.00399517510694804,-0.0683545902165935,-0.0526935037973571,1.21810384862395e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24602,-0.0787273754931296,0.00519595947261817,-0.0889114560594612,-0.0685432949267979,1.26430773692695e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29034,-0.0914481550320213,0.0060417916750477,-0.103290066715115,-0.0796062433489278,1.47716760641751e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,23974,-0.0594410456495071,0.00393081579121926,-0.0671454446002969,-0.0517366466987173,2.0095582778383e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,29122,-0.0761487175888406,0.0050378232939989,-0.0860228512450784,-0.0662745839326027,2.01021769781296e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,28771,-0.03905083366679,0.00258884314582727,-0.0441249662326115,-0.0339767011009686,3.22831531705669e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,29122,0.0469909284052162,0.00311607629463301,0.0408834188677355,0.0530984379426969,3.4159788575695e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24602,-0.0866117395362932,0.00574588944576259,-0.0978736828499879,-0.0753497962225985,4.08377869037393e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28612,-0.0406859148333932,0.00270204607456099,-0.0459819251395327,-0.0353899045272536,4.84242862447641e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,29381,-0.0243133176228064,0.00161751524027423,-0.0274836474937439,-0.0211429877518689,7.08580531820311e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28631,-0.0643158717621275,0.00428375636350136,-0.0727120342345901,-0.0559197092896648,9.29663022283508e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REN,Renin,29172,-0.081737186026145,0.00544445075349509,-0.0924083095029954,-0.0710660625492946,9.35399733767712e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,24579,-0.0811844362645746,0.00541113029227135,-0.0917902516374264,-0.0705786208917228,1.17282867258372e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29226,-0.0760962792906122,0.0050758459305927,-0.0860449373145739,-0.0661476212666505,1.28123996476537e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,24683,0.0519929163485711,0.00346728097046211,0.0451970456464654,0.0587887870506768,1.31739941036156e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,29132,-0.0594970414689914,0.00397314998747319,-0.0672844154444388,-0.0517096674935439,1.65541112706886e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29034,0.0453199054288395,0.00302896147213872,0.0393831409434476,0.0512566699142313,2.00026593274897e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,29069,-0.0439002035582594,0.00293432220826702,-0.0496514750864628,-0.038148932030056,2.03708343215728e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29271,-0.0436385587530594,0.00291705091949493,-0.0493559785552695,-0.0379211389508494,2.06506610587484e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28491,-0.0609854099387513,0.00408253026671608,-0.0689871692615148,-0.0529836506159878,2.88599817299404e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,23940,-0.0740679374284231,0.00496745788797308,-0.0838041548888503,-0.0643317199679959,4.71798763879942e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29271,-0.0911641567878175,0.00612150200128473,-0.103162300710336,-0.0791660128652994,5.62713603999865e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28612,-0.0997632736730226,0.00669895594747955,-0.112893227330083,-0.0866333200159626,5.68922646404057e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,29187,-0.0529917267792836,0.00355858771482802,-0.0599665587003466,-0.0460168948582207,5.73734393315125e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,28455,-0.0338220785149713,0.00227207578084471,-0.0382753470454269,-0.0293688099845157,6.26902786154959e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,29271,-0.0711755454779047,0.00478257929000237,-0.0805494008863093,-0.0618016900695,6.54666026460069e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,29143,-0.033931173187643,0.00228219892998042,-0.0384042830904046,-0.0294580632848814,8.131659390222e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,29409,-0.0427081053330319,0.00287266672104439,-0.0483385321062789,-0.0370776785597849,8.18483601158471e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,29028,-0.0488273752251211,0.00328818603804797,-0.0552722198596951,-0.0423825305905471,1.07002485960509e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29470,-0.0716766640263769,0.00482719922452239,-0.0811379745064408,-0.0622153535463131,1.07656055081857e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,24488,-0.0462861753820149,0.00311906013952474,-0.0523995332554834,-0.0401728175085465,1.33162841359054e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,28491,-0.0430244578825294,0.00290326294590265,-0.0487148532564986,-0.0373340625085602,1.6803706443525e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,24602,-0.0829676178970385,0.00559929764418854,-0.093942241279648,-0.0719929945144289,1.8459960017162e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,24602,-0.0704875448803255,0.00476002342568322,-0.0798171907946646,-0.0611578989659864,2.11642546404286e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24342,-0.0339067714158794,0.00229042821951262,-0.0383960107261241,-0.0294175321056347,2.27514998992159e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24539,-0.108837297118659,0.00735712238861805,-0.123257257000351,-0.0944173372369679,2.63452628439212e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,28491,-0.0622267008321132,0.0042145260064691,-0.0704871718047926,-0.0539662298594338,3.75504738384452e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,29172,0.032715153641913,0.0022186397182244,0.0283666197941932,0.0370636874896329,4.93431771714167e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,29122,-0.0703582584495538,0.00477294111094179,-0.0797132230269998,-0.0610032938721079,5.2770785179785e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,29083,-0.0877435402840205,0.00595280041763738,-0.0994110291025898,-0.0760760514654512,5.37341201809361e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,29381,0.0394812287300932,0.00267883861776282,0.0342307050392781,0.0447317524209084,5.48571880594568e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24539,-0.0880209645846289,0.00597891397122731,-0.0997396359682345,-0.0763022932010234,7.54024687251693e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,29418,-0.072607737208971,0.00493929927385544,-0.0822887637857277,-0.0629267106322143,9.60297283033491e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,29409,-0.116104204886108,0.00791106841277551,-0.131609898975148,-0.100598510797068,1.3617182975978e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,29172,-0.0567501088532968,0.00387768284093974,-0.0643503672215387,-0.0491498504850549,2.49149068587059e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,24602,-0.0555449333859327,0.0037960336178218,-0.0629851592768634,-0.0481047074950019,2.78760114520163e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,23848,-0.065488677019662,0.00447696045667943,-0.0742635195147536,-0.0567138345245703,3.01738938500279e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23593,-0.0346641221437677,0.00237089286452157,-0.03931107215823,-0.0300171721293055,3.36971544114361e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29122,-0.117482149992922,0.00804199269174091,-0.133244455668734,-0.101719844317109,3.66765456754536e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,28491,-0.0302481130085073,0.00207095278118456,-0.034307180459629,-0.0261890455573855,3.84767204283584e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,24119,-0.0604331194441864,0.00413793291440875,-0.0685434679564275,-0.0523227709319452,4.21095022946415e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,29115,-0.0483093177875251,0.00331063712642345,-0.0547981665553151,-0.0418204690197352,4.65981774454281e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29271,-0.0404456673396221,0.00277212353609928,-0.0458790294703767,-0.0350123052088675,4.78835638206703e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23971,-0.0408199699292485,0.00279898016010392,-0.0463059710430522,-0.0353339688154448,5.71306501156842e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,29256,-0.0579936575881224,0.00397892598657597,-0.0657923525218113,-0.0501949626544336,5.95131553458839e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24699,0.0272324213053996,0.00186914513101794,0.0235688968486044,0.0308959457621947,6.94650315507542e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,29326,-0.0603927009991457,0.0041488995659383,-0.0685245441483848,-0.0522608578499066,7.82308385211491e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,24539,-0.0705304073352322,0.00484532031670185,-0.0800272351559679,-0.0610335795144966,8.41977637096014e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24602,-0.0794356513319533,0.00546178785040395,-0.090140755518745,-0.0687305471451615,1.0081081870539e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28491,-0.0658876922078593,0.00453431712166003,-0.0747749537663129,-0.0570004306494056,1.14388600175308e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,29013,-0.0875142741461143,0.00602582818415416,-0.0993248973870565,-0.0757036509051722,1.26996355231871e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,24539,-0.0616105960994914,0.00424640835817068,-0.069933556481506,-0.0532876357174769,1.67527577161676e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,24699,-0.0265442817349119,0.00183017609967806,-0.0301314268902809,-0.0229571365795429,1.80064149590667e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,24699,-0.0316141028652157,0.00218144748806446,-0.035889739941822,-0.0273384657886093,2.12344749075647e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24602,-0.0500931347667067,0.00345715960423793,-0.0568691675910131,-0.0433171019424004,2.20790285371159e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,24119,-0.0527997707116268,0.00364592891354125,-0.0599457913821677,-0.045653750041086,2.49446237959664e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,23974,-0.0514423968815918,0.00355913041947982,-0.0584182925037723,-0.0444665012594114,3.75547986138353e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23979,-0.0796360565589854,0.00551036447515957,-0.0904363709302981,-0.0688357421876726,3.84224182645506e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29034,0.0422932265203168,0.00293176628262904,0.0365469646063639,0.0480394884342697,5.17691934120687e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,24529,-0.0410354464571007,0.0028448020354032,-0.0466112584464909,-0.0354596344677104,5.63566618820682e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,29409,-0.0573607082716625,0.00397989645997215,-0.0651613053332079,-0.0495601112101171,6.23330003243192e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,29132,-0.0283691686108553,0.00197175175300693,-0.0322338020467489,-0.0245045351749617,8.93422981948293e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24653,-0.110710923148093,0.00770630036915277,-0.125815271871632,-0.0956065744245534,1.299944871977e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29145,-0.096520553562259,0.00672548780760851,-0.109702509665172,-0.0833385974593463,1.50406145189514e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,29127,-0.0397247809223453,0.00276997887548077,-0.0451539395182876,-0.034295622326403,1.74269284182019e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,23940,-0.0744451851126389,0.0051993828152849,-0.0846359754305973,-0.0642543947946805,2.62207408830579e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24579,-0.0323110140450155,0.00225825909057111,-0.0367372018625349,-0.0278848262274961,2.99618997143314e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29132,-0.043770241424536,0.00306022827059211,-0.0497682888348965,-0.0377721940141754,3.01021434762317e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24119,-0.0692000418935573,0.00483745962653041,-0.0786814627615569,-0.0597186210255577,3.14780574672627e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29034,-0.0341190194519509,0.00238987651914781,-0.0388031774294806,-0.0294348614744212,4.39490623084702e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,28908,-0.0985948847917462,0.00690981490596775,-0.112138122007443,-0.0850516475760494,4.90920080880101e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,29172,0.0381318807561917,0.00267318294798767,0.0328924421781359,0.0433713193342476,5.19618472689501e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,29034,-0.0964332438595748,0.0067661936537452,-0.109694983420915,-0.0831715042982342,6.20782415540295e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,24579,-0.0679056391549535,0.00476898846434339,-0.0772528565450666,-0.0585584217648405,7.98713128617823e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29122,-0.102952054940814,0.0072393344374267,-0.11714115043817,-0.0887629594434576,9.63408366289049e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29138,-0.057835194205726,0.00406801007188719,-0.0658084939466249,-0.0498618944648271,1.02138734531352e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,29034,-0.0914022756454052,0.00643657723298629,-0.104017967022058,-0.0787865842687521,1.29454868527605e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,29181,-0.107767393758231,0.00759035173920353,-0.12264448316707,-0.0928903043493924,1.33891598840087e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,28631,-0.053456516627266,0.00376746200808177,-0.0608407421631062,-0.0460722910914257,1.52997714818818e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,29132,-0.0379932729254212,0.00268092258571803,-0.0432478811934285,-0.0327386646574138,1.94208822395324e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24119,-0.0293263881842212,0.00206965559936611,-0.0333829131589788,-0.0252698632094636,2.14751647754496e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,23974,-0.0989317638234518,0.00698544706125181,-0.112623240063505,-0.0852402875833983,2.38134735252186e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24602,-0.066980844628533,0.00473170359482579,-0.0762549836743916,-0.0577067055826745,2.59316494626543e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,28467,-0.0726150131588885,0.00513287729573432,-0.0826754526585278,-0.0625545736592493,2.7747079049082e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,24653,-0.101542556965137,0.00717751721599232,-0.115610490708482,-0.0874746232217919,2.91887549862957e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29507,-0.0412845800283559,0.00292201542205297,-0.0470117302555798,-0.0355574298011321,3.54476917822678e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29122,-0.073242139028319,0.00518718330314165,-0.0834090183024766,-0.0630752597541614,4.04088361634887e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29120,-0.0986070300993293,0.00698648890595074,-0.112300548354993,-0.0849135118436658,4.38929220600907e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,24119,-0.0682047387145486,0.00483105046650003,-0.0776735976288886,-0.0587358798002085,4.45104597377491e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,23979,-0.0779804583781206,0.0055297959190665,-0.088818858379491,-0.0671420583767503,5.59740967219407e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,28908,-0.0580787708903704,0.00412108591145939,-0.0661560992768309,-0.05000144250391,5.90430780644401e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,28853,-0.0237783524784081,0.00168825168377195,-0.0270873257786011,-0.0204693791782151,6.65575482751386e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29256,0.0241583778384429,0.00171562846437435,0.0207957460482692,0.0275210096286166,6.93361567597771e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,24529,-0.0364602429442178,0.00259036182713499,-0.0415373521254024,-0.0313831337630332,8.04907321320504e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,28908,-0.0788210104690233,0.00560928183681991,-0.0898152028691904,-0.0678268180688563,1.05295499556484e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,24579,-0.0561167396881687,0.00399786256045781,-0.063952550306666,-0.0482809290696714,1.38258721584444e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24602,-0.0610406565407881,0.0043594567936008,-0.0695851918562456,-0.0524961212253305,2.24767177234959e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,23974,-0.0906253256410869,0.00647258033558303,-0.10331158309883,-0.0779390681833442,2.28585894884904e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28491,-0.077953857326355,0.00557764056975187,-0.0888860328430686,-0.0670216818096413,3.05328587776257e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24119,-0.0694561832161947,0.00497688517109876,-0.0792108781515483,-0.0597014882808411,4.30931593395902e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,23979,-0.0513954734816109,0.00368436793522693,-0.0586168346346556,-0.0441741123285661,4.70498187313727e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29381,-0.0652948193769927,0.00468276391719118,-0.0744730366546874,-0.056116602099298,4.75332896386444e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24602,-0.0842006917196159,0.00604733305317874,-0.0960534645038462,-0.0723479189353855,6.68530935833167e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24579,-0.0415627950964643,0.00300490023964912,-0.0474523995661766,-0.035673190626752,2.38717601131759e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23979,-0.0965227548023873,0.00699111764211849,-0.11022534538094,-0.082820164223835,3.40944707552956e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24579,-0.0316071674258731,0.00229065325570782,-0.0360968478070604,-0.0271174870446858,3.77985436542517e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,24699,-0.0213693598124523,0.00154972367215384,-0.0244068182098738,-0.0183319014150308,4.28097255164329e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,24119,-0.0535468228739491,0.00388924194864573,-0.0611697370932948,-0.0459239086546035,5.7802520950814e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29066,-0.0666780395859865,0.00486165831324643,-0.0762068898799495,-0.0571491892920235,1.12041581449503e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,29199,0.036423137333332,0.0026574174603694,0.031214599111008,0.0416316755556561,1.2632907334529e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,28861,-0.0506902814000569,0.00369847517087781,-0.0579392927349774,-0.0434412700651364,1.27634012679004e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,29038,-0.0860987400219816,0.0062872688691233,-0.0984217870054633,-0.0737756930384999,1.49278799478952e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,29034,-0.0761814800085145,0.00556542812889223,-0.0870897191411433,-0.0652732408758858,1.61604967685098e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29226,0.0803296441318152,0.0058696730786245,0.0688250848977112,0.0918342033659192,1.67580776664382e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,28773,-0.0459786368027515,0.00337419552239812,-0.0525920600266518,-0.0393652135788511,3.76476634841162e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24119,-0.070190511947445,0.00515442015386302,-0.0802931754490165,-0.0600878484458735,4.50899150970074e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24067,-0.0836938929420838,0.00616716644242504,-0.0957815391692368,-0.0716062467149307,8.49619579081827e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28491,-0.0891044498746128,0.00656910968327435,-0.101979904853831,-0.0762289948953951,8.81007973527108e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,24579,-0.10475005559779,0.00772130209303772,-0.119883807700144,-0.089616303495436,8.96513664239204e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,23848,-0.0773030856971143,0.00570303453967879,-0.0884810333948847,-0.0661251379993438,1.06062812631584e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,23940,-0.0476361969635637,0.00351463203901632,-0.0545248757600357,-0.0407475181670917,1.07431601080457e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,24699,-0.0403620743252195,0.0029833451901812,-0.0462094308979746,-0.0345147177524643,1.48076345342716e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,28908,-0.0782149183191628,0.00578533313774868,-0.0895541712691502,-0.0668756653691754,1.60473545457196e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,28859,-0.0443547952507296,0.00328134401497145,-0.0507862295200736,-0.0379233609813856,1.65515119313703e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29381,-0.0452683221337272,0.00335069235371319,-0.051835679147005,-0.0387009651204493,1.81292508726686e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24602,-0.0655452312203078,0.00485331752083092,-0.0750577335611364,-0.0560327288794792,2.04660519080946e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,29470,-0.0475784274815758,0.00352565082834378,-0.0544887031051296,-0.040668151858022,2.22383892003075e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,28289,-0.0815680888343419,0.00604855146343796,-0.0934232497026803,-0.0697129279660035,2.55332177407618e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29122,-0.100731258269124,0.00747973098250995,-0.115391530994844,-0.0860709855434046,3.24073135123881e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,24119,-0.0298802765266089,0.00222071177012268,-0.0342328715960494,-0.0255276814571685,4.03582429349573e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,29080,-0.109441076752148,0.00814445254585762,-0.125404203742029,-0.0934779497622674,4.83486722609888e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,29317,-0.0572038975183479,0.00425849420403797,-0.0655505461582623,-0.0488572488784334,5.13163603408804e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,28467,-0.0650697636147293,0.00484847831311548,-0.0745727811084357,-0.055566746121023,6.097633380193e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29132,-0.0289495926201357,0.00215754642268159,-0.0331783836085916,-0.0247208016316798,6.29195482223704e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,24550,-0.0814520617216193,0.00606983661742467,-0.0933489414917717,-0.069555181951467,6.51201384569393e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,29470,-0.0522961142488997,0.0039009839003957,-0.0599420426936753,-0.0446501858041242,7.36162158304791e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,23979,-0.0711735058161664,0.00530943759621695,-0.0815800035047516,-0.0607670081275812,7.92257431460086e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29507,-0.0688941418947069,0.00514350434326848,-0.0789754104075131,-0.0588128733819007,8.58216698722451e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,23948,-0.0548659779734873,0.00409622156999224,-0.062894572250672,-0.0468373836963025,9.1580334090209e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24529,-0.0573102035419586,0.00427917035192411,-0.0656973774317298,-0.0489230296521873,9.26422388454967e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29256,-0.0586878072953022,0.00438519277614733,-0.067282785136551,-0.0500928294540534,9.99599814569961e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,28612,-0.055551614870488,0.00415264869522734,-0.0636908063131336,-0.0474124234278424,1.08666443422054e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,23843,-0.0382910299552215,0.00286327315513423,-0.0439030453392846,-0.0326790145711584,1.21612456684284e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,24579,-0.0790712645156021,0.00591309353753813,-0.0906609278491768,-0.0674816011820273,1.21904804805964e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29122,-0.0627291886266521,0.00469786604407866,-0.0719370060730463,-0.0535213711802579,1.50387479316038e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,29188,-0.0623839673171997,0.0046726324356631,-0.0715423268910994,-0.0532256077433,1.53892616310746e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,23911,-0.0813746156790936,0.00609639149805644,-0.0933235430152843,-0.069425688342903,1.69953393265233e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29172,-0.0764103131168507,0.00572748374668641,-0.087636181260356,-0.0651844449733453,1.75722691132408e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,29143,-0.0736689031083847,0.00552615605520566,-0.0845001689765878,-0.0628376372401816,2.00946445211091e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,29172,-0.0370447204381941,0.00277887153026024,-0.0424913086375042,-0.0315981322388841,2.01155717110033e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,23848,-0.0637129755165664,0.00478530171411783,-0.0730921668762373,-0.0543337841568955,2.66317310017008e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,29381,-0.0604711603850164,0.00454499825746961,-0.0693793569696568,-0.0515629638003759,2.83264587753357e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,28756,0.026268247962247,0.00197429716261471,0.0223986255235221,0.0301378704009718,2.84453324847843e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,24683,-0.0452108735802854,0.0033991032975389,-0.0518731160434616,-0.0385486311171091,3.15027299875705e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24602,-0.102278751270252,0.00769307728898451,-0.117357182756661,-0.0872003197838422,3.41126310986518e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,23940,-0.0767539435326133,0.00577696573551842,-0.0880767963742294,-0.0654310906909972,3.86267333380239e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28491,-0.0423905237432957,0.00319191463426809,-0.0486466764264611,-0.0361343710601302,3.94984089590362e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,23974,-0.0739609436899743,0.00557086184622134,-0.0848798329085682,-0.0630420544713805,4.39728128434746e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,24653,-0.0613720439516707,0.00462526764564493,-0.0704375685371347,-0.0523065193662066,4.81534341809353e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24119,-0.0510935599461324,0.00385195728734474,-0.0586433962293281,-0.0435437236629367,5.15041394985587e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29127,-0.0707944721081378,0.00534154169823161,-0.0812638938366718,-0.0603250503796038,5.61889406146541e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,28887,0.0268958865472576,0.00203067498043654,0.022915763585602,0.0308760095089132,6.3243690260555e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28612,-0.0719304495917498,0.00543163692473019,-0.082576457964221,-0.0612844412192787,6.5050252694963e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,29271,-0.0876396251530753,0.00662084979723614,-0.100616490755658,-0.0746627595504925,6.99564234618167e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29132,-0.027147551748436,0.00205416065305097,-0.0311737066284159,-0.0231213968684561,9.24969071756411e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,29085,-0.0629387365382184,0.00476481877175949,-0.0722777813308669,-0.0535996917455698,1.01277268738509e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,29256,-0.0664211383739201,0.00503737228577336,-0.0762943880540358,-0.0565478886938043,1.37660255603797e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,29132,-0.0236042621349402,0.00179153738638136,-0.0271156754122477,-0.0200928488576327,1.57740030337684e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,24529,-0.0594207094454217,0.00451825176122476,-0.0682764828974223,-0.0505649359934212,2.27528495972539e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,24602,-0.0455823239824947,0.00346620354862661,-0.0523760829378029,-0.0387885650271866,2.29593976433972e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,23979,-0.0302607903762712,0.00230364524303982,-0.0347759350526293,-0.0257456456999132,2.79772611133202e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24539,-0.138350471844731,0.0105337172952104,-0.158996557743343,-0.117704385946119,2.85125429547546e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29293,-0.0308227983916153,0.00234751608912985,-0.0354239299263098,-0.0262216668569208,2.86382179087488e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,24669,-0.0351588535395151,0.00267829601932,-0.0404083137373823,-0.0299093933416478,3.10967941852014e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28491,-0.0426364029627376,0.00324926984859756,-0.0490049718659888,-0.0362678340594863,3.20879969007904e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24602,-0.0881236549672561,0.00671637654592255,-0.101287752997264,-0.0749595569372479,3.39381485773209e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,23998,-0.0265322180816111,0.00202578263101568,-0.0305027520384019,-0.0225616841248204,4.64819927961759e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,24190,-0.0235911904956154,0.00180239932342593,-0.0271238931695302,-0.0200584878217006,5.18181393140206e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28485,-0.0736751332464563,0.00563157667478328,-0.0847130235290316,-0.0626372429638811,5.37197412201628e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29122,-0.0576360096171539,0.00440768354657142,-0.0662750693684339,-0.0489969498658739,5.79644617187972e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29381,-0.063534855498391,0.00486078081559749,-0.0730619858969621,-0.0540077250998199,6.20199801042924e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,29137,-0.0406024740625207,0.00310997083979635,-0.0466980169085215,-0.0345069312165198,7.593374248038e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,24539,-0.0644914403690086,0.00494045764266579,-0.0741747373486336,-0.0548081433893837,8.15150122709064e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,23974,-0.0415561532755684,0.00318736288746222,-0.0478033845349943,-0.0353089220161424,1.01051599709363e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,24602,-0.0514490159579951,0.00394677603769048,-0.0591846969918685,-0.0437133349241218,1.03025730428158e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,23979,-0.064248472180569,0.00493785164069081,-0.073926661396323,-0.0545702829648151,1.42381801295973e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,28412,-0.0429422125133761,0.00330281823880363,-0.0494157362614313,-0.036468688765321,1.54205628659243e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,23979,-0.0555011187889491,0.00426882364768049,-0.0638680131384028,-0.0471342244394953,1.61965538997006e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,28491,-0.0896818800031502,0.00690760435018699,-0.103220784529517,-0.0761429754767837,1.96275648420694e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,24422,-0.0875255658356194,0.00674475547835688,-0.100745286573199,-0.0743058450980399,2.21861314671042e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28491,-0.0554596844383699,0.0042773328931483,-0.0638432569089406,-0.0470761119677992,2.45078091909493e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,28631,-0.0739222968712357,0.00570194614405941,-0.0850981113135921,-0.0627464824288793,2.4975628144755e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24653,-0.0844104847034732,0.00651570914054539,-0.0971812746189422,-0.0716396947880043,2.93885268584594e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,23979,-0.0375006887891099,0.002899079734537,-0.0431828850688024,-0.0318184925094174,3.81439093241853e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,29034,-0.0550305113058168,0.00425696777208163,-0.0633741681390968,-0.0466868544725368,4.0308561491882e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28491,-0.0910213539025588,0.00704112606635068,-0.104821960992606,-0.0772207468125115,4.05260743712424e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,24119,-0.0518682661957667,0.00401425255553364,-0.0597362012046126,-0.0440003311869207,4.58324743778316e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28612,-0.053082555803783,0.00410961705936088,-0.0611374052401303,-0.0450277063674357,4.63281852599902e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29280,-0.0275575804329439,0.0021336450366619,-0.0317395247048012,-0.0233756361610865,4.66324719888495e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,23974,-0.0536853262520748,0.00415655211332212,-0.0618321683941862,-0.0455384841099635,4.90970207372745e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,23940,-0.121564385677984,0.00941522280127051,-0.140018222368474,-0.103110548987494,5.19587014065218e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,24539,-0.0926730490107228,0.00718662418260654,-0.106758832408632,-0.078587265612814,6.36217875138079e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,24653,-0.0290737552606199,0.00225534469022855,-0.0334942308534679,-0.0246532796677719,6.70415142807569e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,24556,-0.0898607962261638,0.00697307786327592,-0.103528028838185,-0.076193563614143,7.08716476817084e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,29122,-0.0431857168246743,0.00335397428352851,-0.0497595064203902,-0.0366119272289584,7.79650686112025e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28491,-0.0783059103196772,0.00608475695227905,-0.0902320339461441,-0.0663797866932102,8.55360884698683e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,23940,-0.0749348407657316,0.005822943789947,-0.0863478105940277,-0.0635218709374355,8.99052691182525e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24653,-0.0440858370493386,0.0034262781752826,-0.0508013422728925,-0.0373703318257847,9.13864062154682e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,24529,-0.0300605044499947,0.00233662344295936,-0.0346402863981951,-0.0254807225017944,9.39499988153975e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29132,-0.0527736170097338,0.00410475196823069,-0.0608189308674659,-0.0447283031520016,9.99021135015034e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,28724,-0.0391862274711179,0.00304802360212154,-0.0451603537312761,-0.0332121012109597,1.00803967017552e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29132,0.0483404469027787,0.00376054897922614,0.0409697709034955,0.055711122902062,1.02620587190001e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29172,-0.0674037743363462,0.0052511750209096,-0.077696077377329,-0.0571114712953634,1.30424118231819e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,24625,0.0675620883620842,0.00526239821513159,0.0572477878604263,0.0778763888637421,1.31527034873647e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29226,-0.0700370355892221,0.00546336649026468,-0.0807452339101409,-0.0593288372683033,1.612134766117e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,29122,-0.0769450010881588,0.00600753952712484,-0.0887197785613235,-0.0651702236149941,1.86542193309631e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,29122,-0.0538782851659329,0.00420880546214769,-0.0621275438717423,-0.0456290264601234,2.03383577876758e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28631,-0.0501667977305051,0.00392380008852334,-0.0578574459040108,-0.0424761495569994,2.50804952358126e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,29256,-0.0653508952115194,0.00511212380143089,-0.075370657862324,-0.0553311325607149,2.55188087482882e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29122,-0.0879187180759164,0.00688843001923077,-0.101420040913609,-0.0744173952382241,3.30978219698506e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24539,-0.059308580189398,0.00464564626845206,-0.068414046875564,-0.0502031135032319,3.31444254204945e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,24579,-0.084979019026646,0.00666558071988679,-0.0980435572376241,-0.0719144808156679,4.14419838913345e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,24602,-0.0611425582562481,0.0047997831350014,-0.0705501332008508,-0.0517349833116453,4.72523807153992e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29507,-0.0319047912431137,0.00250762333786702,-0.036819732985333,-0.0269898495008943,5.5041952771407e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,24602,-0.0691631431407955,0.00543578463629514,-0.079817281027934,-0.0585090052536571,5.71433150318921e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,23647,-0.0649238096569733,0.0051032037983957,-0.0749260891018289,-0.0549215302121177,5.88804678668363e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,23848,-0.0360572954169888,0.00283718163799916,-0.0416181714274671,-0.0304964194065104,6.95796599673451e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,29104,-0.0826391926220067,0.00650839344948148,-0.0953956437829904,-0.069882741461023,7.66471983554926e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,23979,-0.0825045100078635,0.00649742764235145,-0.0952394681868723,-0.0697695518288546,7.97015409434393e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29507,0.0262946007999087,0.00207183110469349,0.0222338118347094,0.0303553897651079,8.23038856866762e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24602,-0.103989989422925,0.00819488628711014,-0.12005196654566,-0.0879280123001888,8.80643245699197e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24119,-0.0377285840815235,0.00297413076745343,-0.0435578803857322,-0.0318992877773148,9.31815647164592e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,23974,-0.0804245549380119,0.00634125173262006,-0.0928534083339472,-0.0679957015420766,9.67385019879693e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,23974,-0.0383828856148796,0.003026407704942,-0.0443146447165659,-0.0324511265131932,9.68633567139417e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24602,-0.0479961362198503,0.00378648624855115,-0.0554176492670105,-0.04057462317269,1.05140321939629e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,23848,-0.0606835578487443,0.00479110472076931,-0.0700741231014521,-0.0512929925960364,1.19967612177058e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,29409,0.0150650780212998,0.00119228894333526,0.0127281916923627,0.017401964350237,1.67583795200861e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24529,-0.0319802316178473,0.00253080354429613,-0.0369406065646677,-0.0270198566710269,1.72878984823349e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,23979,-0.0395915334971538,0.00313334594842947,-0.0457328915560756,-0.0334501754382321,1.75793415308917e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24669,0.0299244373165076,0.00236936729124625,0.0252804774256649,0.0345683972073502,1.87813018856228e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24185,-0.0605226847770528,0.00479275453505922,-0.0699164836657689,-0.0511288858883367,1.93036636965379e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24602,-0.107394754374092,0.00851185731897125,-0.124077994719275,-0.0907115140289079,2.20449625193749e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24683,-0.0243758655669162,0.00193302471672653,-0.0281645940117002,-0.0205871371221322,2.40156968064962e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,29034,-0.0810223567190933,0.00644044444917424,-0.0936456278394748,-0.0683990855987117,3.37153571643284e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,24621,-0.0422981165386846,0.00336355874002969,-0.0488906916691428,-0.0357055414082265,3.72502913446742e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,29071,-0.0928662458632808,0.0073987069447012,-0.107367711474895,-0.0783647802516664,4.82703838215053e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23470,-0.0446749025752318,0.0035589142154829,-0.0516503744375783,-0.0376994307128854,5.00026330405684e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,29077,-0.0426229552038454,0.00339678179161346,-0.0492806475154078,-0.0359652628922831,5.05298037826826e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29098,-0.031820985614207,0.00253779074246361,-0.0367950554694357,-0.0268469157589783,5.66984605422515e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,23940,-0.0379208014774465,0.00302559068531542,-0.0438509592206647,-0.0319906437342283,6.36040647554745e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,28908,-0.0710652205972118,0.0056802504592985,-0.0821985114974368,-0.0599319296969867,8.05741588252262e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,23144,-0.0219631794243267,0.00175529443611705,-0.0254035565191161,-0.0185228023295373,8.32801156805133e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29034,-0.104264341694794,0.00834395700068393,-0.120618497416135,-0.0879101859734537,9.72930937110758e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,29409,0.0305160584424005,0.00244367553801688,0.0257264543878874,0.0353056624969136,1.07267759259193e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,24579,-0.0637072537309333,0.00510165133006826,-0.0737064903378671,-0.0537080171239995,1.1201517068527e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28612,-0.0310314394430532,0.00248793020949974,-0.0359077826536727,-0.0261550962324337,1.30087180338373e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,24699,-0.031966243100136,0.00256342278794938,-0.0369905517645168,-0.0269419344357552,1.39072080037674e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24602,-0.0557281845289209,0.00447268439125547,-0.0644946459357816,-0.0469617231220602,1.58610065242871e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24539,-0.0811069817011867,0.00651116706843578,-0.0938688691553208,-0.0683450942470525,1.64911187381168e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,24579,-0.121768112777311,0.00981421254103088,-0.141003969357732,-0.102532256196891,3.04180877937494e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,28908,-0.0463153825388383,0.0037338299389155,-0.0536336892191127,-0.0389970758585639,3.04722030520394e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24539,-0.0679113914369037,0.00548947449451182,-0.0786707614461469,-0.0571520214276605,4.76101787832391e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24529,-0.073672412489921,0.00597545718478252,-0.0853843085720947,-0.0619605164077472,8.00293300991376e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29280,0.0267375465864294,0.00217174221726131,0.0224809318405973,0.0309941613322616,9.56864861007702e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23974,-0.0395134876932995,0.00320965772009916,-0.0458044168246939,-0.0332225585619052,1.00894375665441e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,29122,-0.0426616660698013,0.00346741859058631,-0.0494578065073505,-0.0358655256322522,1.05693697674689e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29132,-0.0679786390838874,0.00552836096978779,-0.0788142265846715,-0.0571430515831033,1.15536637745629e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,28908,0.0297386536252772,0.0024220164103454,0.0249915014610002,0.0344858057895542,1.44180513507655e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24683,-0.0555739212460951,0.00453805847248386,-0.0644685158521635,-0.0466793266400268,2.21617318158776e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29034,-0.0774936208395066,0.00633484478774799,-0.0899099166234927,-0.0650773250555205,2.51960691390444e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,29470,-0.0305087109502869,0.00249765292091631,-0.0354041106752829,-0.0256133112252909,3.13035400497313e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29122,-0.0535358302749662,0.00438283495731174,-0.0621261867912972,-0.0449454737586352,3.14001197165041e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,29132,-0.0787444183172619,0.00644718566083451,-0.0913809022124975,-0.0661079344220262,3.18311718344474e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29122,0.046121583418857,0.00377763222387924,0.0387174242600536,0.0535257425776603,3.3692463976865e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24586,-0.0351835563618489,0.00288220945376655,-0.0408326868912313,-0.0295344258324665,3.5761132337978e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,29470,-0.0552996082188499,0.00453761936885771,-0.064193342181811,-0.0464058742558888,4.40918717429946e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24529,-0.075688742920097,0.00621237643276232,-0.0878650007283111,-0.0635124851118829,4.77244486566017e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,29256,-0.049001043066923,0.00402408237218479,-0.0568882445164052,-0.0411138416174408,4.98655380717283e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,23974,0.0283684381142767,0.00232911887444317,0.0238033651203681,0.0329335111081853,5.01507366222887e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,24563,-0.0269239981330083,0.00221380484412825,-0.0312630556274997,-0.022584940638517,6.21242506313475e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,29076,-0.0591528553089204,0.00487144860247789,-0.0687008945697771,-0.0496048160480637,7.57033963690178e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,28981,-0.0618647119583616,0.00509762796531935,-0.0718560627703876,-0.0518733611463357,8.22641231650553e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24683,0.0231075007469629,0.00190545470598025,0.0193728095232416,0.0268421919706842,9.4769495628164e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",23843,-0.0637309865369137,0.00526127143763209,-0.0740430785546726,-0.0534188945191548,1.12904251797093e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,28988,-0.0486702279812431,0.00402224642941437,-0.0565538309828952,-0.0407866249795909,1.2690781278012e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,29409,-0.0333419020166384,0.00275552738914869,-0.0387427356993699,-0.027941068333907,1.26957900877993e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,29256,-0.0284097590820504,0.00234895426234363,-0.0330137094362439,-0.0238058087278569,1.3561845428825e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24539,-0.0558478320072761,0.00461965994306175,-0.0649023654956772,-0.0467932985188751,1.50132769000905e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,28612,-0.0315687122241512,0.00261264341298122,-0.0366894933135944,-0.026447931134708,1.56693984955202e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,28491,-0.0377809416767922,0.00313354157634404,-0.0439226831664266,-0.0316392001871579,2.1502151707247e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23979,-0.0323109333467621,0.00268038634198262,-0.0375644905770481,-0.0270573761164762,2.29160333923053e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,24669,-0.0723322148849623,0.00602455868414273,-0.0841403499058821,-0.0605240798640426,4.07683702235616e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29172,-0.0582035863677733,0.0048492284168553,-0.0677080740648097,-0.0486990986707369,4.11892747141909e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,24699,-0.0230414498719324,0.0019194965808879,-0.0268036631704727,-0.0192792365733921,4.19120653710617e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28491,-0.0514867535757342,0.00429038796418868,-0.059895913985544,-0.0430775931659244,4.24544900307816e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28491,-0.0562408942862938,0.0046883823520354,-0.0654301236962832,-0.0470516648763045,4.49162491049875e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,29226,-0.0745369029349758,0.00621650621602632,-0.0867212551183874,-0.0623525507515643,4.78446329460896e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,28908,-0.080844082479709,0.00674687803133524,-0.0940679634211261,-0.067620201538292,5.25932657948884e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29132,0.0376681500513712,0.00314505182523644,0.0315038484739078,0.0438324516288346,5.60955947913708e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24185,-0.0911939555608769,0.00761319484375938,-0.106115817454645,-0.0762720936671085,5.71715001096299e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,29507,0.0260665747130874,0.00217672330730188,0.0218001970307758,0.0303329523953991,5.71998246519229e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPART,Spartin,24119,-0.066676787574462,0.00557057066652318,-0.0775951060808474,-0.0557584690680765,6.36721392388217e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,28491,-0.040320500142532,0.00337404551684398,-0.0469336293555462,-0.0337073709295178,7.76204470069367e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,29172,-0.10960849317117,0.00917454464039773,-0.12759060066635,-0.0916263856759908,8.02858196369535e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28467,-0.049475126545849,0.00414818202172294,-0.057605563308426,-0.041344689783272,1.02525530271356e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24539,-0.0762479384595154,0.00639541944904485,-0.0887829605796434,-0.0637129163393875,1.11555003901615e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29271,-0.110909526355121,0.00930875777154255,-0.129154691587344,-0.0926643611228974,1.18319624119128e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,23979,-0.0264698349007169,0.00222122685261447,-0.0308234395318413,-0.0221162302695925,1.19713483495059e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29034,-0.0293948246372811,0.00246747609090465,-0.0342310777754542,-0.024558571499108,1.20806994300896e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,29132,-0.0206401587304711,0.00173273062654796,-0.0240363107585051,-0.0172440067024371,1.22165087100749e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23979,0.0300541316853665,0.00252446257654084,0.0251061850353465,0.0350020783353866,1.37475698572186e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,29470,-0.0481198401918956,0.00404633432452948,-0.0560506554679734,-0.0401890249158178,1.54252047734131e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,29271,-0.065625119572451,0.00551952117712447,-0.076443381079615,-0.0548068580652871,1.59226164076255e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,24119,-0.092551398051572,0.00778989313206294,-0.107819588590415,-0.0772832075127286,1.83161958678651e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,28979,-0.0259336299824749,0.0021857279025405,-0.0302176566714542,-0.0216496032934955,2.13899503073435e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,24119,-0.0631240703492456,0.00532289836180354,-0.0735569511383805,-0.0526911895601106,2.37869660871501e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,24653,0.023522751018857,0.00198451152860182,0.0196331084227975,0.0274123936149166,2.53677569111535e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,29132,-0.0442849703551021,0.00374039131864818,-0.0516161373396525,-0.0369538033705516,2.88701991113442e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,29176,0.0233484528759459,0.00197371589062898,0.0194799697303131,0.0272169360215787,3.24857505127074e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,24344,0.0918985724391154,0.00777347212080271,0.0766625670823421,0.107134577795889,3.67664492623442e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24119,-0.0725952501842199,0.00614400942885334,-0.0846375086647725,-0.0605529917036674,3.97623237429174e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,28612,-0.0414020935781075,0.0035077718631415,-0.0482773264298648,-0.0345268607263501,4.47324669663387e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,28467,0.0627346271245755,0.00531794722142495,0.0523114505705826,0.0731578036785684,4.81692116837876e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24669,-0.0197412244419072,0.0016743134025052,-0.0230228787108174,-0.016459570172997,5.31754936988434e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29044,-0.0753679336596298,0.00639429549916463,-0.0879007528379925,-0.0628351144812672,5.40467014576703e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24119,-0.0356693002093455,0.00303200616050972,-0.0416120322839446,-0.0297265681347465,7.29099189662897e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,29507,0.0138308804862683,0.0011769897860361,0.0115239805056376,0.0161377804668991,8.2119962000364e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,24539,-0.0654875091237086,0.0055772393365718,-0.0764188982233893,-0.0545561200240279,9.4509473528608e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29271,-0.0922969614274941,0.00788321256514582,-0.10774805805518,-0.0768458647998083,1.36370677957595e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,28467,-0.0520574405903476,0.00444618665801789,-0.0607719664400626,-0.0433429147406325,1.3652188911382e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,29019,-0.0657605002298011,0.0056179517274841,-0.07677168561567,-0.0547493148439323,1.4082071303931e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29507,-0.0267193634780631,0.00228496701858569,-0.031197898834491,-0.0222408281216351,1.61436587484056e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,24683,-0.0580045790114713,0.00495979431849433,-0.0677257758757202,-0.0482833821472224,1.63826068528499e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29423,-0.0273595959606491,0.00234050302608559,-0.0319469818917769,-0.0227722100295214,1.69109173423279e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24185,-0.0416582003705634,0.00356797966758724,-0.0486514405190344,-0.0346649602220924,2.06358768422886e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29470,0.0216627080601275,0.00186063282416054,0.0180158677247728,0.0253095483954821,2.92841601487574e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29256,-0.0603265251448137,0.0051874678747461,-0.0704939621793161,-0.0501590881103113,3.42686941213543e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24119,-0.0870976940349212,0.00749523525387489,-0.101788355132516,-0.0724070329373264,3.92967819060912e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,24119,-0.0576699833535359,0.00496781695698336,-0.0674069045892232,-0.0479330621178485,4.50222981847057e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29172,0.032968381548664,0.00284227335390339,0.0273975257750133,0.0385392373223146,4.86100697415936e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,24699,0.0228533609316239,0.00197064624583421,0.0189908942897888,0.0267158275734589,5.14302315077856e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29132,-0.0318125596112598,0.00274513009229653,-0.037193014592161,-0.0264321046303586,5.49804050728438e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,23979,-0.0455030729643871,0.00392673533525339,-0.0531994742214838,-0.0378066717072905,5.73271886758645e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23974,-0.0406681381109169,0.00350980788291838,-0.0475473615614369,-0.0337889146603969,5.80108595231756e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28238,-0.101464577885914,0.00876363704057358,-0.118641306485438,-0.0842878492863893,6.26497073220758e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29132,-0.0247679567975841,0.0021401257654265,-0.02896260329782,-0.0205733102973482,6.58951997835399e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24539,-0.0856754807271592,0.00743053786015857,-0.10023933493307,-0.0711116265212484,1.11519562049984e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24304,-0.0464614227663256,0.00403800014662062,-0.054375903053702,-0.0385469424789492,1.47602375035006e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,28467,-0.0384412592200268,0.0033481005086114,-0.0450035362169052,-0.0318789822231485,1.90699556471382e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24669,0.0177257117213505,0.00154798864478749,0.014691653977567,0.020759769465134,2.77913499064762e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,24683,-0.0189984328505345,0.00165952230544593,-0.0222510965692085,-0.0157457691318605,2.86526833305138e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28467,-0.0421265189609716,0.00368256129524208,-0.049344339099646,-0.0349086988222971,3.09206846817175e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28612,0.0176210674131682,0.00154047012803318,0.0146017459622232,0.0206403888641132,3.11467889054895e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,24653,-0.045401634447031,0.0039702672594525,-0.0531833582755579,-0.0376199106185041,3.31604745573861e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28612,-0.0339559727519893,0.00297022817016278,-0.0397776199655083,-0.0281343255384702,3.36154336973331e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,28908,-0.0823375568742991,0.00720346441927457,-0.0964563471360773,-0.068218766612521,3.42781183137948e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24669,0.0216811602092608,0.00190083814775579,0.0179555174396594,0.0254068029788621,4.63713087209411e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,23979,-0.0260082945582517,0.00228059283738723,-0.0304782565195307,-0.0215383325969727,4.76390078450285e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,24579,-0.0378950144260629,0.00332707596484005,-0.0444160833171494,-0.0313739455349764,5.58466938973471e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,24539,-0.0841819578739265,0.00739667315050554,-0.0986794372489174,-0.0696844784989357,6.17838338719182e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,23848,-0.0392286253733744,0.00344852343911632,-0.0459877313140424,-0.0324695194327064,6.61669235697952e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,29280,0.0389867047195478,0.0034282830750371,0.0322672698924751,0.0457061395466206,6.65634839535293e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,28631,-0.0752759768874419,0.00662438964943128,-0.0882597806003272,-0.0622921731745566,7.36792695702689e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,29132,0.0232367256461395,0.00204853149167464,0.0192216039224572,0.0272518473698218,9.26576135073115e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,23940,-0.0353840138781053,0.00312306861142425,-0.0415052283564968,-0.0292627993997138,1.11087575905908e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,28612,0.0190489470146262,0.00168177421934036,0.0157526695447191,0.0223452244845333,1.11965393240755e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,29132,-0.0217893980952491,0.00192386800831978,-0.0255601793915558,-0.0180186167989423,1.12783574306009e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24522,-0.0350856090398201,0.00309817648420292,-0.0411580349488578,-0.0290131831307824,1.17475234761658e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29256,0.0343542967642855,0.003034356747192,0.0284069575397892,0.0403016359887818,1.18030128986411e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,29122,-0.0321966183905299,0.00284500110110979,-0.0377728205487051,-0.0266204162323547,1.24814066434019e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,23848,-0.0543487833491145,0.0048068232449572,-0.0637701569092306,-0.0449274097889983,1.44787315034868e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,29172,-0.0550396724406078,0.00487043982292309,-0.0645857344935371,-0.0454936103876785,1.49875889552292e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,24155,-0.0180099380986921,0.00159394381009485,-0.021134067966478,-0.0148858082309062,1.57481076237085e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29381,-0.0399949197523756,0.00354632167729356,-0.046945710239871,-0.0330441292648802,1.94066478850854e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29507,-0.0179853435661662,0.0015966680016953,-0.021114812849489,-0.0148558742828434,2.26103925243114e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,28908,-0.027654753701091,0.00245767624119258,-0.0324717991338284,-0.0228377082683535,2.59371554588141e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,28907,-0.0547886288918354,0.0048712599524262,-0.0643362983985907,-0.04524095938508,2.74671614655027e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29034,-0.0441893861748231,0.00393000247795866,-0.0518921910316221,-0.0364865813180241,2.84630199912007e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,23848,-0.0547076112793169,0.00486457782904013,-0.0642421838242356,-0.0451730387343983,2.86811229512313e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29256,-0.0270210560902809,0.00240696341372757,-0.031738704381187,-0.0223034077993749,3.47949014982061e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28467,-0.0517200553703644,0.00460813992279888,-0.0607520096190502,-0.0426881011216786,3.59539935359293e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24653,-0.0323747399029181,0.00288655265549522,-0.0380323831076888,-0.0267170966981475,4.01696202066863e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24579,-0.0787217487215848,0.00701988511810033,-0.0924807235530615,-0.0649627738901082,4.09202456380848e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24579,-0.0430007230702047,0.0038345464653433,-0.0505164341422776,-0.0354850119981319,4.09555989563077e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24539,-0.0386505428981617,0.0034488850562836,-0.0454103576084776,-0.0318907281878459,4.44964904326955e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29172,0.0630209384229232,0.0056314865038002,0.0519832248754748,0.0740586519703716,5.18242951072844e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,24699,0.0186486708797501,0.00166650767265644,0.0153823158413434,0.0219150259181567,5.34424270356227e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,28491,-0.0307214626559476,0.00274654697296064,-0.0361046947229504,-0.0253382305889447,5.52000880285676e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,23979,-0.074176803682197,0.00663115833011954,-0.0871738740092313,-0.0611797333551627,5.62716563698818e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29381,-0.0453371632601457,0.00407099750146358,-0.0533163183630144,-0.0373580081572771,9.50222854173272e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23974,-0.0447560286567685,0.00402937033980817,-0.0526535945227925,-0.0368584627907445,1.35546529670352e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24579,-0.0502667149399261,0.00452765730658489,-0.0591409232608324,-0.0413925066190197,1.43227135026214e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,29057,-0.0545458607721207,0.00491685838025555,-0.0641829031974216,-0.0449088183468199,1.53715532122919e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29089,-0.0669644915409748,0.00604384776493946,-0.0788104331602562,-0.0551185499216935,1.79330436003937e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29066,-0.0519979915903277,0.00469475409940127,-0.0611997096251542,-0.0427962735555012,1.8753409833995e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24539,-0.046528278359365,0.00420093932591935,-0.0547621194381669,-0.0382944372805631,1.92288242340138e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,28048,0.0250118913567663,0.00225996489569781,0.0205823601611986,0.029441422552334,2.06825729523711e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,29507,0.0188859441837789,0.00170681160814363,0.0155405934318174,0.0222312949357404,2.10851248500952e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,28952,-0.0182581446631082,0.00165425080127987,-0.0215004762336167,-0.0150158130925996,2.88158454818913e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,29122,-0.0293612457381523,0.00266183558158851,-0.0345784434780658,-0.0241440479982388,3.09976174285969e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28515,-0.0381824701431195,0.00346188000593919,-0.0449677549547603,-0.0313971853314787,3.14451305633719e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29034,-0.0446356126573527,0.00405152425417778,-0.0525766001955411,-0.0366946251191642,3.59897657835522e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,29507,-0.0335168270573887,0.00304323420050149,-0.0394815660903716,-0.0275520880244058,3.73075051115929e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28612,-0.0384486768291291,0.00349224405077722,-0.0452934751686525,-0.0316038784896058,3.90710191915497e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24435,-0.0239824222073952,0.00217868851871102,-0.0282526517040688,-0.0197121927107216,4.08401502917012e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,23974,-0.0715000017258467,0.00650769837267129,-0.0842550905362825,-0.058744912915411,5.14924053194529e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24529,-0.0405199612269795,0.00369385460150372,-0.0477599162459268,-0.0332800062080322,6.21715696447539e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29172,-0.0654962436173215,0.00597471010678445,-0.077206675426619,-0.053785811808024,6.58032130435825e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,23940,-0.0540683981417249,0.00493152066990538,-0.0637341786547395,-0.0444026176287104,6.64541308537637e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,24067,-0.0812588726524866,0.00741308969886617,-0.0957885284622643,-0.0667292168427089,6.81014716484787e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,24579,-0.0174826126667944,0.00159600945014282,-0.0206107911890743,-0.0143544341445144,7.37911781892107e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,29327,-0.0546851207809857,0.00499941816764018,-0.0644839803895604,-0.0448862611724109,8.55698030361318e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,24491,-0.0693973994255482,0.00634413667781349,-0.0818319073140626,-0.0569628915370337,8.71750616223073e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,23940,-0.0387282004462346,0.00354087356504495,-0.0456683126337227,-0.0317880882587465,8.87816174048655e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28491,-0.0665282371194189,0.00608452021964364,-0.0784538967499204,-0.0546025774889173,9.00143987097972e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24579,0.0288680350305251,0.00264168692456848,0.0236903286583709,0.0340457414026793,9.82449534647324e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,29132,0.0227988885180531,0.00208677102464495,0.018708817309749,0.0268889597263573,9.86230024894385e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,28444,0.0938170652605573,0.00859099820947717,0.0769787087699821,0.110655421751133,1.04548004922485e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28491,-0.0310034326493776,0.00284044503580745,-0.0365707049195602,-0.025436160379195,1.10900881103993e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,29327,0.0198966935829855,0.00182308191067163,0.0163234530380691,0.0234699341279019,1.11994137988611e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,24035,-0.0515864907741713,0.00472638514843795,-0.0608502056651097,-0.0423227758832329,1.14039100820396e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,29271,-0.0317304542706281,0.00291010821320026,-0.0374342663685006,-0.0260266421727556,1.25314461592886e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,29256,-0.0488312698172252,0.00449141648832179,-0.0576344461343359,-0.0400280935001145,1.76656208317012e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,29122,-0.0530060999738641,0.00487541938636433,-0.0625619219711382,-0.04345027797659,1.76793985087882e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24119,-0.0645276079606368,0.00594789082667098,-0.076185473980912,-0.0528697419403617,2.33681201226482e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,29172,-0.0513758083203833,0.00473707330303364,-0.0606604719943292,-0.0420911446464373,2.36335482534944e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23935,-0.0279888148197327,0.00258241863833297,-0.0330503553508653,-0.0229272742886001,2.62554266840189e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,24185,-0.0265089748969837,0.00244678733496517,-0.0313046780735154,-0.021713271720452,2.73875854327031e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29172,-0.024872910065645,0.00229705905909367,-0.0293751458214686,-0.0203706743098214,2.85362892407798e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,29122,-0.0606725334886618,0.00560710836792497,-0.0716624658897947,-0.0496826010875288,3.09697515293825e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,23979,-0.0237200861734663,0.00219369659683731,-0.0280197315032674,-0.0194204408436652,3.45811166955987e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,28631,-0.0376459855699381,0.00348452373696468,-0.0444756520943889,-0.0308163190454874,3.72752144990215e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,29256,-0.0531499981644672,0.00492091451665719,-0.0627949906171153,-0.0435050057118191,3.8380499025366e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,24579,-0.065283454808453,0.00604482483665923,-0.0771313114883051,-0.0534355981286009,3.96543313233163e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24653,-0.0696584031977473,0.00645470060586494,-0.0823096163852426,-0.057007190010252,4.32290510207909e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,29122,-0.0522493019184288,0.00484963266599517,-0.0617545819437793,-0.0427440218930783,5.14346587992066e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23979,-0.0372311649808593,0.00345835852496732,-0.0440095476897953,-0.0304527822719234,5.769828219812e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,24669,0.0400587745414153,0.00372738771076862,0.0327530946283088,0.0473644544545218,7.01119513211683e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29260,-0.0862391958677216,0.00803132109881451,-0.101980585221398,-0.0704978065140451,7.58544976254842e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,29507,0.0226696049356642,0.0021118335671698,0.0185304111440114,0.026808798727317,7.85263874346865e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,29034,-0.0235233876680592,0.00219218001514611,-0.0278200604977456,-0.0192267148383728,8.2111992735597e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,29129,0.0454149540926243,0.00423262502878227,0.0371190090362111,0.0537108991490376,8.28401725778945e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24529,-0.0222975647942615,0.00207878755160691,-0.026371988395411,-0.0182231411931119,8.79020999763473e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28467,-0.0517970678950757,0.00483649421631617,-0.0612765965590554,-0.042317539231096,1.03140830482816e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAX,Protein max,28467,-0.0809110616933311,0.00755825802625007,-0.0957252474247812,-0.0660968759618809,1.08422223995385e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25698,0.0239528322774053,0.00223745163721713,0.0195674270684597,0.0283382374863508,1.09301022250935e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29226,-0.0391393250994708,0.00365772827075009,-0.046308472510141,-0.0319701776888007,1.13503431614028e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,23974,-0.069838139471441,0.00652574740005559,-0.08262860437555,-0.0570476745673321,1.14513813335346e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,29445,0.0353251810428228,0.00330641309387918,0.0288446113788196,0.041805750706826,1.35558542493695e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24579,-0.0510445760875271,0.00477692850264789,-0.060407355952717,-0.0416817962223373,1.35933539876537e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,24653,-0.0412096692313104,0.00385718539076775,-0.0487697525972152,-0.0336495858654056,1.38494344537613e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24529,-0.0828850588924752,0.00775950578834244,-0.0980936902376264,-0.067676427547324,1.4178417935841e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24602,-0.0606621282421188,0.00569713752024266,-0.0718285177817944,-0.0494957387024431,2.03789959927561e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29034,0.0202776561403855,0.00190773879904289,0.0165384880942615,0.0240168241865096,2.43823225775052e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C3,Complement C3,23519,-0.0355598538630929,0.00334610610668972,-0.0421182218322048,-0.029001485893981,2.55460050355253e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,23974,-0.0350747807579551,0.00330205870522445,-0.041546815820195,-0.0286027456957152,2.6915404582989e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24653,-0.0193519965583939,0.0018226765618322,-0.022924442619585,-0.0157795504972028,2.8207387115067e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,29034,0.0344057629845093,0.00324666184906406,0.0280423057603437,0.0407692202086748,3.42567980222111e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,29061,-0.0507082898099675,0.00478734327956718,-0.0600914826379192,-0.0413250969820159,3.61709709821948e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24618,0.0112609463223376,0.00106418785519138,0.00917513812616249,0.0133467545185127,4.12201900351083e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24539,-0.0580051353123196,0.00548535537158511,-0.0687564318406264,-0.0472538387840128,4.45070674370614e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,28853,-0.0573357419618336,0.00542892644234886,-0.0679764377888374,-0.0466950461348299,5.03263043978882e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29145,-0.0393788931498686,0.0037315800793857,-0.0466927901054646,-0.0320649961942727,5.48888572891771e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24602,-0.064785814611276,0.00613911162759807,-0.0768184734013682,-0.0527531558211838,5.59397446979842e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,29418,0.0269241011267061,0.00255249915961088,0.0219212027738688,0.0319269994795435,5.76606615330424e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24185,-0.0336733819247991,0.00319253442917932,-0.0399307494059905,-0.0274160144436076,5.93786042434102e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29409,-0.0406375041354867,0.00386643004147826,-0.048215707016784,-0.0330593012541893,8.60159894243209e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,28491,-0.0394823511700704,0.00376866892365283,-0.04686894226043,-0.0320957600797109,1.2336392939945e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,28631,-0.0496702784105117,0.00474118876553479,-0.0589630083909599,-0.0403775484300635,1.23477087703089e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29470,-0.0255543206927764,0.00243973329010979,-0.0303361979413916,-0.0207724434441613,1.25864606452731e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,24467,-0.0350853650197335,0.00334939085809017,-0.0416501711015902,-0.0285205589378767,1.27317301606583e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29049,-0.0202631180539282,0.00193748394963379,-0.0240605865952104,-0.016465649512646,1.4878159265211e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24185,-0.0423605384335663,0.00405134599579365,-0.0503011765853218,-0.0344199002818107,1.5606702663383e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,29311,-0.0443046692339911,0.00424521533327275,-0.0526252912872057,-0.0359840471807765,1.87461165174115e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,28908,-0.0247902042332828,0.00237633893318137,-0.0294478285423183,-0.0201325799242473,1.96344774339696e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24539,-0.0656826299864249,0.00630561449825961,-0.0780416344030137,-0.0533236255698361,2.35425586691795e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28491,-0.0386599042816349,0.0037130567880532,-0.0459374955862192,-0.0313823129770507,2.43036273197328e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28467,-0.0552534147087559,0.00530813474945503,-0.0656573588176877,-0.044849470599824,2.49983483194454e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,23979,-0.0550418305804856,0.00528850431675143,-0.0654072990413184,-0.0446763621196528,2.58601234503907e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,23940,-0.034039535892423,0.00327305109383501,-0.0404547160363396,-0.0276243557485064,2.8087192916456e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,28239,-0.0570464731712771,0.00549226746845783,-0.0678113174094545,-0.0462816289330998,3.1655334913707e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,24579,-0.0744637200925408,0.00717155056959702,-0.088519959208951,-0.0604074809761307,3.33399202434882e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,28716,-0.016684353607663,0.00160747012957603,-0.019834995061632,-0.013533712153694,3.41476813746512e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,24372,-0.0741866629820326,0.00714670449043061,-0.0881942037832766,-0.0601791221807886,3.43160303009302e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24539,-0.039507322961991,0.00380842539772688,-0.0469718367415357,-0.0320428091824463,3.6837006912397e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDK,Midkine,29146,-0.0378338236033905,0.0036484791396015,-0.0449848427170095,-0.0306828044897716,3.76517136097611e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23924,-0.0206795378929791,0.00199522568528584,-0.0245901802361394,-0.0167688955498189,4.06468166473623e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,24567,-0.0192418418899758,0.00185713141071208,-0.0228818194549715,-0.0156018643249801,4.20010525278921e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,24529,-0.0358790296496656,0.00346522599769315,-0.0426708726051441,-0.029087186694187,4.51986146335636e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,28727,-0.0217108941861164,0.00209729796861573,-0.0258215982046033,-0.0176001901676296,4.54413465689354e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,24539,-0.0629357037319386,0.0060813299506042,-0.0748551104351229,-0.0510162970287544,4.76187956452291e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29073,0.0189232626074365,0.00183146561818351,0.0153335899957968,0.0225129352190762,5.56095098814156e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24416,-0.0450200721680924,0.00435797533399481,-0.0535617038227222,-0.0364784405134626,5.77451934349365e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,29256,0.029650391560075,0.00287270642616698,0.0240198869647878,0.0352808961553623,6.22298661496965e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29280,-0.0340163959780796,0.00330087958219383,-0.0404861199591795,-0.0275466719969797,7.35794049051627e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,29234,-0.0220194399611908,0.00213714039705959,-0.0262082351394276,-0.017830644782954,7.51521653248696e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,24551,-0.0479361414466142,0.00465187286359663,-0.0570538122592636,-0.0388184706339648,7.54089988139424e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,28739,-0.0507933137015014,0.00493242993194648,-0.0604608763681165,-0.0411257510348863,7.96076274658928e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24529,-0.0507260025918899,0.00492659162432569,-0.0603821221755683,-0.0410698830082116,8.22071897309977e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,29132,-0.0559564254382403,0.00543994495889158,-0.0666187175576678,-0.0452941333188128,8.96572394017318e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29507,0.0184424346579395,0.001794854815554,0.0149245192194536,0.0219603500964253,1.00377461476394e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,24602,-0.0565025563101932,0.00550580487836925,-0.0672939338717969,-0.0457111787485894,1.16770836105644e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23848,-0.0206190327327415,0.00201230420581152,-0.0245631489761321,-0.0166749164893509,1.38031955891513e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,29470,-0.0340998784607882,0.00333292742376781,-0.0406324162113731,-0.0275673407102033,1.57963545258378e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,23848,-0.0435590477773144,0.00425862505223948,-0.0519059528797038,-0.035212142674925,1.66197377940604e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,29381,-0.0385343080911718,0.0037682285978962,-0.0459200361430483,-0.0311485800392953,1.66525056681519e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,23974,-0.0422929572075399,0.00413588157469118,-0.0503992850939346,-0.0341866293211452,1.70536691551322e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,24579,-0.049878043635543,0.00488329855475024,-0.0594493088028535,-0.0403067784682325,1.92076390134844e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28491,-0.0245725170231119,0.00240638915813572,-0.0292890397730579,-0.0198559942731659,1.94338977547491e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24602,-0.0358873374551169,0.00351444869250586,-0.0427756568924284,-0.0289990180178055,1.97324398854763e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24653,-0.0651094937124814,0.00637761853100674,-0.0776096260332546,-0.0526093613917081,2.02011247176292e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,24535,-0.0236016949637566,0.00231420210072987,-0.0281375310811872,-0.0190658588463261,2.24937815284256e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29034,-0.0148562853319312,0.00145728260234442,-0.0177125592325263,-0.0120000114313361,2.30612049117017e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,24510,-0.0693259574705015,0.00680027257871968,-0.0826544917247921,-0.0559974232162109,2.34490125537456e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28491,-0.0557864642584804,0.00547420725774047,-0.0665159104836517,-0.0450570180333091,2.40028038092033e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,29507,-0.0643162809815864,0.00631744556835254,-0.0766984742955574,-0.0519340876676154,2.65162623825527e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28491,-0.0423481125609652,0.00416059856483444,-0.0505028857480407,-0.0341933393738897,2.72576394434743e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,24579,-0.033396896598847,0.00328150149284272,-0.0398286395248187,-0.0269651536728752,2.79739820045357e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,24185,-0.0398293342608392,0.00391351564897307,-0.0474998249328265,-0.032158843588852,2.80079186116072e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24653,-0.0220871493036555,0.00217182345174811,-0.0263439232690818,-0.0178303753382292,3.01810172040041e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23974,-0.0584844298231893,0.00575858044282746,-0.0697712474911311,-0.0471976121552475,3.48638350890794e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,29034,-0.0600557548479661,0.00591666157764422,-0.0716524115401488,-0.0484590981557835,3.6262443306476e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,24529,-0.0297618508129782,0.00293215240678765,-0.035508869530282,-0.0240148320956744,3.69253504733558e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24635,-0.0349972340906756,0.00345351469529824,-0.0417661228934602,-0.0282283452878911,4.36121376621538e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,28908,-0.0277377536518781,0.00273788222780386,-0.0331040028183736,-0.0223715044853825,4.41165458720333e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BSG,Basigin,29445,-0.0149128018089682,0.00147307943431623,-0.017800037500228,-0.0120255661177084,4.75601328930015e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24653,-0.0449443604853927,0.0044418904500544,-0.0536504657674993,-0.0362382552032861,5.10660887992081e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,28853,0.0352404645676103,0.00348359648854588,0.0284126154500604,0.0420683136851602,5.13980216027909e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,29359,-0.0376443600558673,0.00372210362523235,-0.0449396831613227,-0.0303490369504119,5.25761745862544e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,29122,0.0192679359392354,0.00190609962905168,0.0155319806662941,0.0230038912121766,5.54534407021207e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24602,-0.0307359564080354,0.00304199832957203,-0.0366982731339966,-0.0247736396820742,5.91448908503461e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,29034,-0.0543257827237541,0.00538048395622307,-0.0648715312779514,-0.0437800341695569,6.25026452997429e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,24119,0.0373933419035604,0.00372913805929522,0.0300842313073418,0.044702452499779,1.28592953344842e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29271,-0.0198078281147751,0.00197868393372939,-0.0236860486248847,-0.0159296076046655,1.49401569942511e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24065,-0.0392411360350972,0.00391997391198368,-0.0469242849025852,-0.0315579871676092,1.5231625651836e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,29034,0.0552040504851242,0.00551642776674661,0.0443918520623009,0.0660162489079476,1.54712714476577e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,29256,0.0197810080047811,0.00197738606574599,0.0159053313159189,0.0236566846936432,1.6030936325562e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,23974,-0.0251960397111827,0.00252051803859522,-0.0301362550668293,-0.0202558243555361,1.75752270844694e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,23979,-0.0844771185080663,0.00846593185199053,-0.101070344937968,-0.0678838920781649,2.10353223845956e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29145,-0.0278005577756777,0.00278751907230972,-0.0332640951574047,-0.0223370203939507,2.17654243202517e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24602,-0.0276381627954854,0.00277167303540174,-0.0330706419448728,-0.022205683646098,2.24663593125925e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29034,-0.0427185529563501,0.00429128069515264,-0.0511294631188493,-0.034307642793851,2.62090241258392e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,29226,-0.0411335336475848,0.00413258735703889,-0.0492334048673811,-0.0330336624277886,2.65310046718916e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,29226,-0.0409220729602685,0.00411363985367629,-0.048984807073474,-0.032859338847063,2.80499961984265e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23974,-0.0256932436028479,0.00258412025572668,-0.0307581193040722,-0.0206283679016236,3.00904503229347e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24653,-0.0702129136413243,0.00706236062394948,-0.0840551404642653,-0.0563706868183834,3.0274642301672e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24119,-0.0851087098346757,0.0085682880364118,-0.101902554386043,-0.0683148652833085,3.31513585895072e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,23848,-0.0489045988603065,0.00492841488691992,-0.0585642920386695,-0.0392449056819435,3.66758260753579e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,29132,0.0171318653781448,0.00172707810004626,0.0137467923020541,0.0205169384542355,3.72461863158329e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,24119,-0.061241443495538,0.00617379087714748,-0.0733420736147471,-0.049140813376329,3.78984955143212e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,28908,0.0815278259062621,0.00822406694792993,0.0654086546883194,0.0976469971242047,3.96672600596989e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24602,-0.033832939154481,0.00341452915556219,-0.0405254162993829,-0.0271404620095791,4.22344673022025e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,28908,0.029949732484804,0.00302771189268724,0.024015417175137,0.035884047794471,4.91244773924441e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24602,-0.0336545123957872,0.00340212012136377,-0.0403226678336602,-0.0269863569579142,4.96813484592779e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_E,,29122,-0.0205955737073531,0.00208356544458667,-0.0246793619787429,-0.0165117854359632,5.26871683255228e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29187,0.0169434157398223,0.0017152918587791,0.0135814436966153,0.0203053877830294,5.64268786747316e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,28612,-0.0598389724484491,0.00606232722141429,-0.0717211338024211,-0.0479568110944771,6.07349589715995e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28491,-0.0478135909888062,0.00484581139374591,-0.0573113813205482,-0.0383158006570643,6.2989827123641e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29034,-0.0733031685860905,0.00743730793280946,-0.087880292134397,-0.0587260450377839,7.00435875751156e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29256,-0.05900893719004,0.00600009653575289,-0.0707691264001157,-0.0472487479799644,8.66073039682142e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29187,-0.0188244990488525,0.00191505783513531,-0.0225780124057177,-0.0150709856919873,9.096157540776e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,24683,-0.0644883369988337,0.00657691937142077,-0.0773790989668184,-0.051597575030849,1.17577266985805e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,29381,0.0211110481944143,0.00215620872880485,0.0168848790859567,0.0253372173028718,1.3351966679864e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24579,-0.0209505775072401,0.00214333750493157,-0.025151519016906,-0.0167496359975742,1.58859683291822e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28491,-0.0399265741599051,0.00409195657161853,-0.0479468090402774,-0.0319063392795327,1.86102141388377e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24602,-0.0471327329407506,0.00483207951597798,-0.0566036087920675,-0.0376618570894338,1.94514698465625e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,29409,-0.0300706341276711,0.0030898460399882,-0.036126732366048,-0.0240145358892942,2.37829457070482e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",28853,-0.0670327945419072,0.00689018966233543,-0.0805375662800847,-0.0535280228037298,2.46138121665609e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,23979,-0.0634160579066523,0.00652523509211661,-0.0762055186872009,-0.0506265971261038,2.76223284486744e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24653,-0.0514641893941628,0.00529712937698261,-0.0618465629730487,-0.0410818158152769,2.83989212049116e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24579,0.0474497621163623,0.00489125114710603,0.0378629098680345,0.0570366143646901,3.27438611569277e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28467,-0.02670572730173,0.00275577333943093,-0.0321070430470147,-0.0213044115564454,3.5694198363902e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,29476,0.0298443608122418,0.00308418707392527,0.0237993541473482,0.0358893674771353,4.09085348757912e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,28712,-0.0521466803281219,0.00539098070276524,-0.0627130025055418,-0.0415803581507021,4.24644024893023e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,28467,-0.0427181065430269,0.00441697082084376,-0.0513753693518806,-0.0340608437341731,4.31563482486338e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,24119,-0.029822842255564,0.00308320640880905,-0.0358659268168298,-0.0237797576942983,4.32128662467454e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,29034,-0.0205849689925111,0.00212919514184794,-0.0247581914705331,-0.0164117465144891,4.45413878086804e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,24119,-0.0230606617077179,0.00238521629707486,-0.0277356856499846,-0.0183856377654512,4.51511180957331e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24529,-0.0656058523479401,0.00679839979153721,-0.078930715939353,-0.0522809887565272,5.36907333896964e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,24529,-0.0490549951337214,0.00508689442086818,-0.0590253081986231,-0.0390846820688198,5.73466005300548e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,28770,0.0264077942846746,0.00273925729304149,0.0210388499903133,0.0317767385790359,5.82172874640037e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,29473,-0.0162775284208225,0.00169162596319749,-0.0195931153086896,-0.0129619415329555,6.92530903299902e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,29367,-0.0416446318857041,0.0043447537842639,-0.0501603493028614,-0.0331289144685469,9.94517612286292e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,29381,0.0201444273696253,0.00210217848313748,0.0160241575426759,0.0242646971965748,1.01774626121843e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,23974,-0.0301202906959817,0.00314529846592855,-0.0362850756892016,-0.0239555057027617,1.10003616039154e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,28566,-0.0343833944540247,0.00359243907528802,-0.0414245750415892,-0.0273422138664602,1.14063470093067e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,24579,-0.0487839787673273,0.00509696903550681,-0.0587740380769207,-0.038793919457734,1.15311101338102e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,23843,-0.0683125958843851,0.00715653661054573,-0.0823394076410547,-0.0542857841277155,1.48052683862181e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29122,-0.0257923520402002,0.00270347585322944,-0.0310911647125299,-0.0204935393678705,1.52929608782563e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,29381,-0.0538861756547753,0.00565249314072195,-0.0649650622105903,-0.0428072890989603,1.63893353280509e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24602,-0.0404018993500531,0.00423852430659313,-0.0487094069909756,-0.0320943917091305,1.67955549220221e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,29507,-0.0386204325384585,0.00405338430679663,-0.0465650657797799,-0.0306757992971371,1.7226988269826e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,24669,-0.056845280291919,0.00597524861902689,-0.0685567675852117,-0.0451337929986263,2.00724103781866e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24185,-0.0504131608092556,0.00530077300645132,-0.0608026759019002,-0.040023645716611,2.06784188830737e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28612,-0.0757979317928392,0.00797460236747022,-0.0914281524330808,-0.0601677111525975,2.15320315289954e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24119,-0.0413488633915311,0.00435014349672775,-0.0498751446451175,-0.0328225821379447,2.17720278982269e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,24539,-0.0388483411243338,0.00408837452034941,-0.0468615551842186,-0.0308351270644489,2.23783740202003e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,23756,-0.0384199326436363,0.00404689840666587,-0.0463518535207014,-0.0304880117665712,2.43355881525721e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24579,-0.0262270528091119,0.00276341511189831,-0.0316433464284326,-0.0208107591897912,2.49378032489238e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,24683,-0.0166488789413672,0.00175559697666578,-0.0200898490156321,-0.0132079088671023,2.67803074528029e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,29172,-0.0165511759043874,0.0017475468428842,-0.0199763677164404,-0.0131259840923343,2.97126596055285e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,28779,-0.0792918436222327,0.0083737094630825,-0.0957043141698744,-0.062879373074591,3.0299700077136e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28467,-0.0761237040334013,0.00804252213846937,-0.0918870474248012,-0.0603603606420013,3.14995290131401e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFP,Properdin,24699,-0.0156709489658188,0.00165605297933697,-0.0189168128053193,-0.0124250851263183,3.25594270415929e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,23848,-0.0454463363663274,0.00480498741933186,-0.0548641117082179,-0.036028561024437,3.41419361713214e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,28491,-0.0394465294099718,0.00417210127179729,-0.0476238479026945,-0.0312692109172492,3.47534836396339e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24539,-0.0321076092009712,0.00339749183429489,-0.0387666931961891,-0.0254485252057532,3.66768739556285e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,28540,-0.0299039203165153,0.00316704046489653,-0.0361113196277125,-0.0236965210053181,3.91812795945869e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,23848,-0.0470687224716781,0.00499072556762612,-0.0568505445842253,-0.0372869003591309,4.41069530388676e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,29132,-0.0495480668975394,0.00526007108696627,-0.0598578062279933,-0.0392383275670855,4.84878616786301e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,23974,-0.0383328371988615,0.00406959099202969,-0.0463092355432397,-0.0303564388544833,4.93625257543668e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28612,-0.0627544497072297,0.00666868102174708,-0.075825064509854,-0.0496838349046054,5.30445640211303e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29122,-0.0675119205646538,0.00717624399206557,-0.0815773587891024,-0.0534464823402053,5.43169502435077e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,28467,-0.0351624827847412,0.00374165467555809,-0.0424961259488351,-0.0278288396206473,5.9878949780131e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,24653,-0.0186198087208546,0.00198159816219319,-0.0225037411187532,-0.0147358763229559,6.1230003554793e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,29409,-0.0256043330319676,0.00273508364197557,-0.0309650969702397,-0.0202435690936955,8.40767087020388e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,23974,-0.0581462993179975,0.00621198125619367,-0.0703217825801371,-0.0459708160558579,8.62427030005668e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,29381,-0.0201939598058759,0.0021583928141807,-0.0244244097216701,-0.0159635098900818,8.84997780446114e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,23243,-0.0831265154217583,0.00889022116291951,-0.100551348901081,-0.065701681942436,9.50230079806068e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29256,-0.0180647045286798,0.00193294824883139,-0.0218532830963893,-0.0142761259609703,9.75913156243034e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,23940,-0.0458313455856052,0.0049074137031654,-0.0554498764438094,-0.036212814727401,1.05259813194392e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",28853,-0.0489363030455044,0.00524719879614755,-0.0592208126859536,-0.0386517934050552,1.17358386425259e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,24602,0.0311680110711172,0.00334307251672806,0.0246155889383302,0.0377204332039042,1.22130996056726e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,23979,-0.0161183965167677,0.00173313426562484,-0.0195153396773924,-0.012721453356143,1.51884599935376e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,23979,-0.054121681601589,0.00582208108394502,-0.0655329605261212,-0.0427104026770568,1.57993960615489e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29122,-0.0545127895994941,0.00587498904928427,-0.0660277681360913,-0.0429978110628969,1.82927444635867e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24581,-0.0133359941464041,0.00143809180466464,-0.0161546540835468,-0.0105173342092614,1.94709602275384e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24529,-0.0290349119902502,0.00314155974797636,-0.0351923690962838,-0.0228774548842165,2.60547558135951e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,24653,-0.0476875966530339,0.00516925001274732,-0.0578193266780186,-0.0375558666280491,3.04959499192633e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23979,0.0139391921899655,0.00151330920392922,0.0109731061502642,0.0169052782296668,3.48631529232222e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,23979,-0.0343236641060749,0.00373211648641626,-0.0416386124194508,-0.0270087157926991,3.97835276674343e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,29062,0.0416655009855643,0.0045319810110416,0.0327828182039228,0.0505481837672058,4.04304907205192e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24539,-0.0633712937304323,0.00689330298776258,-0.076882167586447,-0.0498604198744177,4.10880446483889e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,24539,-0.0237219305207549,0.00258355479396694,-0.0287856979169301,-0.0186581631245797,4.5609864149287e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,29372,-0.0615406149803429,0.00671457938378127,-0.0747011905725542,-0.0483800393881316,5.25755446353263e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29122,-0.0285278308973333,0.00311479740579561,-0.0346328338126927,-0.022422827981974,5.58161490088267e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,24602,-0.0381356435080094,0.0041655418977613,-0.0463001056276216,-0.0299711813883973,5.84578228143623e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23979,-0.0674657895166877,0.00736931758050897,-0.0819096519744852,-0.0530219270588901,5.86054489930194e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24669,-0.0400180824243387,0.00437326274387019,-0.0485896774023243,-0.0314464874463532,6.08693521916095e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29409,-0.0411037579720568,0.00450003687098202,-0.0499238302391815,-0.032283685704932,7.00704328571671e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29445,-0.0336490798214503,0.00368916692497662,-0.0408798469944045,-0.0264183126484961,7.9006519150723e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29215,-0.0781433053320342,0.00857174452860733,-0.0949439246081046,-0.0613426860559638,8.25123574220171e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,28612,-0.0343399564083489,0.00377568079581363,-0.0417402907681436,-0.0269396220485542,1.00515509185106e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,23979,-0.0336369888315411,0.0037010190752659,-0.0408909862190623,-0.02638299144402,1.07915337528415e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,23782,-0.0360557389062701,0.00396987506492823,-0.0438366940335294,-0.0282747837790108,1.14331738058955e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,28491,-0.0525143408687617,0.00578964197177558,-0.0638620391334419,-0.0411666426040816,1.26012597976472e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,23756,-0.0332926547317909,0.00367193281386272,-0.0404896430469618,-0.0260956664166199,1.31816320534262e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,29132,-0.078818318091733,0.00870670249900288,-0.0958834549897787,-0.0617531811936874,1.48077247379107e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29271,-0.0175485344917666,0.00193880865200907,-0.0213485994497044,-0.0137484695338289,1.49952045483983e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,24651,-0.0239116271035109,0.00264583763047224,-0.0290974688592364,-0.0187257853477853,1.71856447263707e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,23940,-0.0398254688644208,0.0044072018917848,-0.048463584572319,-0.0311873531565226,1.73783764650429e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,23979,-0.0502717859537438,0.0055679296793359,-0.0611849281252422,-0.0393586437822454,1.86289684149084e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,23979,-0.0367654096647079,0.00407615431314894,-0.0447546721184798,-0.028776147210936,2.0252286192317e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAT,Catalase,24326,-0.0345884598082855,0.00384845549367066,-0.04213143257588,-0.027045487040691,2.70577868590238e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,23979,0.0275746420494149,0.0030727851852706,0.0215519830862845,0.0335973010125453,3.0689730289645e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,29009,-0.050786232344039,0.00566447807805291,-0.0618886093770228,-0.0396838553110553,3.26280925217837e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28491,-0.0281955691287457,0.003146381759644,-0.0343624773776479,-0.0220286608798434,3.40102048382073e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,24493,-0.0183256551803485,0.00204599445488627,-0.0223358043119255,-0.0143155060487714,3.57328985135329e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,29122,-0.0218391292796387,0.00244212549785591,-0.0266256952554362,-0.0170525633038411,4.01825895371279e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29034,-0.0604485695441923,0.00676094649524657,-0.0737000246748756,-0.047197114413509,4.08582459364675e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,23848,-0.0453100691599346,0.00506976211983794,-0.0552468029148169,-0.0353733354050522,4.26978186698333e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24185,-0.0486043922626024,0.00544228090557961,-0.0592712628375384,-0.0379375216876664,4.5202642535773e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,29145,-0.0168721719128903,0.00189094627614997,-0.0205784266141443,-0.0131659172116364,4.81499861700625e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24653,-0.0182809374567708,0.00204919579057001,-0.022297361206288,-0.0142645137072535,4.93356531025807e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,29172,-0.0436732143846954,0.00490930044502123,-0.053295443256937,-0.0340509855124538,6.11572198682942e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,29172,-0.0272235675076724,0.00306197050195784,-0.0332250296915098,-0.0212221053238351,6.40518494312195e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,24119,0.0182355457011782,0.00205376421704337,0.0142101678357732,0.0222609235665832,7.20084064146522e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29156,-0.060406615084378,0.00681073885956139,-0.0737556632491183,-0.0470575669196377,7.77037008018154e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,28467,-0.0194809271576997,0.0021965948788944,-0.0237862531203327,-0.0151756011950666,7.82426294167706e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,29132,0.0164358061317864,0.00185482053303882,0.0128003578870303,0.0200712543765425,8.36169864910713e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,24648,-0.0143682892578023,0.00162537028244533,-0.0175540150113952,-0.0111825635042094,1.01976599549846e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,28580,-0.0261536943759519,0.00296006939693872,-0.0319554303939517,-0.020351958357952,1.05242873276909e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,28450,-0.0696231229436055,0.00788408811457551,-0.0850759356481735,-0.0541703102390375,1.09736752353749e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,23843,-0.040744389685635,0.00462025072733951,-0.0498000811112204,-0.0316886982600495,1.23616236115286e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,28823,-0.0190077969074313,0.00215670964338177,-0.0232349478084595,-0.014780646006403,1.28169894471883e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28612,-0.0558468257819446,0.00633988520132083,-0.0682730007765334,-0.0434206507873557,1.33487445884285e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,29034,-0.0853477024606582,0.00970341603445635,-0.104366397888193,-0.0663290070331238,1.4995261054853e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24119,-0.0795818067646302,0.00905145418961288,-0.0973226569762714,-0.0618409565529889,1.56323764614777e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24579,-0.0295261380532887,0.0033591344802826,-0.0361100416346425,-0.0229422344719348,1.59431349232949e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24602,-0.0559565810377053,0.00636935952027805,-0.0684405256974503,-0.0434726363779603,1.65957845622405e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23974,-0.0222323841543236,0.00253223792270689,-0.0271955704828291,-0.0172691978258181,1.74592439265953e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,23974,-0.027540669299011,0.00313937305102579,-0.0336938404790216,-0.0213874981190005,1.85880685163397e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24579,-0.0234920771416008,0.00267901902228699,-0.0287429544252833,-0.0182411998579183,1.91866526358682e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24119,-0.055144872511019,0.00629280872089757,-0.0674787776039783,-0.0428109674180598,2.02123917580705e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,28975,-0.0378690865854068,0.00432342810427506,-0.0463430056697859,-0.0293951675010277,2.07435508320553e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,29160,0.0136858845287164,0.00156327382219351,0.0106218678372171,0.0167499012202157,2.15617833937926e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,29256,0.0172600449991051,0.00197481978380097,0.0133893982228552,0.021130691775355,2.45199311046455e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,29111,-0.0595400203161812,0.00682097390057674,-0.0729091291613116,-0.0461709114710508,2.70494820965602e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,23848,-0.0378925562218673,0.00434481497073602,-0.0464083935645099,-0.0293767188792247,2.92585335381016e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,29470,0.0055489791769275,0.000639327178525384,0.00429589790701774,0.00680206044683725,4.17973460738186e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24653,-0.0202520125790007,0.00233348343252032,-0.0248256401067405,-0.0156783850512609,4.23978082324724e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29132,-0.026297639935041,0.00303757550204038,-0.0322512879190401,-0.0203439919510418,5.06906089561933e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,28882,-0.0296383129088479,0.00342443274684775,-0.0363502010926695,-0.0229264247250264,5.18281478250205e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24602,-0.0619209322711263,0.00716296982170113,-0.0759603531216606,-0.0478815114205921,5.72336423276472e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,23843,-0.0340220604990731,0.00393558123509869,-0.0417357997198666,-0.0263083212782797,5.72662185415923e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29079,-0.0179120434022512,0.0020729524177855,-0.0219750301411107,-0.0138490566633916,5.8613661857425e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,28415,-0.0442533711159081,0.00512331869417702,-0.054295075756495,-0.0342116664753211,6.03426316082892e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24119,-0.0251129429531835,0.0029130151006854,-0.0308224525505268,-0.0194034333558401,7.04183049418319e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,24272,-0.0203362439826091,0.002364579325964,-0.0249708194614985,-0.0157016685037196,8.41901601548191e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24653,-0.0439509757099132,0.00511089312073108,-0.0539683262265462,-0.0339336251932803,8.47707360254233e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24602,0.0162208239718489,0.00188885305727688,0.0125186719795862,0.0199229759641116,9.39359753422616e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,24119,-0.0587483851055466,0.006846343516405,-0.0721672183977004,-0.0453295518133928,9.96428500896249e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,28467,-0.0440221031460217,0.00513112238233823,-0.0540791030154047,-0.0339651032766388,1.00113610929645e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,29034,-0.0258504679925574,0.00301354670321689,-0.0317570195308625,-0.0199439164542523,1.01188792057866e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,24185,-0.0458591418984087,0.0053538640872546,-0.0563527155094277,-0.0353655682873897,1.13813523789318e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,29132,0.0194085554807198,0.00226825902385251,0.0149627677939689,0.0238543431674708,1.21876477081168e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",28908,-0.0357252828798609,0.00417754455957088,-0.0439132702166198,-0.027537295543102,1.27136847115762e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23979,-0.0260582015582539,0.00304880548692058,-0.0320338603126182,-0.0200825428038896,1.33725239535779e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",23979,-0.0536327566178808,0.00628097976275347,-0.0659434769528776,-0.041322036282884,1.43413716419877e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,29507,0.0184751942155449,0.00216438287096322,0.014233003788457,0.0227173846426329,1.45499023433755e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,29034,0.0179889686823493,0.00210794272829697,0.0138574009348872,0.0221205364298114,1.48285765756639e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24119,-0.0227273375237695,0.00266394049420758,-0.0279486608924164,-0.0175060141551227,1.52868897378904e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,28331,-0.0685508315383144,0.00803849190476797,-0.0843062756716596,-0.0527953874049692,1.56443277971296e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,24539,-0.02077493426752,0.00243768502491272,-0.025552796916349,-0.0159970716186911,1.6513527222605e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24602,0.0275451539186808,0.00323710818520021,0.0212004218756884,0.0338898859616732,1.85000506439628e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29022,-0.0270204264094858,0.00317612350639846,-0.0332456284820268,-0.0207952243369448,1.86371844046251e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24529,-0.0337454886862775,0.00397157214484964,-0.0415297700901827,-0.0259612072823722,2.05880774767806e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23979,-0.0280666223033956,0.00331047417318289,-0.0345551516828341,-0.0215780929239571,2.41853188977705e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29034,-0.0422384493650059,0.004987144756669,-0.0520132530880771,-0.0324636456419346,2.5799291176971e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,29470,-0.0371475958075351,0.00438749493663959,-0.0457470858833487,-0.0285481057317215,2.64000702526385e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24185,-0.0412997864887677,0.00488128435344755,-0.0508671038215249,-0.0317324691560105,2.8028022099522e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29034,-0.0197970771572432,0.00234077395288989,-0.0243849941049074,-0.015209160209579,2.85828442456245e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,24669,-0.0153722161922124,0.00182056795477172,-0.018940529383565,-0.0118039030008598,3.24314812595859e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,23979,-0.0374397983188342,0.00443401125973143,-0.0461304603879078,-0.0287491362497606,3.24424521018351e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,24669,-0.0330325340160285,0.00391435076266353,-0.040704661510849,-0.025360406521208,3.37899301340603e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,29172,-0.0323687726290873,0.00383729774969434,-0.0398898762184883,-0.0248476690396864,3.45392857253107e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24579,-0.0135856862247069,0.0016110963864846,-0.0167434351422168,-0.0104279373071971,3.56482446386156e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,23979,-0.0318467145055329,0.00377712840038934,-0.0392498861702961,-0.0244435428407698,3.60345668716492e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29082,-0.0181242998996755,0.00215530113009771,-0.022348690114667,-0.0138999096846839,4.31548054465455e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",23979,-0.0388198286702382,0.00461735269026684,-0.0478698399431612,-0.0297698173973152,4.42312587570154e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,24185,-0.0320298575310095,0.00381042380482208,-0.0394982881884608,-0.0245614268735582,4.47882138613501e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,29089,-0.0530306890547855,0.00631100290615338,-0.0654002547508461,-0.0406611233587249,4.55203998642224e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,29122,-0.0388034414895411,0.00462615265073347,-0.0478707006849787,-0.0297361822941035,5.1723232958977e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24471,0.0163836039823509,0.0019537311830508,0.0125542908635713,0.0202129171011304,5.30635254004339e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,29172,0.0422266887444436,0.00504116621610525,0.0323460029608773,0.0521073745280099,5.70011376285274e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,29132,-0.039050011645509,0.0046705555600721,-0.0482043005432504,-0.0298957227477677,6.49858179620364e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,29470,-0.0465612433973975,0.00557772856209013,-0.0574935913790941,-0.0356288954157008,7.26098938555486e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28612,-0.0320059279313474,0.00384090494142334,-0.0395341016165372,-0.0244777542461577,8.23661582729589e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,29122,0.0296033749531764,0.00355262840325889,0.022640223282789,0.0365665266235638,8.23760175153016e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29172,-0.0375726815911804,0.00451625702973439,-0.0464245453694598,-0.028720817812901,9.2196256319182e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29034,-0.0125320082463515,0.00150759770569409,-0.015486899749512,-0.00957711674319113,9.76945371945016e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29086,-0.0145840261820505,0.00175594118272327,-0.0180256709001881,-0.0111423814639128,1.03638877645238e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24251,-0.0081239678687153,0.000978355163925798,-0.0100415439900099,-0.00620639174742073,1.06130370011968e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24185,-0.0422553344592748,0.0050949062506736,-0.052241350710595,-0.0322693182079545,1.15492200536793e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,23848,-0.0214740201534523,0.00258957329892887,-0.0265495838193529,-0.0163984564875517,1.16693669052716e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24653,-0.0203668716095468,0.00246256879022703,-0.0251935064383918,-0.0155402367807019,1.39970936894333e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,29271,-0.0394193152888718,0.00477256044895724,-0.048773533768828,-0.0300650968089156,1.52291274745753e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28491,-0.0311495206825645,0.00377661685279073,-0.0385516897140343,-0.0237473516510946,1.67939891770292e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29271,-0.0517913350764621,0.00628427062713251,-0.0641085055056418,-0.0394741646472824,1.77209324589422e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,28631,-0.0261070827111309,0.00316782753416345,-0.0323160246780913,-0.0198981407441706,1.77521656392207e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,29280,0.0344780735155637,0.00419266271479439,0.0262604545945667,0.0426956924365607,2.05864174597925e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24470,-0.0295201454220041,0.00358948928350979,-0.0365555444176833,-0.0224847464263249,2.06425082153988e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24498,-0.0242524735430748,0.00294950984788491,-0.0300335128449293,-0.0184714342412204,2.09019438075105e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,28908,-0.0240982547813977,0.00293675416248635,-0.0298542929398709,-0.0183422166229244,2.38595740349299e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28631,-0.0387116297956422,0.00471778396814297,-0.0479584863732024,-0.029464773218082,2.39235906358817e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,23854,-0.0243336855177743,0.00296598461776949,-0.0301470153686025,-0.0185203556669461,2.43639970012292e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,28415,-0.0532523665172824,0.00650707008186825,-0.0660062238777441,-0.0404985091568206,2.86494815891375e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,24119,-0.0661360628964795,0.00808128849699935,-0.0819753883505982,-0.0502967374423607,2.88377627403322e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24579,-0.0281206294030787,0.00344018426071638,-0.0348633905540828,-0.0213778682520746,3.1216888003258e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,28908,-0.013675197111281,0.00167453047961793,-0.0169572768513322,-0.0103931173712299,3.30044592048468e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,23979,-0.0171800659026721,0.00210524629442069,-0.0213063486397366,-0.0130537831656075,3.49611053945031e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28631,-0.0252673936963595,0.00310187325124933,-0.0313470652688081,-0.0191877221239108,3.91823554729129e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,24447,-0.0283738195164862,0.00348344275179042,-0.0352013673099954,-0.021546271722977,3.96148739981076e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29409,-0.018844421196003,0.00231462742255794,-0.0233810909442166,-0.0143077514477894,4.05876170346487e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,29271,-0.0209326070368555,0.00257125959518228,-0.0259722758434128,-0.0158929382302983,4.07477434055001e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28612,-0.0206535134731789,0.00254013865989485,-0.0256321852465728,-0.015674841699785,4.43336460224507e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29034,-0.031280400812823,0.00385116887373024,-0.0388286918053342,-0.0237321098203117,4.75363516406306e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29172,-0.0205267863761893,0.00252789670379477,-0.0254814639156271,-0.0155721088367516,4.83986540035667e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28612,-0.0303897786906184,0.00374336613148549,-0.03772677630833,-0.0230527810729068,4.91578722303498e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28491,-0.0301401162025427,0.00371587829616399,-0.0374232376630241,-0.0228569947420612,5.21335851577094e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,23848,-0.0719071837880405,0.00886438357432662,-0.0892813755937207,-0.0545329919823603,5.22077727589954e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,24013,0.0200574514906178,0.00247380307751858,0.0152087974586814,0.0249061055225542,5.39238533517052e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,28908,-0.0275506466608995,0.00340293817836499,-0.0342204054904949,-0.0208808878313041,5.89445791983604e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,23843,-0.044510997282401,0.00550049501000313,-0.0552919675020071,-0.0337300270627949,6.13814035025324e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,29018,-0.0166531876829697,0.0020588404382868,-0.0206885149420118,-0.0126178604239275,6.26767726090339e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,29172,-0.0198300596852001,0.00246302731963285,-0.0246575932316805,-0.0150025261387197,8.51578670645958e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29507,0.0150870430818055,0.00187503676851398,0.0114119710155181,0.0187621151480929,8.85380316596585e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29271,-0.0689437981043847,0.00857064603251179,-0.0857422643281078,-0.0521453318806616,9.00834919556332e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",23974,-0.0209670172234976,0.00260642170822441,-0.0260756037716175,-0.0158584306753778,9.06772495461463e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,28467,-0.0214618612193932,0.00266895645290017,-0.0266930158670775,-0.0162307065717089,9.23207608035815e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28412,-0.03823521871713,0.00476936593453374,-0.0475831759488161,-0.0288872614854438,1.12643337651786e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,28543,-0.05139993697755,0.00641317511270419,-0.0639697601984502,-0.0388301137566498,1.14554907504911e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,29143,-0.0540665594804448,0.00675033336604836,-0.0672972128778996,-0.04083590608299,1.19474636943028e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,23974,-0.0286138131397706,0.00357288708468711,-0.0356166718257573,-0.0216109544537839,1.21264341456452e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,29381,-0.0705810723823351,0.00881690379765756,-0.0878622038257439,-0.0532999409389262,1.23644306852041e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,23848,-0.0211416526908034,0.00264287726186884,-0.0263216921240663,-0.0159616132575405,1.3058960139921e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,23979,-0.0172344616211622,0.00215522244824324,-0.0214586976197189,-0.0130102256226054,1.33637449364952e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,23848,-0.068303080658372,0.0085416754213801,-0.085044764484277,-0.051561396832467,1.33836968562272e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23974,-0.0194261941285796,0.00243034273343947,-0.024189665886121,-0.0146627223710383,1.37382616935557e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28631,-0.0217219164234576,0.00271844960060339,-0.0270500776406402,-0.0163937552062749,1.39351658874891e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24539,0.0172108394224596,0.00215441082389183,0.0129881942076316,0.0214334846372875,1.4237803218464e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24602,-0.0226734899345627,0.00283826965354567,-0.0282364984555122,-0.0171104814136132,1.425492460992e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29132,-0.0157866614587722,0.00198566266969009,-0.0196785602913648,-0.0118947626261797,1.92713946166744e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29172,-0.0382075170988301,0.0048066352556158,-0.047628522199837,-0.0287865119978231,1.94909750200703e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29122,-0.0209662037921661,0.00263778224549709,-0.0261362569933404,-0.0157961505909918,1.95692647106076e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,28908,-0.0169781539633539,0.00213671482108617,-0.0211661150126828,-0.012790192914025,1.99733785000965e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29089,-0.0624913441250245,0.00786780913394928,-0.077912250027565,-0.0470704382224839,2.04987923126201e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24602,-0.0724012996848663,0.00911569232533592,-0.0902680566425247,-0.0545345427272079,2.06592297315268e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,29470,-0.0154252419657951,0.00194320247337263,-0.0192339188136054,-0.0116165651179847,2.1263595963829e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,28908,0.0146732102043548,0.00184849150974484,0.0110501668452549,0.0182962535634547,2.12975004859343e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29271,-0.0146787918621772,0.00185301512022868,-0.0183107014978254,-0.011046882226529,2.42799277160379e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,28399,-0.0430772454256102,0.00544331655466278,-0.0537461458727492,-0.0324083449784711,2.58721848859615e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,29470,-0.0498283070009771,0.00629700798502668,-0.0621704426516294,-0.0374861713503248,2.5999525044337e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28631,-0.0409165737870035,0.00517452179088741,-0.0510586364971428,-0.0307745110768642,2.72418478715431e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,24653,-0.037160239702601,0.00470906177690443,-0.0463900007853337,-0.0279304786198683,3.11626370429871e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,24648,0.0211994044276438,0.00269188340348633,0.0159233129568106,0.026475495898477,3.5386078834074e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,29034,-0.048350807123521,0.00615045623862085,-0.0604057013512179,-0.0362959128958241,3.93165201749321e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,28491,-0.0273074730892101,0.00347641687005266,-0.0341212501545133,-0.0204936960239069,4.13576404118492e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24602,-0.037434339020116,0.00477516221989233,-0.046793656971105,-0.028075021069127,4.71033192716942e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,28863,-0.0328593481011799,0.00419700862758273,-0.0410854850112421,-0.0246332111911178,5.07621685271091e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28491,-0.0423863993087464,0.00542147068443326,-0.0530124818502356,-0.0317603167672573,5.54062320110468e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,29122,0.0240403183394779,0.00307556234871787,0.0180122161359909,0.0300684205429649,5.61109399037053e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,24683,-0.0400711147116629,0.00512602696167587,-0.0501181275565476,-0.0300241018667782,5.6165323832045e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24467,-0.0249505728912212,0.00319552447611597,-0.0312138008644085,-0.0186873449180339,6.04360180098772e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,29188,-0.0521733408897048,0.0066900517235758,-0.0652858422679134,-0.0390608395114962,6.46544277012103e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,23974,-0.0288099957760015,0.00369557901194297,-0.0360533306394097,-0.0215666609125932,6.65955990308728e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29281,0.0135871033222449,0.00174319615367554,0.0101704388610408,0.0170037677834489,6.68735702738802e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,24579,-0.0157363161919013,0.0020190581068045,-0.0196936700812381,-0.0117789623025644,6.75423117448444e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29172,-0.0322185371398145,0.004135517705974,-0.0403241518435235,-0.0241129224361055,6.88507449311021e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,29034,0.0157315655559217,0.00202254985686472,0.0117673678364668,0.0196957632753765,7.60642125562222e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,28612,-0.0262664509782688,0.00337878680321299,-0.0328888731125662,-0.0196440288439713,7.863532349918e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24498,-0.0393044912121308,0.00505576879269169,-0.0492137980458066,-0.0293951843784551,7.89108652909329e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24539,-0.0169049143842371,0.00217516207445208,-0.0211682320501632,-0.0126415967183111,8.040657608987e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29409,0.0326580646766803,0.00421576525002417,0.0243951647866329,0.0409209645667277,9.73762200517613e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,23940,-0.0269754764516374,0.00348571929448041,-0.033807486268819,-0.0201434666344558,1.04269832116236e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,28565,-0.0212924794846921,0.00275322314022649,-0.026688796839536,-0.0158961621298482,1.07933921276261e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24261,-0.0311289858313567,0.0040253980587273,-0.0390187660264622,-0.0232392056362512,1.08989443672544e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,29132,-0.0254618257275225,0.00329523592591405,-0.031920488142314,-0.0190031633127309,1.13768649969325e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,28448,0.0256161326699977,0.00332243924974257,0.0191041517405022,0.0321281135994931,1.29878493340588e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24579,-0.05890781549197,0.00764034088437859,-0.0738828836253521,-0.043932747358588,1.30468552939873e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,23974,-0.0221438720702476,0.00287578246168344,-0.0277804056951471,-0.016507338445348,1.41181249627569e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23979,-0.0293642219593747,0.00382316178281371,-0.0368576190536896,-0.0218708248650599,1.64374640775598e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29034,-0.0298817729755799,0.00389198565985078,-0.0375100648688874,-0.0222534810822724,1.66961587206571e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29093,0.0306977055869802,0.00400330226337272,0.0228512331507697,0.0385441780231908,1.80008344699232e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,28829,0.0344560935896402,0.0044938634854811,0.0256481211580973,0.0432640660211832,1.81084801543172e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,23940,-0.0342838662515632,0.00447264621075629,-0.0430502528246455,-0.0255174796784809,1.85280897002873e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24653,-0.0278984483675163,0.00365002953355481,-0.0350525062532837,-0.0207443904817489,2.19347100926248e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29034,0.0360858307160542,0.00472606652012213,0.0268227403366148,0.0453489210954936,2.31870623579538e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,28631,-0.0622283702197667,0.00816559621619396,-0.0782329388035068,-0.0462238016360265,2.59899736599335e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24539,-0.0537688027938219,0.00706921341874543,-0.067624461094563,-0.0399131444930809,2.92730264771e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,24653,-0.0536155750022198,0.00705451999744096,-0.0674424341972041,-0.0397887158072356,3.0625697774238e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24185,-0.0191687106554646,0.00252559298587705,-0.0241188729077836,-0.0142185484031456,3.31996349087639e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27646,-0.0218133766643067,0.00287541386790866,-0.0274491878454076,-0.0161775654832057,3.3986119744402e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28491,-0.0255482436655118,0.00337469384996766,-0.0321626436114484,-0.0189338437195751,3.82926810882307e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24539,-0.0267092648149531,0.00353120805001835,-0.033630432592989,-0.0197880970369171,4.05266422701902e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28467,-0.0346999238177045,0.00459246301908462,-0.0437011513351103,-0.0256986963002986,4.28659599226197e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,24539,-0.0232232131767313,0.00308030979786707,-0.0292606203805508,-0.0171858059729119,4.89060192967125e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,29381,-0.0354398454355034,0.00470229098642163,-0.0446563357688898,-0.026223355102117,4.95822163716947e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,24539,-0.0372329713094373,0.00495292571963718,-0.0469407057199261,-0.0275252368989484,5.78018236859176e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24669,-0.0225694362842585,0.00300868469992953,-0.0284664582961204,-0.0166724142723967,6.52558587607677e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,29280,-0.0166448619681586,0.002219777540905,-0.0209956259483324,-0.0122940979879849,6.64121116112365e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,24683,0.0324087519064852,0.00432404486546519,0.0239336239701734,0.0408838798427969,6.85225031493088e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24602,-0.0366861557075954,0.0048978729268326,-0.0462859866441873,-0.0270863247710035,7.107011063786e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24539,-0.0635914397115665,0.00849340171833046,-0.0802385070794942,-0.0469443723436388,7.27508480382487e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,23766,0.0338049470967443,0.00451692432212813,0.0249517754253732,0.0426581187681155,7.45616772451885e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24119,0.0221341755473551,0.00295786542351897,0.0163367593172579,0.0279315917774522,7.50383629632756e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29194,0.0264853727056427,0.00354142442066583,0.0195441808411377,0.0334265645701478,7.71508343252339e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,23603,-0.0435410617626572,0.00582492847624585,-0.0549579215760991,-0.0321242019492154,7.99196790339159e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,28491,-0.0390760457880982,0.00522843576915626,-0.0493237798956445,-0.028828311680552,8.01777580246343e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28357,-0.0309293153161166,0.00414135191052316,-0.039046365060742,-0.0228122655714912,8.35060618091661e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,28467,-0.023900274662842,0.00320976274740111,-0.0301914096477482,-0.0176091396779358,9.88500177274661e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,28491,-0.0359690433757124,0.00483126454859799,-0.0454383218909644,-0.0264997648604603,9.96438802162636e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,24529,-0.0207924103538146,0.00279775837669597,-0.0262760167721387,-0.0153088039354906,1.10624195814924e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,24529,-0.0225266595118024,0.00304248527310207,-0.0284899306470824,-0.0165633883765223,1.36366364256286e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24529,-0.0259730709959302,0.00351150401995162,-0.0328556188750354,-0.0190905231168251,1.44235709437374e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,23979,-0.0325303290755746,0.00440734643317978,-0.0411687280846069,-0.0238919300665422,1.62301708717701e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24602,-0.0203693359089363,0.00276316962337081,-0.0257851483707431,-0.0149535234471295,1.73746335419667e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,29122,-0.0275869780943254,0.00374491729667005,-0.0349270159957987,-0.0202469401928521,1.79796915049472e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29172,0.05521144125496,0.00749503457634714,0.0405211734853196,0.0699017090246004,1.79936236469484e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29381,-0.0242288364546152,0.00329640465381121,-0.0306897895760852,-0.0177678833331453,2.03251205000129e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,23848,-0.0403865303435835,0.0055142418589958,-0.0511944443872152,-0.0295786162999517,2.48252439759788e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,23940,-0.0329293389197427,0.00449919732605586,-0.0417477656788122,-0.0241109121606732,2.57825682621702e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,29132,0.0126459571927021,0.00172962513170421,0.00925589193456181,0.0160360224508423,2.71206167046768e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,24699,-0.0171616039750571,0.00234759674891478,-0.0217628936029301,-0.0125603143471841,2.74679822820833e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24653,0.0186746343284552,0.00255622989554304,0.0136644237331908,0.0236848449237195,2.8455109125521e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29034,-0.0204509946957253,0.00280363317446259,-0.025946115717672,-0.0149558736737787,3.0752915976173e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,24539,-0.0182755418816259,0.00250789914976329,-0.0231910242151619,-0.0133600595480898,3.26047975861965e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,23974,-0.0334970800354207,0.00460020302038004,-0.0425134779553656,-0.0244806821154758,3.39929600558467e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,29172,-0.0451369586629691,0.00622147778504585,-0.0573310551216589,-0.0329428622042792,4.11606279463667e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,29100,-0.0315192978296712,0.00434748625238579,-0.0400403708843474,-0.022998224774995,4.27140916588467e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,28561,-0.0310678102673146,0.0042915551508968,-0.0394792583630724,-0.0226563621715569,4.62428301607332e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,29172,-0.0396586033119636,0.00548501571562404,-0.0504092341145867,-0.0289079725093405,4.93584033371148e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,23979,-0.016896610904848,0.0023385147784621,-0.0214800998706337,-0.0123131219390622,5.14723702493997e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29271,-0.0139525982763875,0.00193325511336255,-0.0177417782985781,-0.0101634182541969,5.43787257927901e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,24699,-0.0161327127571748,0.00223756562315078,-0.0205183413785503,-0.0117470841357993,5.75876654988887e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,28612,-0.0199565140383053,0.00277062727282796,-0.0253869434930481,-0.0145260845835625,6.04071444185098e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,23974,-0.0278466924923852,0.0038695086308741,-0.0354309294088985,-0.020262455575872,6.36238211942666e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,29381,-0.0137881696219525,0.00191720438314342,-0.0175458902129136,-0.0100304490309914,6.54661305182661e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,23848,-0.0233181606390214,0.00324341234809622,-0.02967524884129,-0.0169610724367528,6.69995470864432e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23979,-0.0257217640997775,0.00357803986251235,-0.0327347222303017,-0.0187088059692533,6.72857343980724e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29271,-0.0136230598752981,0.00189741251189753,-0.0173419883986172,-0.00990413135197891,7.14724970640288e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,23940,-0.0353526345568964,0.00492563821944712,-0.0450068854670127,-0.02569838364678,7.31918247684704e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,23848,-0.0205709936801284,0.00286740346670414,-0.0261911044748685,-0.0149508828853883,7.49208398349385e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24119,-0.0328533464508022,0.00458319274939835,-0.0418364042396229,-0.0238702886619814,7.81662980598357e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,23848,-0.0318133047234344,0.00444491232668666,-0.0405253328837402,-0.0231012765631285,8.47014820869967e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,28491,-0.0314912275457949,0.0044041329591816,-0.0401233281457908,-0.0228591269457989,8.86227854241958e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29085,-0.0210572014174075,0.00294570787470301,-0.0268307888518254,-0.0152836139829896,8.98418759307857e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,23974,-0.0209691258198636,0.00293476835264924,-0.0267212717910561,-0.0152169798486711,9.25236389680424e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,28582,-0.0285023350310408,0.00399076279842307,-0.03632423011595,-0.0206804399461316,9.41290278883544e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29187,-0.0173829083812506,0.00243516554521976,-0.0221558328498814,-0.0126099839126199,9.67091634324487e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,28631,0.0205380886230231,0.00287782863546038,0.0148975444975207,0.0261786327485254,9.79004148094034e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,28491,-0.022460025118767,0.00314872357452885,-0.0286315233248436,-0.0162885269126904,1.00506533036006e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28467,-0.0375412836249136,0.00527647165443468,-0.0478831680676056,-0.0271993991822216,1.1468691954031e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,28884,-0.0499598310036998,0.0070391568085913,-0.0637565783485388,-0.0361630836588609,1.30043073157445e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29122,-0.042024270151458,0.00592986765546303,-0.0536468107561655,-0.0304017295467504,1.40288043758387e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24529,-0.0303035686748495,0.00427992268836674,-0.0386922171440483,-0.0219149202056507,1.47613771767763e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29122,-0.0616084393528837,0.00871511158163619,-0.0786900580528907,-0.0445268206528768,1.5939567188495e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,28811,-0.0290762538260132,0.00411472147925376,-0.0371411079253506,-0.0210113997266758,1.62623580746848e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,29205,-0.0192478579208923,0.00272693079947601,-0.0245926422878653,-0.0139030735539193,1.72150123870953e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29122,-0.0609376679825159,0.00864464374710818,-0.0778811697268479,-0.0439941662381838,1.83981008821703e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,23922,-0.0297071804309132,0.00421419986810215,-0.0379670121723934,-0.021447348689433,1.84700481365846e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,24388,-0.0222249644121175,0.00315495127976912,-0.028408668920465,-0.0160412599037701,1.91114938524683e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,29122,-0.0282767593688696,0.004016804647529,-0.0361496964780264,-0.0204038222597127,1.9704186429725e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,23848,-0.0258611595945086,0.00368105157192526,-0.0330760206754821,-0.018646298513535,2.19067647032939e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,23940,-0.0226381053180436,0.00323127355291006,-0.0289714014817473,-0.0163048091543399,2.51836060196767e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,28047,-0.0158586009720394,0.00226379467933097,-0.0202956385435281,-0.0114215634005507,2.51987858315112e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,29256,0.0140442216162419,0.00200672179575204,0.010111046896568,0.0179773963359159,2.64123346469747e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24539,0.0355097091202453,0.00507798053980949,0.0255568672622187,0.0454625509782719,2.76208242653908e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,24143,0.0155454774007223,0.00222576636592962,0.0111829753235003,0.0199079794779444,2.93655777573433e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,29089,-0.0201620824946768,0.00289303941620165,-0.025832439750432,-0.0144917252389216,3.25611724164063e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,24020,-0.0214879277463569,0.00309064392301134,-0.0275455898354592,-0.0154302656572547,3.67872480322878e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29122,-0.0456488452831674,0.00658720899664655,-0.0585597749165946,-0.0327379156497402,4.29837791915854e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,23974,-0.0599196461780687,0.00865406289447387,-0.0768816094512374,-0.0429576829048999,4.50552171594488e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28631,-0.0332494688263807,0.00480680599571388,-0.0426708085779799,-0.0238281290747815,4.70459248255882e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29153,-0.0288469033749425,0.00417412030190412,-0.0370281791666746,-0.0206656275832104,4.91514870673351e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24185,-0.0373030018397239,0.00540609811043132,-0.0478989541361693,-0.0267070495432786,5.32224044814626e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,29034,-0.0365454390830731,0.00529942656528904,-0.0469323151510396,-0.0261585630151066,5.453963138598e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,28908,0.0179120690679942,0.00259858815177402,0.0128188362905172,0.0230053018454713,5.57494379238303e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29473,-0.0135956781000417,0.00197647522695148,-0.0174695695448666,-0.00972178665521676,6.15861130061382e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24539,-0.0405504644552285,0.00590591461921145,-0.052126057108883,-0.0289748718015741,6.7565876380604e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,29327,-0.0356548822923161,0.00520579398298278,-0.0458582384989623,-0.0254515260856698,7.57947772517419e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29409,-0.0192365973596481,0.00280978712984478,-0.0247437801341439,-0.0137294145851523,7.72825077805122e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,29381,0.0143072802953436,0.00209534626371147,0.0102004016184691,0.018414158972218,8.77073467406617e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,28962,-0.0128119715083878,0.00187809175296941,-0.0164930313442078,-0.00913091167256772,9.16734846668231e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,24653,-0.0259408729257671,0.00380267464347992,-0.0333941152269878,-0.0184876306245465,9.20234955320644e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24185,-0.0187744360081326,0.00275445488877668,-0.0241731675901349,-0.0133757044261303,9.57946139810861e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,29271,0.0315091916236823,0.00463402375935017,0.022426505055356,0.0405918781920086,1.06976067997724e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24669,-0.0246705364699828,0.00363008691052496,-0.0317855068146117,-0.0175555661253539,1.09916955721098e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28467,-0.0201724170207109,0.00296950111220054,-0.0259926392006239,-0.0143521948407978,1.11831588968358e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29409,0.0281332760211558,0.00414319606834825,0.0200126117271933,0.0362539403151184,1.14079737442702e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,23979,-0.0208285274326436,0.00307834782064501,-0.0268620891611078,-0.0147949657041794,1.35312783885911e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,29122,-0.0151766548683875,0.00224539841117306,-0.0195776357542867,-0.0107756739824883,1.41564708576004e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,24602,-0.0144359763372408,0.00214184681089301,-0.0186339960865911,-0.0102379565878905,1.61925811916457e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29409,-0.0162857398789586,0.00241710798934841,-0.0210232715380815,-0.0115482082198358,1.63884875606828e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24583,-0.0315127880359983,0.0046844789785486,-0.0406943668339535,-0.022331209238043,1.76923083606749e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29470,-0.0327909389716187,0.00487509664203318,-0.0423461283900037,-0.0232357495532336,1.77318561782991e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29100,-0.0222729037965644,0.00331603612949437,-0.0287723346103734,-0.0157734729827555,1.8927558170714e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,28969,-0.0132534408398681,0.00197476256862845,-0.0171239754743798,-0.00938290620535628,1.96306749629013e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,29122,-0.0453192069271352,0.00675778406505,-0.0585644636946332,-0.0320739501596372,2.03378127961672e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,28860,0.0154497529331444,0.00230920319045995,0.0109237146798429,0.0199757911864459,2.26455747212948e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29256,0.0138701179652032,0.00207940129863299,0.00979449141988257,0.0179457445105239,2.59925092416277e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,28491,-0.035654029787604,0.00534657586317117,-0.0461333184794195,-0.0251747410957885,2.63025121929727e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,24567,-0.0150614026900656,0.00225932491279608,-0.0194896795191459,-0.0106331258609853,2.67842120713196e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,23974,-0.0194200818777014,0.0029214950595406,-0.0251462121944009,-0.0136939515610018,3.04912820140562e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2,Complement C2,29231,-0.011127425672659,0.00167806538620281,-0.0144164338296165,-0.00783841751570145,3.38990841277552e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24683,-0.0346843021855264,0.00523675745053973,-0.0449483467885842,-0.0244202575824685,3.58636828187674e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,29381,-0.0142413534353421,0.00215048345394415,-0.0184563010050726,-0.0100264058656115,3.59516352152214e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,24579,-0.0275921477719848,0.00419961607476634,-0.0358233952785269,-0.0193609002654428,5.12670222188871e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,28855,-0.0332430171546255,0.0050600605925037,-0.0431607359159328,-0.0233252983933183,5.12788602855895e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28491,-0.0277849813498587,0.00423726950152069,-0.0360900295728393,-0.0194799331268782,5.5733796089783e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29063,-0.015442267759704,0.00235788138765039,-0.0200637152794988,-0.0108208202399093,5.88061476544367e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,24669,0.0234450374411735,0.00359482102019333,0.0163991882415946,0.0304908866407524,7.07698922049789e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24539,-0.023830964113684,0.00365407195627906,-0.0309929451479909,-0.016668983079377,7.08417842521483e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28612,-0.0253486372297887,0.00388706496732838,-0.0329672845657523,-0.017729989893825,7.08720201828797e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,29172,-0.0316458345886514,0.00486110821393388,-0.0411736066879618,-0.022118062489341,7.63686980658475e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,23979,-0.0244780370959763,0.00375984461742962,-0.0318473325461384,-0.0171087416458142,7.64414726223795e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29314,0.00946895683406968,0.00145600301021259,0.006615190934053,0.0123227227340864,7.97928935927456e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23979,-0.02123777237527,0.00326614121218596,-0.0276394091511545,-0.0148361355993855,8.06025436683318e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,23940,-0.0280004363200786,0.00430933667551366,-0.0364467362040854,-0.0195541364360718,8.32048530276167e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,24669,0.0146871176613287,0.00226045976680398,0.0102566165183929,0.0191176188042645,8.32774272541206e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,23974,-0.0294154387370136,0.00454003414063302,-0.0383139056526543,-0.0205169718213729,9.40488930411796e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28491,-0.0246591634992652,0.0038064029089664,-0.0321197132008393,-0.017198613797691,9.42510423306176e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,29317,-0.0286911263549409,0.00442973766987276,-0.0373734121878915,-0.0200088405219903,9.50859716844726e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,28612,-0.0207674712971641,0.00321434392884271,-0.0270675853976958,-0.0144673571966324,1.05772538704506e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,29483,-0.0156200223459758,0.00243266744347619,-0.0203880505351892,-0.0108519941567625,1.37491860451175e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,23848,-0.0177766886314021,0.00276883010451537,-0.0232035956362522,-0.0123497816265519,1.38577603358924e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28631,-0.0180315983913086,0.00281422128005276,-0.023547472100212,-0.0125157246824052,1.50407321910037e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29445,-0.0175052573695588,0.00273673460918349,-0.0228692572035584,-0.0121412575355592,1.61466855202637e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,24529,-0.0374492967643882,0.00586621138265829,-0.0489470710743984,-0.0259515224543779,1.75725821163741e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,24529,-0.0181287212287343,0.00284701771631068,-0.0237088759527033,-0.0125485665047654,1.95388344428954e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29312,-0.0376597570997442,0.00591534409108048,-0.049253831518262,-0.0260656826812265,1.96312828211248e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,23848,-0.0255946122054996,0.00402231802392509,-0.0334783555323928,-0.0177108688786064,2.01251124676767e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29077,0.0219901815040078,0.00345656187909654,0.0152153202209786,0.028765042787037,2.0228309982319e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,23974,-0.014963536308403,0.00235259624419623,-0.0195746249470276,-0.0103524476697784,2.04814716588272e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,28811,-0.0476672987498507,0.00751171825679846,-0.0623902665331757,-0.0329443309665257,2.24671118324278e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,28467,-0.0163735270283146,0.00258242601621556,-0.0214350820200971,-0.0113119720365321,2.32656802073354e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,29187,-0.01353403238306,0.00213511393217496,-0.0177188556901229,-0.00934920907599704,2.34964378298987e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,24602,-0.0354088625809387,0.00558756924948209,-0.0463604983099236,-0.0244572268519538,2.38222697284072e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24539,0.0229925921996365,0.00362985206712078,0.0158780821480798,0.0301071022511932,2.42549158793519e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24529,-0.0155493941634328,0.0024597297732696,-0.0203704645190412,-0.0107283238078244,2.63349946192011e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29470,-0.0333036624355885,0.00527372911354158,-0.04364017149813,-0.022967153373047,2.73991623036213e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29100,0.00799018602790885,0.0012662227639448,0.00550838941057704,0.0104719826452407,2.8258991572961e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,24699,0.0138183716545375,0.00219092652070145,0.00952415567396263,0.0181125876351123,2.89148404421194e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,29187,0.015055832177151,0.00239167628631482,0.0103681466559739,0.019743517698328,3.11577029796714e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24119,-0.031135092584505,0.00494561644569638,-0.0408285008180699,-0.0214416843509401,3.11705435874455e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,24119,0.0147045440282875,0.00233735323321916,0.010123331691178,0.0192857563653971,3.20622881800585e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,28358,-0.0318785501951204,0.00507202373531274,-0.0418197167163334,-0.0219373836739074,3.32250667362828e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,29122,0.0142740597275376,0.00227311287206813,0.00981875849828409,0.0187293609567911,3.44410359130589e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29056,-0.0298248763468485,0.00479164107810148,-0.0392164928599274,-0.0204332598337696,4.90146081347554e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29172,0.0142166932063076,0.00228849453613156,0.00973124391548975,0.0187021424971255,5.29375415341993e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,24579,-0.0432778212015755,0.00697940951307077,-0.0569574638471942,-0.0295981785559568,5.70769751080939e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28556,-0.0233783552015416,0.00377349673718841,-0.0307744088064309,-0.0159823015966523,5.89274321115979e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,24529,-0.0275495641824422,0.00445596108733444,-0.0362832479136177,-0.0188158804512667,6.40365922085703e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24653,0.0145646990280086,0.00235831490320342,0.0099424018177299,0.0191869962382873,6.68192192870776e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24653,-0.0237741289370887,0.00385071941701588,-0.0313215389944398,-0.0162267188797375,6.76467146253333e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,29409,-0.0110231522309695,0.00178921458507818,-0.0145300128177228,-0.00751629164421631,7.32755222663139e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24669,-0.027672909416123,0.00450197050460133,-0.0364967716051416,-0.0188490472271044,8.02519603563717e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24529,-0.0163956183952537,0.00266867699595393,-0.0216262253073234,-0.011165011483184,8.1848933436561e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,29122,-0.0176801551525496,0.00288362141459378,-0.0233320531251534,-0.0120282571799458,8.83207636845796e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,23756,-0.015888619901229,0.00259944980607147,-0.0209835415211291,-0.0107936982813289,9.97346667640234e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,28906,-0.0200250545223257,0.00327714541518699,-0.0264482595360922,-0.0136018495085592,1.005770007058e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,23974,0.0116206516722224,0.00190227969695342,0.00789218346619375,0.0153491198782511,1.01927322956633e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24579,0.0135206762592289,0.00221731587624975,0.00917473714177934,0.0178666153766784,1.09164340145809e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24119,0.0123170473173811,0.00202935521966912,0.00833951108682961,0.0162945835479326,1.30273771300105e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29122,-0.0144982938924963,0.00239030042916775,-0.0191832827336651,-0.0098133050513275,1.33189129403622e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,24602,-0.0260929536726816,0.00430676194158556,-0.0345342070781893,-0.0176517002671739,1.39305071658867e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24669,-0.0122313774214387,0.00202017030218171,-0.0161909112137149,-0.00827184362916259,1.42777385986798e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,28467,-0.035599367465444,0.00590974350532099,-0.0471824647358731,-0.0240162701950149,1.72412385492679e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28491,-0.0202998994966745,0.00338273073090975,-0.0269300517292576,-0.0136697472640914,1.9842572932841e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23155,0.0479406720338926,0.00799935452641163,0.0322619371621258,0.0636194069056594,2.08966283902818e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24529,-0.0223611603025894,0.0037315297228857,-0.0296749585594453,-0.0150473620457334,2.09534527297625e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCT,Secretin,23940,-0.0203015893529399,0.00338917266147156,-0.0269443677694242,-0.0136588109364557,2.12666017278096e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29280,0.014804395978487,0.00247474601391114,0.00995389379122119,0.0196548981657529,2.22714188687731e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29507,-0.0125261308432727,0.0020945153779069,-0.0166313809839702,-0.00842088070257516,2.25089818510311e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,29132,0.0210399597360311,0.00352081706918408,0.0141391582804303,0.0279407611916319,2.31517379194738e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29231,0.0117390902942275,0.00196460824211176,0.00788845813968851,0.0155897224487666,2.32348351949133e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,28467,-0.031185343275862,0.00524013981456054,-0.0414560173124007,-0.0209146692393234,2.692265261435e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29132,-0.0156358654192672,0.00262807606210609,-0.0207868945009951,-0.0104848363375393,2.71952549766369e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28631,-0.0181328675327603,0.0030596171104801,-0.0241297170693013,-0.0121360179962193,3.12970419723171e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29034,-0.0309734537057161,0.00523808341146645,-0.0412400971921903,-0.0207068102192419,3.39425713722044e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,28467,-0.0288756961545886,0.0048974974227707,-0.0384747911032192,-0.019276601205958,3.76594410466529e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",24185,-0.0194535700814763,0.00331089003529663,-0.0259429145506577,-0.0129642256122949,4.26754825315375e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,23848,-0.0193904479625964,0.00330324921882563,-0.0258648164314946,-0.0129160794936981,4.41264240848534e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,29034,-0.0119937065236108,0.00204494013595702,-0.0160017891900865,-0.007985623857135,4.53819054112486e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28631,-0.0149795950448321,0.00255429306780866,-0.0199860094577371,-0.00997318063192712,4.55494513413623e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,29132,0.0192175991890054,0.00328368612427018,0.0127815743854359,0.025653623992575,4.89576495875625e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,23940,0.0134765036704867,0.00230365663965791,0.0089613366567572,0.0179916706842162,4.97825597290993e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28412,-0.0178659299247734,0.00305457557199827,-0.02385289804589,-0.0118789618036568,5.00229781614156e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,28363,0.0378308673584994,0.00648094303196614,0.0251282190158458,0.0505335157011531,5.36478286994461e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,28631,-0.0199523449972429,0.00342474474076403,-0.0266648446891404,-0.0132398453053454,5.74008612844404e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28612,-0.0258368763420289,0.00444121782485523,-0.0345416632787451,-0.0171320894053127,6.03627127765974e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24539,-0.0225232889675242,0.00387206550665389,-0.0301125373605658,-0.0149340405744826,6.07054664988393e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24602,-0.0149415750974828,0.00257474986333518,-0.0199880848296198,-0.00989506536534588,6.5892047466794e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,28631,-0.0342535449288085,0.00590897507486404,-0.0458351360755421,-0.022671953782075,6.82739331019598e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,23848,0.0150039446301371,0.00259188772706143,0.00992384468509673,0.0200840445751775,7.17758883020169e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24503,-0.0364086350123253,0.00630433504305541,-0.0487651316967139,-0.0240521383279367,7.78028167772864e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29172,-0.0203645132422134,0.00352692103185538,-0.0272772784646499,-0.0134517480197768,7.81868843516175e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,23848,-0.0250809655057588,0.00434400011297346,-0.0335952057271867,-0.0165667252843308,7.8510727752002e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,29038,-0.0299118108058447,0.00518165196875399,-0.0400678486646026,-0.0197557729470869,7.88332231096331e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29361,-0.0175545968386792,0.00304170218234047,-0.0235163331160665,-0.0115928605612919,7.94499150953116e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24119,-0.0370469871560507,0.00642089750097654,-0.0496319462579647,-0.0244620280541367,8.03598533786505e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,23848,-0.0412297187136997,0.00718017672599635,-0.0553028650966526,-0.0271565723307469,9.46124741186558e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,23843,-0.018116879489146,0.00316161821614685,-0.0243136511927938,-0.0119201077854981,1.01488325194663e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24529,-0.0186118936769195,0.00324906395621901,-0.0249800590311087,-0.0122437283227302,1.02576665193094e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24185,-0.0358874471651763,0.00628719176546885,-0.0482103430254953,-0.0235645513048574,1.15632290840152e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23365,-0.0445164976220695,0.00780308092257775,-0.0598105362303219,-0.0292224590138171,1.17756783965376e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,28908,-0.0145514979489665,0.00255298277542259,-0.0195553441887948,-0.00954765170913826,1.21112957225956e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,23756,-0.0274414906024071,0.00481933115705044,-0.0368873796702259,-0.0179956015345882,1.25528232206933e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,29409,0.0257515656404776,0.00452301161807172,0.016886462869057,0.0346166684118982,1.25678721305287e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24060,0.0200386865525798,0.00352100135631153,0.0131375238942092,0.0269398492109504,1.27624373436126e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29034,-0.0155412852293149,0.00274054409179695,-0.0209127516492369,-0.0101698188093928,1.43418211396522e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29122,-0.0608218628601286,0.0107827159883322,-0.0819559861972596,-0.0396877395229975,1.70948977626787e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,28860,-0.0162200097649573,0.00287977559252959,-0.0218643699263153,-0.0105756496035993,1.79385769741205e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28612,0.0138678437255246,0.00246443178207681,0.00903755743265405,0.0186981300183952,1.84873578992698e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29122,-0.0137220276971712,0.00244391526848318,-0.0185121016233982,-0.00893195377094415,1.98613432463678e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,23974,0.0121970585451747,0.00217851809589581,0.00792716307721892,0.0164669540131305,2.18220259638252e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,28680,0.0120786629926692,0.00215902690614147,0.0078469702566319,0.0163103557287065,2.23283428340197e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23940,-0.0217233201818145,0.0038875439344997,-0.0293429062934339,-0.0141037340701951,2.32293781893882e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,23848,-0.0145972680707471,0.00261835054395777,-0.0197292351369044,-0.00946530100458993,2.50229300424519e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,24119,-0.0145233804467493,0.0026054071917171,-0.0196299785425148,-0.00941678235098378,2.51153128414479e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29327,-0.0116112472057336,0.00208329297708626,-0.0156945014408227,-0.00752799297064456,2.5185550440463e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,24361,0.0167728984069856,0.00301702106513716,0.0108595371193167,0.0226862596946544,2.73503803392715e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24669,-0.0244764196266458,0.00441204439690142,-0.0331240266445726,-0.015828812608719,2.92528796764315e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29122,-0.0190388173583453,0.00343208894692242,-0.0257657116943132,-0.0123119230223773,2.92639460786281e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,24119,0.00863377995234657,0.00155775532600449,0.00558057951337777,0.0116869803913154,3.01390056241255e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,24602,-0.0274828224055063,0.00496738086488577,-0.0372188889006824,-0.0177467559103301,3.18625384503435e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29127,-0.0191544624216295,0.00346889081648838,-0.0259534884219467,-0.0123554364213123,3.3843929395913e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,28853,-0.0138268090942482,0.00250968303493102,-0.018745787842713,-0.00890783034578339,3.63164276632876e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,29381,-0.013643425213222,0.00248223486366552,-0.0185086055460064,-0.00877824488043752,3.90780317037198e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,29328,-0.0160821594899245,0.00292745801420768,-0.0218199771977716,-0.0103443417820775,3.97187504788952e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,24579,-0.0151912789313491,0.00276932529349044,-0.0206191565065903,-0.00976340135610779,4.16243531352238e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29147,-0.0378707897350913,0.00695941677761117,-0.0515112466192092,-0.0242303328509734,5.32110144425919e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,29146,0.0249454973664322,0.00458447546951337,0.015959925446186,0.0339310692866784,5.33195901159802e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,29172,-0.0140943054404447,0.00259259600672886,-0.0191757936136333,-0.00901281726725617,5.48135207715103e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,29151,-0.0207555633183711,0.00382091095509191,-0.0282445487903512,-0.0132665778463909,5.6140663816637e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28491,-0.0180212645697101,0.00331914284793171,-0.0245267845516562,-0.0115157445877639,5.69757935093373e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,28467,-0.0200113986442796,0.00369472956017045,-0.0272530685822137,-0.0127697287063455,6.13715283391342e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24539,-0.0154788631200665,0.00286011619806797,-0.0210846908682798,-0.00987303537185333,6.29192269279844e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,23922,-0.0170193336641953,0.00314510694227246,-0.0231837432710494,-0.0108549240573413,6.31457908314842e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24600,-0.00883966541025025,0.00163392875103635,-0.0120421657622815,-0.005637165058219,6.35889369528245e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,28908,-0.0235573437395669,0.00438451900834128,-0.0321510009959158,-0.014963686483218,7.81026067397721e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,24119,-0.013308981856754,0.00247914052308088,-0.0181680972819926,-0.00844986643151551,8.01786192354912e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29034,-0.00840644467733551,0.00156612470086409,-0.0114760490910291,-0.0053368402636419,8.03705342450162e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,24119,-0.0116040408831597,0.00216200169445387,-0.0158415642042893,-0.00736651756203016,8.06765169267385e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,23756,-0.0236922660126672,0.00443588782917784,-0.0323866061578558,-0.0149979258674786,9.326338105492e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,24602,-0.0105851323017203,0.00198248745755568,-0.0144708077185295,-0.00669945688491122,9.41238443806467e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,29181,-0.0247323684202341,0.00463774134183748,-0.0338223414502356,-0.0156423953902327,9.740332927689e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23848,-0.0255053261150034,0.0047839881795275,-0.0348819429468773,-0.0161287092831295,9.83482384224117e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,28805,-0.0152291896024933,0.00286390158567494,-0.0208424367104162,-0.00961594249457041,1.05906618368203e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,24699,-0.020322094358986,0.00383258623470694,-0.0278339633790116,-0.0128102253389605,1.15241572272962e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,29226,0.0103905868589339,0.00196451000642769,0.00654014724633562,0.0142410264715322,1.2377019522539e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28412,-0.0178854639384213,0.0033823111281748,-0.0245147937496439,-0.0112561341271987,1.24614713959592e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28491,-0.0204265003231726,0.00386813864939612,-0.028008052075989,-0.0128449485703562,1.29631013849157e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,28467,-0.0187030096860805,0.00354253953689928,-0.0256463871784031,-0.0117596321937579,1.30451978822187e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,24539,-0.0116939112323155,0.00221534388739181,-0.0160359852516035,-0.00735183721302757,1.31282596188417e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,28612,-0.0189475829535678,0.003595149132001,-0.0259940752522898,-0.0119010906548459,1.37173489648485e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,28908,-0.0211814182349223,0.00403626476434946,-0.0290924971730472,-0.0132703392967974,1.55030958250548e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24579,-0.0265089418500782,0.0050573728661339,-0.0364213926677007,-0.0165964910324558,1.60468136807388e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23979,-0.00987073811872416,0.00188370634805154,-0.0135628025609052,-0.00617867367654314,1.61880527411657e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,23848,-0.0236854222232894,0.0045207308680372,-0.0325460547246423,-0.0148247897219365,1.62565463498253e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,24292,-0.023258106386765,0.00444100909358957,-0.0319624842102006,-0.0145537285633294,1.64458785057957e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,24683,0.00926294803735005,0.00177061493968961,0.0057925427555584,0.0127333533191417,1.69525333925937e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,29010,-0.01566802439029,0.00301561317502964,-0.0215786262133481,-0.00975742256723186,2.05401828863452e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24539,-0.0328351927230088,0.00632082434970236,-0.0452240084484254,-0.0204463769975922,2.06617478097959e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,29409,-0.00786163362747957,0.00152288731302015,-0.0108464927609991,-0.00487677449396007,2.454925606395e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,29280,0.0112063585813264,0.00217230528723631,0.00694864021834321,0.0154640769443096,2.50236846230317e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29122,0.0208259337399747,0.00403808583743621,0.0129112854985998,0.0287405819813497,2.52071203126941e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,21429,-0.0392056417048198,0.00760262756350072,-0.0541067917292812,-0.0243044916803584,2.53368300623889e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,24529,0.0415541678384599,0.00806054997214368,0.0257554898930583,0.0573528457838615,2.55255755164747e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,29470,0.0146472163647714,0.0028477001560391,0.00906572405893474,0.020228708670608,2.71356559239769e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24185,-0.0258713191231398,0.00503795209757147,-0.0357457052343799,-0.0159969330118997,2.83901671958304e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,24669,0.0123308622013274,0.00240265525688085,0.00762165789784092,0.0170400665048139,2.88575727176173e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28491,-0.0186183277518179,0.00363694127817177,-0.0257467326570346,-0.0114899228466012,3.08784700440635e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PI3,Elafin,28710,-0.0202485594388088,0.00396283034080172,-0.0280157069067801,-0.0124814119708374,3.24873464132781e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29034,-0.0126990158452722,0.00248780281331147,-0.0175751093593627,-0.00782292233118173,3.3374345831532e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,29037,-0.0398824777254978,0.00781684858349605,-0.0552035009491501,-0.0245614545018455,3.37988963046347e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24529,-0.0147032222857735,0.00288329078593042,-0.0203544722261971,-0.00905197234534982,3.43160816855183e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29280,0.010129667213607,0.00198754966170116,0.0062340698766727,0.0140252645505412,3.48030077981393e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,28860,-0.00910578507230644,0.00178736210136824,-0.0126090147909882,-0.00560255535362469,3.51793292635749e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,29507,-0.0116543373260699,0.00228913561965814,-0.0161410431405998,-0.00716763151153992,3.58080931365494e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,24119,-0.0280988339752872,0.00552890542208416,-0.0389354886025722,-0.0172621793480022,3.75935497092015e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,24669,-0.0171306098230069,0.00337319046129553,-0.0237420631271461,-0.0105191565188677,3.83278951059204e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29121,-0.0268878359037615,0.00529732577039847,-0.0372705944137425,-0.0165050773937805,3.88370265011694e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,29381,-0.01320354017816,0.00260205603051942,-0.0183035699979781,-0.00810351035834193,3.91351416564186e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,28990,-0.0112459458898282,0.00221640943206268,-0.0155901083766711,-0.00690178340298537,3.92050613656408e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29507,-0.00844574467159599,0.00166499915149322,-0.0117091430085227,-0.00518234633466927,3.94955601811485e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,28467,-0.0155907425004489,0.00307736359666502,-0.0216223751499124,-0.00955910985098549,4.08229977968909e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24185,-0.0264707056050589,0.00522665421728816,-0.0367149478709436,-0.0162264633391741,4.12352372097042e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29219,-0.0178585247937744,0.00353203624958631,-0.0247813158429636,-0.0109357337445853,4.3037643826404e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28412,-0.017454064419848,0.00345628239090349,-0.0242283779060189,-0.0106797509336772,4.44650671394728e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,28149,-0.0218132506204721,0.0043212082173824,-0.0302828187265416,-0.0133436825144026,4.4935466650171e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23848,-0.014739432266321,0.00292573309920122,-0.0204738691407554,-0.00900499539188662,4.74204602112745e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,24683,0.0230591569275508,0.00458813499916955,0.0140664123291785,0.0320519015259231,5.04780393366005e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,24539,-0.01616578847196,0.00321691576300363,-0.0224709433674471,-0.00986063357647286,5.06324824001646e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29256,0.0162990839797936,0.0032517434913397,0.00992566673676777,0.0226725012228194,5.40650088368308e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,23940,0.0113197652395622,0.00225916874194628,0.00689179450534744,0.0157477359737769,5.46503272599736e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,23811,-0.0355459815513066,0.00709778000373772,-0.0494576303586325,-0.0216343327439806,5.5379524645034e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28491,-0.0170845824369513,0.00341179265654009,-0.0237716960437699,-0.0103974688301328,5.54680358734681e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29034,-0.00870112720507672,0.00173984285265245,-0.0121112191962755,-0.00529103521387791,5.73364491525682e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,24648,-0.00531372593609322,0.0010626853229297,-0.00739658916903543,-0.003230862703151,5.76395062576474e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,23940,-0.0183447599072,0.00367052417348627,-0.0255389872872331,-0.0111505325271669,5.83794323834822e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,24579,0.015076453368512,0.00302782165941081,0.00914192291606683,0.0210109838209572,6.42444730693759e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,29122,-0.0317693287625575,0.00640617967915486,-0.044325440933701,-0.019213216591414,7.11934073665382e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,28908,0.0180821488300894,0.00364896351709333,0.0109301803365864,0.0252341173235923,7.258168904875e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24529,-0.0193967177219688,0.00391616235083689,-0.0270723959296091,-0.0117210395143285,7.35670948339057e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29359,-0.0237623610345789,0.00480687974995981,-0.0331838453445001,-0.0143408767246577,7.71921161152864e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,29042,-0.0174859937565381,0.00354230680054215,-0.0244289150856007,-0.0105430724274755,8.00475073758776e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29381,0.00977104744872847,0.00198313050171952,0.00588411166535821,0.0136579832320987,8.39202472554466e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,28674,-0.0120637016993776,0.00244884557599842,-0.0168634390283345,-0.00726396437042072,8.42759326339376e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24539,-0.0403296634957819,0.00819738977213795,-0.0563965474491723,-0.0242627795423915,8.71857095964535e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,29172,0.0120575680181548,0.00245249639823755,0.00725067507760919,0.0168644609587004,8.86076170016175e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28491,-0.0184564255737588,0.00377485871615513,-0.0258551486574228,-0.0110577024900947,1.01744651385294e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,24529,-0.0179988470799997,0.00368218198762829,-0.0252159237757512,-0.0107817703842483,1.02460792969481e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,29122,0.0212236375140914,0.00434321949932382,0.0127109272954167,0.0297363477327661,1.03129866295378e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,24185,-0.0103384920432982,0.00211644583470933,-0.0144867258793285,-0.00619025820726792,1.04176249864444e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29145,-0.0103612164741952,0.00212214369839503,-0.0145206181230494,-0.00620181482534091,1.05341224935239e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,23756,-0.0148942442716289,0.00305720042989655,-0.0208863571142261,-0.00890213142903164,1.11266021353522e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,24567,0.0166024631840405,0.00340974467127301,0.0099193636283454,0.0232855627397356,1.12791651562695e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23848,0.00719483406624501,0.00147840396296812,0.00429716229882751,0.0100925058336625,1.14246826507011e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,24699,-0.00732866449327806,0.00150655081161279,-0.0102815040840391,-0.004375824902517,1.15434489608711e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,28902,0.0117816314005576,0.00242209502686148,0.00703432514790912,0.0165289376532061,1.15506512684025e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,23848,0.0145520834619592,0.00299173574102314,0.00868828140955384,0.0204158855143645,1.157154887875e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,23756,-0.0268857599481388,0.00553529776483407,-0.0377349435672136,-0.016036576329064,1.19846726958213e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29507,0.0110322519057878,0.00227182792531539,0.00657946917216961,0.015485034639406,1.20325382662076e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24284,0.00283475689875992,0.000586585464482924,0.00168504938837339,0.00398446440914645,1.35556461254799e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,28612,-0.0266108407604783,0.00550756393907157,-0.0374056660810585,-0.015816015439898,1.36079842726501e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,23848,0.0109212003019659,0.00226773529236742,0.00647643912892579,0.0153659614750061,1.47432518072739e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,28965,0.00993727009765272,0.00206515405448316,0.00588956815086573,0.0139849720444397,1.50270879641437e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,29122,0.0160153867289079,0.00332891310818395,0.00949071703686737,0.0225400564209485,1.50931472254246e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,28415,-0.0213156274957138,0.0044332845124933,-0.0300048651402007,-0.0126263898512269,1.53159196576178e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,28612,-0.040301699308539,0.00838629946436195,-0.0567388462586885,-0.0238645523583896,1.5502424595151e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,23974,-0.0133542576846437,0.00278568562302624,-0.0188142015057751,-0.00789431386351223,1.64562679121015e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29061,-0.030197081898409,0.00630884816796582,-0.042562424307622,-0.0178317394891959,1.70578695705536e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,24683,0.0497014537800366,0.0104095477057553,0.0292987402767562,0.070104167283317,1.81094959210801e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,23843,0.00996919601145063,0.00208829606300718,0.00587613572795655,0.0140622562949447,1.81816346492359e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24579,-0.0159286691242763,0.00335137590261203,-0.0224973658933958,-0.00935997235515669,2.01679552468378e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24602,-0.0102941183316285,0.00217031622996252,-0.0145479381423551,-0.00604029852090197,2.11608713191885e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,23756,-0.0124485175082726,0.00263518009444689,-0.0176134704933885,-0.00728356452315669,2.32604729364726e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,29120,0.0225246145102311,0.00477392276322402,0.013167725894312,0.0318815031261502,2.38973017076188e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",23848,-0.0213696963887415,0.00453540612970277,-0.0302590924029589,-0.0124803003745241,2.46984721862216e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,28908,-0.0352793661142594,0.00752019716508715,-0.0500189525578302,-0.0205397796706885,2.72740060614375e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29122,0.0157873718677454,0.0033680973079156,0.00918590114423079,0.0223888425912599,2.78049684470485e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,24699,0.00763263519237898,0.00162931007105353,0.00443918745311406,0.0108260829316439,2.82027056038163e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,29158,-0.0134566439506517,0.00287368918845911,-0.0190890747600315,-0.00782421314127184,2.84385990439304e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,29470,-0.0140640821163567,0.00300435138706124,-0.0199526108349967,-0.00817555339771668,2.8641717645143e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24579,-0.012478531172987,0.00266795490680715,-0.017707722790329,-0.00724933955564494,2.92380223195374e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29034,0.0112609528338328,0.0024119440933093,0.00653354241094662,0.0159883632567191,3.0427659060986e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,28298,0.0234911383417997,0.0050345399007842,0.0136234401362627,0.0333588365473368,3.08532550969625e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",23940,-0.013132961482115,0.00282117684974788,-0.0186624681076208,-0.00760345485660913,3.25503610002901e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29363,-0.00907404557086627,0.0019532554297876,-0.01290242621325,-0.00524566492848257,3.40558036013095e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24529,-0.00958637732608054,0.00206644126289467,-0.0136366022013541,-0.00553615245080699,3.51778575556819e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24579,-0.0799164654253836,0.0172664857227275,-0.11375877744193,-0.0460741534088376,3.70357235142622e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,29075,-0.00956557646374872,0.0020769598135169,-0.0136364176982418,-0.0054947352292556,4.1308708004565e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28467,-0.0279347008688171,0.0060718829782232,-0.0398355915061345,-0.0160338102314996,4.2295857922438e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,23940,-0.010400510748169,0.00226066755744701,-0.0148314191607651,-0.00596960233557287,4.23359999014883e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,24669,-0.0291813850480828,0.00637264448473938,-0.041671768238172,-0.0166910018579936,4.69118526419361e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23979,-0.00927352429595095,0.00202962352435822,-0.0132515864036931,-0.00529546218820885,4.92297432344867e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,29409,-0.0104176042511527,0.00228138809947917,-0.0148891249261318,-0.00594608357617349,4.98313977334014e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,29256,-0.0136307167369338,0.00298843049326106,-0.0194880405037254,-0.0077733929701421,5.10775647794772e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,23848,-0.0120933443794781,0.00266352102845889,-0.0173138455952575,-0.00687284316369867,5.64329667862924e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,28549,-0.0238797085626877,0.00527584724137715,-0.0342203691557869,-0.0135390479695885,6.02870087996416e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,24653,-0.0122818943229024,0.00271626698372029,-0.0176057776109941,-0.00695801103481062,6.16574714606226e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,28631,-0.00941714338640792,0.00208680195200014,-0.0135072752123282,-0.00532701156048764,6.42575116720793e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,23843,0.0108172365404361,0.00240068836010679,0.00611188735462684,0.0155225857262454,6.64095460585664e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,29409,0.0193400933945672,0.00429953020346263,0.0109130141957804,0.027767172593354,6.87974023741689e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,29359,0.00999994378727554,0.00222380773351544,0.00564128062958527,0.0143586069449658,6.92588113865909e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCN,Decorin,28612,0.00740240901886729,0.0016463310398835,0.00417560018069562,0.010629217857039,6.94154982289753e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28467,-0.0124062786136336,0.00276674713373842,-0.0178291029957609,-0.00698345423150626,7.35197504097994e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LXN,Latexin,28809,0.0216513197195378,0.00483447444158628,0.0121757498140287,0.0311268896250469,7.54488485039911e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,28631,-0.0181691994918305,0.00406198101038807,-0.0261306822721911,-0.0102077167114699,7.74301332804397e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29172,0.00916166255472416,0.00204840865742392,0.00514678158617328,0.013176543523275,7.75746808004954e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,24699,-0.0233685716975313,0.00522583663074667,-0.0336112114937947,-0.0131259319012678,7.79321328029923e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29341,-0.00900838341595694,0.00202133980795692,-0.0129702094395525,-0.00504655739236137,8.35624107288861e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',23848,-0.0138411203142337,0.00311048608641669,-0.0199376730436104,-0.00774456758485696,8.63292521479019e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,24602,0.0113502850053717,0.00255966274656601,0.00633334602210234,0.0163672239886411,9.27766029994552e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,29172,0.0122134760143291,0.00276009588513924,0.00680368807945621,0.017623263949202,9.6783196780087e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,23974,-0.0179075529923781,0.00404675577675444,-0.0258391943148168,-0.00997591166993942,9.67945498676659e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,29132,0.00625406942910831,0.00141341393208554,0.00348377812222065,0.00902436073599597,9.68831656752172e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24539,-0.0159080054668787,0.0036095953209499,-0.0229828122959405,-0.00883319863781687,1.05186906739345e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29317,-0.0225270054527889,0.00511493470993335,-0.0325522774842582,-0.0125017334213195,1.06569022292733e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,24081,-0.0183455044315452,0.00416787256768986,-0.0265145346642174,-0.0101764741988731,1.07894277015764e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,23974,-0.0118931548996653,0.00270486017844349,-0.0171946808494145,-0.00659162894991604,1.1025128165516e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,29002,-0.00778505672657016,0.001772682956767,-0.0112595153218335,-0.00431059813130685,1.12876139155652e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,24529,-0.0213823969236933,0.00488137579259522,-0.0309498934771799,-0.0118149003702067,1.18950646274597e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29381,-0.00733815970769667,0.00167643284723273,-0.0106239680882728,-0.00405235132712053,1.20602703009302e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,23940,-0.020584440922209,0.00472221439000302,-0.029839981126615,-0.0113289007178031,1.31163673714137e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24185,-0.0138552697523188,0.00317975349465052,-0.0200875866018338,-0.00762295290280382,1.32194626262775e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RETN,Resistin,29054,-0.0131039543633947,0.00302364052586034,-0.019030289794081,-0.00717761893270843,1.4702721236193e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,29423,-0.00859641758518626,0.00198917344349878,-0.0124951975344439,-0.00469763763592866,1.55408016263621e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28612,-0.0178361503031343,0.00413241729646181,-0.0259356882041995,-0.00973661240206917,1.59304185382439e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,23848,0.013087847380446,0.00303281367532714,0.00714353257680484,0.0190321621840872,1.59945423505497e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24185,-0.0180913908558751,0.00419850092125386,-0.0263204526615327,-0.00986232905021754,1.64632970044313e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,24119,0.0161313923475482,0.00374381680497494,0.00879351140979733,0.0234692732852991,1.64785631483422e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,28907,-0.0160155803931997,0.00372006661477605,-0.0233069109581608,-0.00872424982823866,1.67394277677338e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24539,-0.02486301804741,0.00577964570167936,-0.0361911236227016,-0.0135349124721185,1.70052930471703e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24579,-0.0102816924932373,0.00239894893127472,-0.0149836323985358,-0.00557975258793886,1.82680814431123e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",29409,-0.0225693651847261,0.00527354551856508,-0.0329055144011137,-0.0122332159683386,1.87709688348833e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,28612,-0.0174883300342768,0.00408754787858591,-0.0254999238763051,-0.00947673619224838,1.88818485044986e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,23848,0.00853835899072048,0.00199669441625651,0.00462483793485772,0.0124518800465832,1.90809399505003e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,24349,-0.0198183050891109,0.00463704837506676,-0.0289069199042417,-0.0107296902739801,1.92808895443319e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,24699,-0.00456378417084289,0.00106785170234574,-0.00665677350744053,-0.00247079483424524,1.92889834214921e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29031,-0.0107060186490049,0.00250778134441659,-0.0156212700840614,-0.00579076721394833,1.96868786945801e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,23979,-0.0125099430506878,0.00293195693239227,-0.0182565786381767,-0.00676330746319897,1.99097140104216e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,24529,-0.0137577374801924,0.00322641228459703,-0.0200815055580026,-0.00743396940238226,2.01462287922667e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28491,0.00936896263789477,0.00219815321486827,0.00506058233675296,0.0136773429390366,2.0307721051994e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24602,0.014307644347025,0.0033579399152658,0.007726082113104,0.0208892065809459,2.04417402382415e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,28908,-0.0127750217588761,0.00300106900381545,-0.0186571170063543,-0.00689292651139777,2.08005345103056e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24529,-0.0160303733711468,0.00378016104246374,-0.0234394890143758,-0.0086212577279179,2.23680926565281e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,23979,-0.00907206555288857,0.00214077547632654,-0.0132679854864886,-0.00487614561928854,2.26617373175352e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28491,-0.0121363639068955,0.00286451007435865,-0.0177508036526384,-0.00652192416115252,2.27437508956598e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29132,0.0102922300108143,0.00243700448004217,0.00551570122993167,0.015068758791697,2.41468998385271e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,23940,-0.0148451445224934,0.00352627256584979,-0.021756638751559,-0.00793365029342783,2.56451821923618e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24539,-0.0129975419304521,0.00309032288996882,-0.0190545747947909,-0.00694050906611318,2.60985462944091e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28491,-0.0110188492296759,0.00262370027069555,-0.0161613017602392,-0.00587639669911261,2.68037911020625e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,23940,-0.0233734397213898,0.0055694189314737,-0.0342895008270783,-0.0124573786157014,2.71753354671359e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29132,-0.0113476334964129,0.00270506418392059,-0.0166495592968972,-0.00604570769592854,2.73728281034131e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,28148,-0.0108374961473199,0.00258392634762812,-0.0159019917886711,-0.00577300050596881,2.74677818662606e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,24539,-0.0182117402695577,0.00434381985458476,-0.0267256271845438,-0.00969785335457152,2.76786806961753e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,24539,-0.0184760383665786,0.00441088477105789,-0.0271213725178521,-0.00983070421530514,2.8149057635097e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,29256,-0.00657165079621424,0.00156957030952515,-0.00964800860288353,-0.00349529298954494,2.8360389709017e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,24683,-0.0159376352686771,0.00380717985493562,-0.0233997077843509,-0.00847556275300328,2.84640050558871e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,24602,-0.0134394542054894,0.00321258311627212,-0.0197361171133828,-0.00714279129759604,2.88203277868896e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24539,-0.00850606471543633,0.00204129467883282,-0.0125070022859487,-0.00450512714492401,3.09698301427713e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",23848,0.0143925337458334,0.00345586522934804,0.00761903789631121,0.0211660295953555,3.12901540890209e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28491,-0.0089639080891523,0.00215755476732186,-0.0131927154331031,-0.00473510074520145,3.26720460046453e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29172,-0.00837615714993986,0.00203898547971581,-0.0123725686901829,-0.00437974560969687,4.00184807404455e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24653,-0.0081421214024334,0.00198322455908876,-0.0120292415382474,-0.00425500126661943,4.04747192157556e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24669,-0.00667415287594292,0.00164025707541738,-0.00988905674376098,-0.00345924900812486,4.73688702543988e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23711,-0.0257941521218405,0.00634317864657244,-0.0382267822691225,-0.0133615219745585,4.78910794861253e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,29172,-0.0341772508375059,0.0084052975721573,-0.0506516340789342,-0.0177028675960776,4.79203733900601e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23974,-0.0130686908752811,0.00321742017754505,-0.0193748344232694,-0.00676254732729283,4.88394065635973e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28491,-0.0119249533545562,0.00294016860327814,-0.0176876838169813,-0.00616222289213101,5.00801023935892e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24699,0.00566350449593839,0.00139921996184206,0.00292103337072794,0.00840597562114883,5.18996837320179e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28631,-0.00920717605434176,0.00227577009776171,-0.0136676854459547,-0.0047466666627288,5.22947255449287e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23974,-0.00910869365240319,0.00225420365721631,-0.0135269328205472,-0.00469045448425922,5.34446673145161e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29470,-0.0129539765937185,0.00321905834616297,-0.0192633309521979,-0.0066446222352391,5.73240330706239e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24602,-0.0141316872640418,0.00352140155503285,-0.0210336343119062,-0.00722974021617741,6.01075220365362e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,28491,-0.0102575954108413,0.00255627772312573,-0.0152678997481678,-0.00524729107351491,6.01796016074012e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,23756,-0.00850223247553253,0.00211914674225423,-0.0126557600903508,-0.00434870486071423,6.03649154519789e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24119,-0.00725259893007201,0.00181249000805614,-0.010805079345862,-0.00370011851428198,6.31419825895208e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,23974,-0.00886226064339425,0.00221513923573738,-0.0132039335454395,-0.00452058774134898,6.33265708271928e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,24602,-0.00735441745917359,0.00184226973213838,-0.0109652661341648,-0.00374356878418236,6.56970106033138e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,29132,-0.00971175025343024,0.00243711230865531,-0.0144884903783946,-0.00493501012846584,6.76610191149504e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,24529,-0.0106033953129751,0.00266252156304891,-0.015821937576551,-0.00538485304939925,6.84013245623079e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,23848,0.0108010352503848,0.00271248423845023,0.00548456614302234,0.0161175043577473,6.85486580677779e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,29034,-0.0125106825087859,0.00314546353766805,-0.0186757910426152,-0.00634557397495648,6.98497138323566e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28491,-0.0226345341160525,0.00570921113214688,-0.0338245879350604,-0.0114444802970447,7.37096529196973e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,29122,-0.0193904210352102,0.00489150095313033,-0.0289777629033456,-0.0098030791670747,7.38478375810879e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24602,-0.00917246566773359,0.00231646653916862,-0.0137127400845041,-0.00463219125096309,7.52615642780345e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,23843,-0.0135336765536274,0.00341859544652806,-0.0202341236288224,-0.00683322947843239,7.55328402702259e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29034,-0.0102858738894464,0.00260740934981466,-0.0153963962150831,-0.00517535156380965,8.00331532016267e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,28865,0.0136054965469363,0.00345295481919805,0.00683770510130812,0.0203732879925645,8.15892050204491e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,28908,0.0099074313920153,0.00251740945991098,0.00497330885058978,0.0148415539334408,8.31950281269194e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,24602,-0.00860142913191064,0.00218672050567089,-0.0128874013230256,-0.00431545694079569,8.39533670798375e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,28631,-0.0139986060677314,0.00355905583630505,-0.0209743555068893,-0.00702285662857348,8.40074970284017e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29145,-0.0834194145320758,0.0212331767275492,-0.125036440918072,-0.0418023881460793,8.55926169076296e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,23848,-0.0242969181457699,0.00618801007875888,-0.0364254179001373,-0.0121684183914025,8.645091837615e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,24699,-0.00731962118696995,0.00186570010627434,-0.0109763933952677,-0.00366284897867224,8.75963308153109e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,23843,0.0134972707566164,0.00344230195903697,0.0067503589169039,0.0202441825963288,8.84285189917561e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29132,-0.00987920045237048,0.00252843163650688,-0.014834926459924,-0.00492347444481699,9.35656269143156e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24653,-0.0197043272548959,0.00504367450976649,-0.0295899292940382,-0.00981872521575354,9.37992514477625e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28631,0.0110689963248208,0.00283837605105805,0.00550577926474701,0.0166322133848945,9.65063227331444e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,23756,0.00858662612107953,0.00220844917769456,0.00425806573279819,0.0129151865093609,0.000101315389465246
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,23848,0.0156182513719332,0.00401953833115333,0.00773995624287263,0.0234965465009937,0.000102360422422807
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23979,-0.0256541514647032,0.00661136867532519,-0.0386124340683406,-0.0126958688610659,0.00010460302095743
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29208,-0.00750957536930226,0.00193628358866582,-0.0113046912030873,-0.00371445953551725,0.000105400041517751
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,24522,-0.0159488265999178,0.00411341356795391,-0.0240111171931075,-0.00788653600672818,0.000105909365036804
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24119,-0.0103486256951215,0.00266979964321169,-0.0155814329958164,-0.00511581839442659,0.000106389967677102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24185,0.00790122530197235,0.0020441849935299,0.00389462271465374,0.011907827889291,0.00011127903313871
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,29085,-0.00719982635299264,0.0018632189715479,-0.0108517355372265,-0.00354791716875876,0.000111701758072872
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24539,-0.00726466782594555,0.00188081136670287,-0.0109510581046832,-0.00357827754720792,0.000112512557302761
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,23974,0.0120971487335512,0.00313287690222809,0.00595671000518412,0.0182375874619182,0.000113056251603061
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,27979,-0.00637844356338726,0.00165821834434068,-0.00962855151829499,-0.00312833560847954,0.00012005132378477
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,23974,0.0118693110306167,0.00309126383008861,0.00581043392364298,0.0179281881375903,0.000123536404954134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,23940,-0.00931487217384882,0.00242608307298805,-0.0140699949969054,-0.00455974935079224,0.000123617819148554
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,29172,-0.0127594061993345,0.00332717484202897,-0.0192806688897113,-0.00623814350895774,0.000125875911643648
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,24653,-0.00734045356223856,0.00191597213303245,-0.0110957589429822,-0.00358514818149497,0.000127841099143885
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,23843,0.0118544294992647,0.00309626573665812,0.00578574865541482,0.0179231103431146,0.000129192575247675
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,29172,-0.0221797570723486,0.00580731691592305,-0.0335620982275578,-0.0107974159171394,0.000134120037450494
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24529,-0.011584878793045,0.00303562509492843,-0.0175347039791048,-0.00563505360698532,0.000135796337767914
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,23848,0.0110790695040604,0.00290610247677979,0.00538310864957202,0.0167750303585488,0.000138000089059011
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24535,-0.0102514541559873,0.00269156526724432,-0.0155269220797862,-0.00497598623218843,0.000140020917362485
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,23940,0.0101371371150335,0.00266411215626581,0.0049154772887525,0.0153587969413145,0.000142116030813413
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,24185,0.00947864105150342,0.00249132194522944,0.00459565003885372,0.0143616320641531,0.000142346863309619
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28491,-0.0129727939574976,0.00341112373984114,-0.0196585964875862,-0.00628699142740892,0.000143203375284299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,23843,0.017292025310248,0.00454789438520723,0.00837815231524186,0.0262058983052542,0.000143771483647716
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24602,-0.0250913494674347,0.00660337480125221,-0.038033964077889,-0.0121487348569803,0.000145175394565841
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23979,-0.0171985828459728,0.00452810872404337,-0.0260736759450978,-0.00832348974684776,0.000146120711154768
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,24119,0.0255554601528077,0.0067443682212578,0.0123364984391424,0.0387744218664729,0.000151527764742647
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,28467,-0.015193493652095,0.00401049980465134,-0.0230540732692116,-0.00733291403497834,0.000151914915610268
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23848,0.0160083822519582,0.00424707404167295,0.00768411713027918,0.0243326473736371,0.000164118304571989
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,24529,-0.0143396680303897,0.00380776999967633,-0.0218028972297553,-0.0068764388310241,0.000166340102412598
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,28999,-0.0180108724702214,0.00478808893707341,-0.0273955267868853,-0.00862621815355756,0.000169162362145355
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,23843,-0.0229736235903896,0.00611592103995295,-0.0349608288286974,-0.0109864183520819,0.000172810472036827
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24658,-0.00527300943993211,0.00140510624860064,-0.00802701768718937,-0.00251900119267485,0.000175307853800012
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24699,0.0069900250018855,0.00186390413778988,0.00333677289181734,0.0106432771119537,0.00017709262884347
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29437,-0.0140624589026388,0.0037658414339518,-0.0214435081131843,-0.00668140969209323,0.000188657066369887
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23979,-0.00993783816987487,0.00266517367262951,-0.0151615785682287,-0.00471409777152104,0.000192854292160191
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,23848,-0.0118753268961324,0.00319037531493187,-0.0181284625133989,-0.00562219127886595,0.000197921111259866
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24579,-0.0150532298684302,0.00404564133820475,-0.0229826868913115,-0.00712377284554888,0.000198994664290462
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29507,0.00423628838301387,0.00113972997235415,0.00200241763719973,0.006470159128828,0.000202036661486623
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,24669,0.00645878025361959,0.00173869750855608,0.00305093313684968,0.00986662737038951,0.000203874870700993
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28467,-0.0131799664279566,0.00355587348794669,-0.0201494784643321,-0.00621045439158106,0.000210513218556115
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,23843,0.00753599701101248,0.00203432326032938,0.00354872342076689,0.0115232706012581,0.000212349742122487
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,23979,-0.0255715080834233,0.00691402934525689,-0.0391230056001268,-0.0120200105667198,0.000217365178328888
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,24110,0.00865452910397995,0.00234163579784331,0.00406492294020707,0.0132441352677528,0.000219565890477222
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23848,0.0135767014581118,0.00367723402457488,0.006369322769945,0.0207840801462785,0.000222909407677144
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,29187,-0.00639065338608123,0.00173299624993063,-0.00978732603594527,-0.0029939807362172,0.000226760691165312
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29256,-0.0260219371826429,0.00707921788918512,-0.0398972042454458,-0.0121466701198401,0.000237509621261144
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,24579,-0.00716149753117019,0.0019491861119495,-0.0109819023105912,-0.00334109275174917,0.000239199776781243
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,28908,-0.0160978300959278,0.00438564127476733,-0.0246936869944717,-0.0075019731973838,0.000242439880293678
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28467,-0.00728559175176964,0.00199024008122056,-0.0111864623109619,-0.00338472119257736,0.000252021722994729
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,23979,-0.00875566855692728,0.00239593591472989,-0.0134517029497979,-0.0040596341640567,0.000258350929831886
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,28446,-0.022786439256294,0.00624223625174483,-0.0350212223097139,-0.0105516562028742,0.000262337234995782
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,23848,0.00944339204487145,0.00259045286877886,0.00436610442206488,0.014520679667678,0.00026748158628447
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23848,0.00979818268948988,0.00269051686409742,0.00452476963585894,0.0150715957431208,0.000271367356549277
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,28631,0.0161408063154746,0.00443251537271379,0.00745307618495553,0.0248285364459936,0.00027157934057355
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,29409,-0.00739917358915265,0.0020390146359997,-0.0113956422757121,-0.00340270490259324,0.000285225690227084
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,29122,-0.0169981596665551,0.00469388120055782,-0.0261981668196484,-0.00779815251346176,0.000293573895821666
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29381,0.0118510469785694,0.00327712274897934,0.00542788639056987,0.0182742075665689,0.000299348611849631
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,29507,0.0106319290066528,0.00294721096661556,0.00485539551208626,0.0164084625012192,0.00030972673084893
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,23756,-0.0145644994627367,0.00404579599547404,-0.0224942596138658,-0.00663473931160761,0.000318976163805005
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,24699,-0.00479881627090608,0.00133510226746383,-0.00741561671513519,-0.00218201582667698,0.00032584368542705
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,23848,0.0104374418531832,0.00291571908535241,0.00472263244589246,0.0161522512604739,0.000344653008141428
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,28467,0.00843542707602831,0.00235802953017371,0.00381368919688785,0.0130571649551688,0.000347710654229533
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24579,0.0154120059880424,0.00432558987992762,0.00693384982338428,0.0238901621527006,0.000367357836033196
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,24065,-0.0291176505536471,0.00818754217623827,-0.0451652332190741,-0.01307006788822,0.000376785398882592
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,28631,-0.0179209758362551,0.00506418059304442,-0.0278467697986221,-0.00799518187388799,0.000402631216859521
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24669,0.0101262175324499,0.00286218974152199,0.00451632563906677,0.015736109425833,0.000404023022428498
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,23848,0.00872813037876185,0.00246850825263837,0.00388985420359065,0.013566406553933,0.00040732656931341
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29132,0.00616256727237841,0.0017470451375567,0.00273835880276729,0.00958677574198953,0.000420271345922104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,29217,0.00710318989775929,0.00202050734751631,0.00314299549662733,0.0110633842988913,0.00043951277074049
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,23756,0.00663883755553848,0.00188900042070157,0.00293639673096341,0.0103412783801136,0.000441450657226498
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,28446,-0.014208643084727,0.00405149073409466,-0.0221495649235525,-0.00626772124590143,0.00045386053767312
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29064,-0.00932399232478072,0.00266168928068392,-0.0145409033149212,-0.00410708133464023,0.00046067920858481
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29367,-0.00755077895906697,0.0021559858720364,-0.0117765112682583,-0.00332504664987564,0.000462050199067777
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,24539,-0.0285402288891741,0.00817121449165218,-0.0445558092928124,-0.0125246484855358,0.000478867473998791
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,23756,-0.0183819980415324,0.00527074232742957,-0.0287126530032943,-0.00805134307977039,0.000488342327196726
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24119,-0.00809922200499965,0.0023248044589408,-0.0126558387445236,-0.00354260526547569,0.000495171629453433
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,23974,-0.00979553915752552,0.00281351031425227,-0.01531001937346,-0.00428105894159106,0.00049930094850143
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24653,-0.00690285931271764,0.00198734894609422,-0.0107980632470623,-0.00300765537837297,0.000514789594586176
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,23843,0.0226815102421798,0.00653123092582981,0.00988029762755338,0.0354827228568062,0.000516016366247634
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24579,-0.00705633481104196,0.00203229442152967,-0.0110396318772401,-0.0030730377448438,0.000517286780301176
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,23843,0.00858972920511129,0.00247635159887525,0.0037360800713158,0.0134433783389068,0.000523900108032272
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29187,-0.00844847928641773,0.00244094751461731,-0.0132327364150677,-0.00366422215776779,0.000538647673600007
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,24653,0.00864713484450858,0.00249973420016999,0.00374765581217539,0.0135466138768418,0.000542654652201041
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28093,-0.0158838022592653,0.00460132026846429,-0.0249023899854553,-0.00686521453307532,0.000557246734693714
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23848,0.00787226314797801,0.00228060166534962,0.00340228388389275,0.0123422424120633,0.00055775127371382
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,29132,-0.00964010478647937,0.00279345240979,-0.0151152715096678,-0.00416493806329097,0.00055937924099529
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",28467,-0.0134609364450308,0.00390209868493598,-0.0211090498675053,-0.0058128230225563,0.000562094165039287
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,28467,-0.00964012018632362,0.00279567560397493,-0.0151196443701145,-0.00416059600253275,0.00056509884230587
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,23848,0.0110040283750374,0.00319157082161329,0.0047485495646754,0.0172595071853995,0.000566062432706235
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28612,0.0078898265642789,0.00228904699597333,0.00340329445217118,0.0123763586763866,0.000568139258435993
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,28415,-0.00897584548930724,0.00260687172404887,-0.014085314068443,-0.00386637691017146,0.000575813073763549
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23940,0.0156787324210424,0.00455586112397551,0.00674924461805037,0.0246082202240344,0.000579610496765624
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24602,0.0104450632625933,0.00305269980421977,0.00446177164632251,0.016428354878864,0.000623591717791733
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,29172,-0.00703934472431125,0.00206046362405834,-0.0110778534274656,-0.0030008360211569,0.000635441310479858
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,24185,0.00839078537022879,0.00245648350026884,0.00357607770970186,0.0132054930307557,0.000637062568885645
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29034,-0.00768681983588083,0.00225247819702381,-0.0121016771020475,-0.00327196256971417,0.000644327859603934
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,28973,0.00552087884962602,0.00161873555822303,0.00234815715550888,0.00869360054374315,0.000649057131834489
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29477,-0.0140758980382479,0.00413640568048744,-0.0221832531720033,-0.00596854290449248,0.000667560813635464
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,29271,-0.0103690979133337,0.00305101784216468,-0.0163490928839764,-0.0043891029426909,0.000678294049259149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,29122,0.0142948855288935,0.00421303982257325,0.00603732747664994,0.0225524435811371,0.000692212163223017
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24539,-0.00627069673810506,0.00184937105895458,-0.00989546401365603,-0.00264592946255409,0.000698195630338999
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,29507,-0.00667594176511322,0.00197858912372539,-0.010553976447615,-0.00279790708261145,0.000741549430124013
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,29331,-0.0119580732699385,0.00354578167622995,-0.0189078053553492,-0.00500834118452779,0.000745911419756007
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23843,0.0149443409899008,0.00443434002576714,0.00625303453939721,0.0236356474404044,0.000752495471033376
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,29132,0.00814195915834707,0.00242533993214071,0.00338829289135128,0.0128956254253429,0.000788829925890065
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,24119,-0.020396495819567,0.00608243449671497,-0.0323180674331283,-0.00847492420600565,0.000799642948284671
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,23843,0.0232086261046729,0.00692267962756421,0.00964017403464704,0.0367770781746987,0.000801955105424245
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,29271,-0.00805181710140137,0.00240268352364962,-0.0127610768077546,-0.00334255739504812,0.000805707453557293
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,29089,0.0169882762099576,0.00508575881904341,0.00702018892463254,0.0269563634952827,0.000837744658549086
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29409,0.0144257651096857,0.00432566442626563,0.00594746283420506,0.0229040673851663,0.000854280303876159
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,23974,-0.0105462513132388,0.00316967300443846,-0.0167588104019382,-0.00433369222453945,0.000878439064108971
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,28491,-0.0181883343347204,0.00548234311603578,-0.0289337268421506,-0.00744294182729031,0.000909014151623477
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,29284,-0.0267372596516363,0.00807478460121135,-0.0425638374700106,-0.0109106818332621,0.000930078093524064
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23848,-0.0109633263473758,0.00331095823280532,-0.0174528044836742,-0.00447384821107738,0.000930266290357604
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29232,-0.0120701661124533,0.00368737193596095,-0.0192974151069368,-0.00484291711796983,0.00106393273080893
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,29132,-0.00990452013784692,0.00302615902624705,-0.0158357918292911,-0.00397324844640269,0.00106548680644544
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,23756,0.00715414555664926,0.00218683116923144,0.00286795646495563,0.0114403346483429,0.00107143750198842
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,28914,-0.0137400327900809,0.00420053424513284,-0.0219730799105413,-0.00550698566962055,0.00107285705946775
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,23979,-0.0166602844244759,0.00509898460337175,-0.0266542942470846,-0.00666627460186729,0.00108703244996252
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23848,0.00611399431750303,0.00187310447619678,0.00244270954415734,0.00978527909084872,0.00109968365446371
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28631,-0.0139630804504461,0.00428032466146283,-0.0223525167869132,-0.00557364411397893,0.00110698310366805
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,29145,0.00839633041889311,0.00257413427623437,0.00335102723747376,0.0134416336003125,0.00110831578760014
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERVV_1,,23848,0.010850981403895,0.00333637909229508,0.00431167838299664,0.0173902844247933,0.00114625129273093
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24529,-0.0156302561144623,0.00481205918511634,-0.0250618921172904,-0.0061986201116343,0.00116317158699233
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,23979,0.00585981036558372,0.00180458279287643,0.00232282809154592,0.00939679263962152,0.00116713683157966
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,23843,0.00824238022172307,0.002541109711219,0.00326180518773383,0.0132229552557123,0.00118185878206115
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,24699,-0.0045131683639246,0.00139629940567306,-0.0072499151990438,-0.0017764215288054,0.00122986971733506
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24579,-0.0127689971729118,0.00396796528199423,-0.0205462091256205,-0.00499178522020309,0.00129245616018102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,23843,0.0124681919672958,0.00387840264463749,0.00486652278380632,0.0200698611507853,0.00130720706450357
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,24185,0.0096717106036746,0.00301072610071625,0.00377068744627075,0.0155727337610784,0.0013179513343357
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,28804,-0.00762899728150535,0.00238903293635294,-0.0123115018367571,-0.00294649272625358,0.00140787954313464
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29034,-0.0102717991905864,0.00322685585726288,-0.0165964366708216,-0.00394716171035113,0.00145799422917793
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,23756,0.0080436046518735,0.00253153112509758,0.00308180364668225,0.0130054056570648,0.00148808921828344
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,23545,-0.00897885295934526,0.00282726798560016,-0.0145202982111216,-0.00343740770756894,0.00149613865289919
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,23940,-0.00873966285019385,0.00275457116793417,-0.0141386223393448,-0.00334070336104288,0.00151174994629161
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,23848,0.010683495327235,0.00337661465186734,0.00406533060957497,0.0173016600448949,0.00155830233933824
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29332,0.00515659452840679,0.00163285244850763,0.00195620372933184,0.00835698532748173,0.00159001097823185
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24119,0.00582367541838685,0.0018442878081668,0.00220887131437992,0.00943847952239378,0.00159224687247003
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,29015,-0.0134457566633744,0.00426659975529885,-0.0218082921837601,-0.00508322114298862,0.00162655826558456
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28631,-0.00957843286717411,0.0030531224426207,-0.0155625528547107,-0.00359431287963753,0.00170708883959436
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,23848,-0.0109202817505039,0.00349712338342555,-0.0177746435820179,-0.00406591991898978,0.00179447083061301
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28467,-0.0326284789210548,0.0104600122278352,-0.0531301028876118,-0.0121268549544978,0.00181429160857275
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,28491,-0.00695220782980408,0.00224020450874727,-0.0113430086669487,-0.00256140699265942,0.0019151055559413
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,23974,-0.00643928476215965,0.00208577913857357,-0.0105274118737638,-0.00235115765055546,0.00202260279328432
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,28729,0.0380481291698449,0.0123645967202575,0.0138135195981401,0.0622827387415497,0.00209163518658168
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,23974,-0.014247535908234,0.00463735324107869,-0.0233367482607482,-0.00515832355571974,0.00212624322697351
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29271,0.00940124438023157,0.00306070583732782,0.00340226093906904,0.0154002278213941,0.00213114798948676
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28631,-0.013913513278948,0.00452977898084588,-0.0227918800814059,-0.00503514647649009,0.00213139136086612
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,29034,0.00334563375112781,0.0010903550733479,0.00120853780736593,0.00548272969488969,0.00215414451653518
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,28631,-0.0180392573489265,0.00588863472775618,-0.0295809814153286,-0.00649753328252438,0.0021903893221767
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28612,-0.00596741399351541,0.00196228479318136,-0.00981349218815087,-0.00212133579887994,0.00235964926528307
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C5,Complement C5,24699,-0.00331618127908208,0.00109260167189106,-0.00545768055598856,-0.0011746820021756,0.00240687336849358
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23940,-0.0119348723850681,0.00393979228427792,-0.0196568652622528,-0.00421287950788334,0.00245370309293437
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,29079,-0.00613220966172778,0.00202883804371551,-0.0101087322274102,-0.00215568709604538,0.00250895327073496
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,23848,0.00834055058122978,0.00276988778729003,0.00291157051814131,0.0137695306443182,0.00260531950802782
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,29449,-0.0129927949731146,0.00431656926205981,-0.0214532707267518,-0.00453231921947737,0.00261484604062471
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29127,-0.00694036028430356,0.00230798606236683,-0.0114640129665425,-0.00241670760206456,0.00263972253714138
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29280,-0.00924882354205498,0.00308393712547051,-0.0152933403079772,-0.00320430677613278,0.00271067259706501
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24653,-0.0159975014539076,0.00533523748334068,-0.0264545669212553,-0.00554043598655987,0.00271617631406409
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,23940,-0.0163371548402315,0.00545229004789781,-0.0270236433341112,-0.00565066634635183,0.00273482135666367
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24539,0.00738398236152328,0.00246518101983088,0.00255222756265476,0.0122157371603918,0.00274439451984959
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29041,-0.0399263564733858,0.0133410143769777,-0.066074744652262,-0.0137779682945095,0.00276706220106613
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",23848,-0.00851026349813586,0.00284876337906963,-0.0140938397211123,-0.00292668727515938,0.00281690402602197
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23974,-0.00604863106581661,0.00202662820776365,-0.0100208223530334,-0.00207643977859985,0.00284255756891133
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29470,0.00612484902302157,0.00205354438795331,0.00209990202263308,0.0101497960234101,0.00286069085532693
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29361,-0.00647451067768794,0.00218545014415543,-0.0107579929602326,-0.0021910283951433,0.00305344407980008
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29256,0.00516363793648401,0.00174745455789232,0.00173862700301506,0.00858864886995296,0.00312970664220843
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29507,0.00875451854371007,0.00296506039827328,0.00294300016309445,0.0145660369243257,0.00315399196677256
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29172,0.00600627930520914,0.00203965123453943,0.00200856288551185,0.0100039957249064,0.0032346246471251
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23848,0.00917464941150486,0.00313863482343754,0.00302292515756727,0.0153263736654424,0.00346853408917962
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28279,-0.0080308160366045,0.00276123521525069,-0.0134428370584959,-0.00261879501471314,0.00363549448932113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,23940,0.00792497273252775,0.00272592249770041,0.00258216463703495,0.0132677808280205,0.00364941670889233
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,29226,-0.0172793865876858,0.00594901571706795,-0.028939457393139,-0.00561931578223261,0.0036802291793273
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28467,-0.0112646361324878,0.0038845917516285,-0.0188784359656797,-0.00365083629929596,0.00373656698642446
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,23974,-0.00855468555526919,0.00295381021726227,-0.0143441535811032,-0.00276521752943514,0.00378110073704463
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,28979,-0.0116529122722846,0.00403626576454875,-0.0195639931708001,-0.00374183137376904,0.00389156554675851
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,23974,0.0120407612880508,0.00419273055044132,0.00382300940918583,0.0202585131669158,0.00408475162103714
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,23940,-0.0108618275623373,0.00378316835465854,-0.018276837537468,-0.00344681758720657,0.00409414286396567
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,28631,0.00589048866236893,0.00205238773111147,0.00186780870939045,0.00991316861534741,0.00410686521909639
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24535,-0.00795598528707729,0.00277248102399089,-0.0133900480940994,-0.00252192248005515,0.00411307966482703
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,29023,-0.00704345380674036,0.00245874453171815,-0.0118625930889079,-0.00222431452457279,0.00417763983341707
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23940,-0.0213939198342973,0.00747992773235637,-0.0360545781897158,-0.00673326147887879,0.00423770572837635
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,28811,-0.00887721679632077,0.00310577042413414,-0.0149645268276237,-0.00278990676501784,0.00426225952534809
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,29122,-0.00798347500665885,0.00279596296586178,-0.0134635624197479,-0.00250338759356976,0.00430187436679032
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,23848,0.0111264854130772,0.00391541545379646,0.00345227112363611,0.0188006997025182,0.00449100016404433
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29507,-0.00621059939838361,0.00218663093253959,-0.0104963960261612,-0.00192480277060601,0.0045107694945826
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,28580,-0.00870818230576945,0.00307504365230077,-0.014735267864279,-0.00268109674725995,0.00463062632087797
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,29034,0.00429344602821718,0.00151611880312017,0.00132185317410164,0.00726503888233271,0.00463090169493034
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,23843,0.0120916308285691,0.00427035920150677,0.00372172679361588,0.0204615348635224,0.00463653581065029
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,24185,-0.00891683369752589,0.00315965235662938,-0.0151097523165195,-0.00272391507853231,0.00477502326302357
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,24392,-0.00606861713362206,0.00215403722374514,-0.0102905300921625,-0.00184670417508158,0.00484648460673941
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,29401,-0.00427038100226708,0.00152220525918223,-0.00725390331026424,-0.00128685869426992,0.00502885847546763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24539,-0.00434343368141118,0.00154869196706824,-0.00737886993686494,-0.00130799742595742,0.0050421484378726
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,28908,0.00575355905960378,0.00205362183202767,0.00172846026882955,0.00977865785037801,0.00508735464442941
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29060,0.0119987274204802,0.0042832745796131,0.00360350924443855,0.0203939455965219,0.00509311873078217
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,29132,-0.00886613571083429,0.00316869590772101,-0.0150767796899675,-0.0026554917317011,0.00514476227080889
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,29034,-0.0379544515458256,0.0136073472699339,-0.0646248521948959,-0.0112840508967552,0.00528627918573052
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,23974,-0.00340561535009922,0.00122308755371291,-0.00580286695537652,-0.00100836374482191,0.00536620996534901
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,27817,-0.00562474679367351,0.0020249635950272,-0.00959367543992682,-0.00165581814742021,0.00547813654040602
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29122,0.00936262859730632,0.00337368408637215,0.00275020778801691,0.0159750494065957,0.00552039404285082
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,29226,0.00626206600315551,0.00226100594905608,0.0018304943430056,0.0106936376633054,0.00561618125704838
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,24539,-0.0228284136324095,0.00824454745304928,-0.0389877266403861,-0.00666910062443291,0.00562863268053991
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,23756,-0.0172838160070725,0.00625926531800704,-0.0295519760303663,-0.00501565598377874,0.00576129782129253
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,29205,-0.00894942367418674,0.00325135004980371,-0.015322069771802,-0.00257677757657146,0.0059174074843592
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,29409,0.00905902472020941,0.00329240814267977,0.00260590476055706,0.0155121446798618,0.00593613485905085
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24529,-0.00698400073000659,0.00253873167663171,-0.0119599148162047,-0.00200808664380843,0.00594608285821007
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,23843,0.0122587344632155,0.00446450230623163,0.0035083099430015,0.0210091589834295,0.00604045283280024
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,23843,0.0152733327601349,0.00556457591646875,0.00436676396385612,0.0261799015564136,0.00606035870070643
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29145,0.00776083840509112,0.00284603187119855,0.00218261593754195,0.0133390608726403,0.00639710680887392
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23974,-0.0117152129515985,0.00430314687737572,-0.0201493808312549,-0.00328104507194207,0.00648416574027598
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,23940,0.00845195193088486,0.00311805057292021,0.00234057280796126,0.0145633310538085,0.00671988233161532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,29006,0.00676235844437713,0.00250447659940369,0.00185358430954591,0.0116711325792084,0.00693570999088817
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,28272,0.0129668492583443,0.00481505288999007,0.00352934559396379,0.0224043529227249,0.00708579233945337
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29069,-0.00785054015153291,0.0029244013085646,-0.0135823667163195,-0.00211871358674629,0.00726807064375837
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28467,-0.00583905617689994,0.00217617714204351,-0.0101043633753052,-0.00157374897849465,0.00729697733029877
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,24453,0.00542558470197048,0.00202509267509071,0.00145640305879268,0.00939476634514828,0.00738524561161841
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28631,-0.0112118067229501,0.00418706100407478,-0.0194184462909366,-0.00300516715496348,0.00741658816807197
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,24699,0.00609067908618285,0.00228078507078125,0.00162034034745161,0.0105610178249141,0.00758035742269414
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,23843,0.00966914861200311,0.00362108960528824,0.00257181298563816,0.016766484238368,0.007585032693578
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28491,0.00617677556846185,0.00231491614543695,0.00163953992340543,0.0107140112135183,0.00762906165384132
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,28631,-0.00963457489418904,0.00361192625048137,-0.0167139503451325,-0.00255519944324555,0.00764759178122854
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,28847,0.00540156510999887,0.00202570362152143,0.00143118601181686,0.00937194420818088,0.00766853949665768
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29034,-0.00881899385173055,0.00331131402652737,-0.0153091693437242,-0.00232881835973691,0.00774231031563266
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,23974,-0.00920239735504012,0.00345614962464165,-0.0159764506193378,-0.00242834409074248,0.00775877554522734
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29172,-0.00861122449536805,0.00323701087552739,-0.0149557658114017,-0.00226668317933437,0.00781278012349475
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,23974,0.00566559327152018,0.00213468477938797,0.00148161110391975,0.00984957543912061,0.00795808930530939
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23974,-0.0118600263892721,0.00447011407733281,-0.0206214499808444,-0.00309860279769977,0.00797894398780235
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,24683,-0.011433141972652,0.00431624652367835,-0.0198929851590616,-0.00297329878624242,0.00808147017800071
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,28631,0.00960059514865525,0.00362659166691702,0.00249247548149788,0.0167087148158126,0.00811871434233081
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29256,0.00520544733816025,0.00196699963713494,0.00135012804937577,0.00906076662694473,0.00813996215234067
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,23848,0.0137504948091666,0.00521786673786256,0.00352347600295595,0.0239775136153772,0.0084124445409697
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,23756,0.00900060602056418,0.00341810761480255,0.00230111509555118,0.0157000969455772,0.00846360345920312
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,28491,-0.0101301852052715,0.00385097384345395,-0.0176780939384412,-0.00258227647210175,0.00852923161083006
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29122,0.00780521490842778,0.00297195815384196,0.00198017692689754,0.013630252889958,0.00863671977496516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,24529,-0.0097251607269694,0.00370514588819976,-0.0169872466678409,-0.00246307478609788,0.00867609559294253
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,24185,0.00542278452706516,0.00206606907482144,0.00137328914041514,0.00947227991371519,0.00867832204989775
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,29226,-0.00565002178729966,0.00215345168121687,-0.00987078708248472,-0.0014292564921146,0.00870243106721248
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,23974,-0.0038672369646369,0.00147412257150233,-0.00675651720478146,-0.000977956724492344,0.00871080133184854
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24683,-0.00490556445039854,0.00187878125408058,-0.00858797570839648,-0.0012231531924006,0.0090323145649689
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,23979,-0.0161731136646742,0.00623530588194118,-0.0283943131932789,-0.00395191413606947,0.00949804264753231
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23848,0.00748671309117775,0.00290049643514,0.00180174007830335,0.0131716861040522,0.0098521454746883
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,23940,-0.00554225848889521,0.00214968495607636,-0.00975564100280487,-0.00132887597498555,0.0099383644304645
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29165,0.0072228578038129,0.00280752139239264,0.00172011587472331,0.0127255997329025,0.0100963096441673
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,29507,0.00318719576884377,0.00123918024557183,0.000758402487522984,0.00561598905016455,0.0101155685957106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,23848,0.00962645283749744,0.00375025178707464,0.00227595933483114,0.0169769463401637,0.0102678075831251
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,29381,-0.00526121723309804,0.00205282748406794,-0.00928475910187119,-0.00123767536432489,0.0103847572890754
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28491,-0.00612143699839846,0.0023889256922071,-0.0108037313551244,-0.00143914264167254,0.0103995727957005
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,23843,-0.020505505976438,0.00801959613451485,-0.0362239144000871,-0.00478709755278893,0.0105663370268116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24185,-0.0119835769087752,0.00469460604122005,-0.0211850047495665,-0.00278214906798387,0.0106974914811839
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,24340,-0.0056717527312586,0.00223661257498621,-0.0100555133782316,-0.00128799208428562,0.0112231256311774
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,24185,-0.0131879522986521,0.0052023670257185,-0.0233845916690604,-0.00299131292824385,0.0112512804451414
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24185,-0.00834234893482726,0.00329426779310218,-0.0147991138093075,-0.00188558406034698,0.0113352802819086
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,24119,-0.00523330651794625,0.00206663196858367,-0.00928390517637025,-0.00118270785952226,0.011338392808915
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29507,-0.00579886928817459,0.00229102572534851,-0.0102892797098577,-0.0013084588664915,0.0113749292439557
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,29252,0.00699174540320239,0.00277304253570208,0.0015565820332263,0.0124269087731785,0.0116966050920607
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,23848,0.0107982451245159,0.00428892547276781,0.00239195119789103,0.0192045390511409,0.0118187517690722
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29122,-0.0153815014600387,0.00611532577971004,-0.0273675399882703,-0.00339546293180698,0.0119005369121021
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29132,0.00649040147039938,0.00258323489087618,0.00142726108428208,0.0115535418565167,0.0119929572837784
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,28631,-0.00976095368126546,0.00389204395470702,-0.0173893598324912,-0.0021325475300397,0.0121497392822057
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,23940,-0.00724105439788322,0.00288800371781417,-0.012901541684799,-0.00158056711096745,0.0121727574282747
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,28894,0.0229641219896143,0.00917741463057589,0.00497638931368559,0.0409518546655431,0.0123464004488847
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,23974,0.00528111970466429,0.002121430503233,0.0011231159183276,0.00943912349100097,0.0128021013175391
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,23848,0.00635587162185317,0.00255445988957864,0.00134913023827904,0.0113626130054273,0.0128478428897808
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,23879,-0.00709490567635836,0.00285156895003385,-0.0126839808184247,-0.00150583053429201,0.0128505822585393
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,23843,0.00884501124129993,0.0035643896671598,0.00185880749366673,0.0158312149889331,0.0130901363199692
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,23974,0.00783480657558698,0.00316838313188077,0.00162477563710068,0.0140448375140733,0.0134124599623759
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FST,Follistatin,29226,-0.00895093714781581,0.00363021072830874,-0.0160661501753009,-0.00183572412033067,0.0136810567625417
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,29305,0.00733781409370229,0.00297765105291422,0.00150161802999042,0.0131740101574142,0.0137339607738998
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29132,-0.00897590853817123,0.00364576195882817,-0.0161216019774745,-0.00183021509886801,0.0138217670352995
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23848,0.00935937412747252,0.00380291641904074,0.00190565794615268,0.0168130903087924,0.0138580416249436
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29119,0.00393311052454595,0.0016041150205091,0.000789045084348113,0.00707717596474379,0.0142167170720299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,29507,0.012791544566798,0.00522107584763833,0.0025582359054269,0.0230248532281691,0.0142920852340222
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29172,-0.00560147977042561,0.00228692327412684,-0.0100838493877142,-0.001119110153137,0.0143171982533051
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,23756,0.00728184453043051,0.00297507094816738,0.00145070547202244,0.0131129835888386,0.014387495411609
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28612,0.00548422218051132,0.00225268983667403,0.00106895010063022,0.00989949426039241,0.0149175623608477
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,23843,0.00923657535143679,0.00380166541354133,0.00178531114089579,0.0166878395619778,0.0151222940906113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24539,0.00816610813357211,0.00336342891921881,0.00157378745190324,0.014758428815241,0.0151931891355435
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23979,0.00703255534462374,0.00290971145539167,0.00132952089205607,0.0127355897971914,0.0156596452144087
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28199,0.0148543304641133,0.00616053669235388,0.00277967854709975,0.0269289823811269,0.0159061664921439
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24185,-0.0122590637957942,0.00508557790089454,-0.0222267964815475,-0.00229133111004095,0.0159356973934104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28631,-0.00608642513980458,0.0025298689700771,-0.0110449683211557,-0.00112788195845346,0.0161422391630333
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,23848,-0.0128022145115848,0.00533485770554711,-0.0232585356144572,-0.00234589340871249,0.016414824113998
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,23848,0.00874183379081787,0.00364895239751171,0.00158988709169491,0.0158937804899408,0.0165958478827819
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,23974,0.00691980152691937,0.00288986079428344,0.00125567437012382,0.0125839286837149,0.0166502102096708
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24602,-0.0123042894511726,0.00514333685318967,-0.0223852296834243,-0.00222334921892082,0.0167516349361818
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,27294,0.00842455408088867,0.00353056322967995,0.00150465015071598,0.0153444580110614,0.0170312625165875
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,29273,-0.00586157946497095,0.00246039456610797,-0.0106839528145426,-0.00103920611539934,0.0172077772435211
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29256,-0.00631396710035721,0.00265208260454396,-0.0115120490052634,-0.00111588519545105,0.0172834191816395
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,29381,0.00536744603431323,0.00226140706671717,0.000935088183547571,0.00979980388507888,0.0176268654040829
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,23974,0.00826145329820158,0.00349542538562618,0.00141041954237426,0.0151124870540289,0.0181109472991058
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28467,-0.00810116064643282,0.00343116401629198,-0.0148262421183651,-0.00137607917450054,0.0182298207907256
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28631,-0.00617865368071767,0.00261876332274168,-0.0113114297932914,-0.00104587756814398,0.0183122558245797
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,29470,-0.00793694230525815,0.00336976575042203,-0.0145416831760853,-0.00133220143443098,0.0185123101357294
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29201,-0.00384472777384599,0.00163373707621573,-0.00704685244322882,-0.000642603104463163,0.0186125467535675
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24238,-0.00718706005955531,0.0030634665786491,-0.0131914545537075,-0.00118266556540308,0.0189813414283622
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,23843,0.00511092490532484,0.0021798515419602,0.000838415883082849,0.00938343392756684,0.0190546118036231
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,28631,-0.00512364543260805,0.00218763955088028,-0.00941141895233341,-0.000835871912882697,0.0191829856775706
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29470,-0.00589164641352737,0.00251682850188614,-0.0108246302772242,-0.000958662549830531,0.0192438998690763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,23979,-0.00385438826967594,0.00164811080227315,-0.00708468544213131,-0.000624091097220573,0.019360663427828
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23843,0.00968131479475726,0.00414274239974768,0.00156153969125181,0.0178010898982627,0.0194508647316508
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,23848,-0.00649726740485416,0.00278414621703884,-0.0119541939902503,-0.00104034081945804,0.019621486084504
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,28037,0.00801567227934715,0.00344950271517866,0.00125464695759696,0.0147766976010973,0.0201477172903086
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,23974,-0.0145698156032507,0.00627723617861932,-0.0268731985133445,-0.0022664326931568,0.0202921791555342
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29089,0.00483977711056157,0.00210250823496361,0.000718860970032898,0.00896069325109024,0.0213474851362224
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23843,-0.00533224155589711,0.00232263278002361,-0.00988460180474339,-0.000779881307050826,0.021697407806558
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,23756,0.00943282220600321,0.00410975892686094,0.00137769470935577,0.0174879497026506,0.0217289000706531
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23843,0.0054366237678308,0.0023713912212864,0.000788696974109459,0.0100845505615521,0.0218803902992088
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24529,-0.00785277543692067,0.00342762087958868,-0.0145709123609145,-0.00113463851292685,0.0219702375766273
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,23974,-0.00535213068376557,0.00233670624844725,-0.00993207493072218,-0.000772186436808956,0.0220033471012121
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,23848,0.00568921357059074,0.00249059114200565,0.000807654932259652,0.0105707722089218,0.0223636888702722
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,28631,0.00804465131671024,0.00353114157329454,0.00112361383305293,0.0149656888003675,0.0227219242607592
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",23848,-0.00655928817467318,0.00287954644556341,-0.0122031992079775,-0.000915377141368895,0.0227419839525367
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,23756,0.00428025599363146,0.00187998800234656,0.000595479509032205,0.00796503247823072,0.0228102296543251
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28467,-0.0111558512875126,0.00490714606402259,-0.0207738575729968,-0.0015378450020283,0.0230101744850826
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,23756,-0.00970382117125122,0.0042871953026628,-0.0181067239644703,-0.00130091837803213,0.0236173970474331
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,23974,-0.00598433531903284,0.00264424046735427,-0.0111670466350472,-0.000801624003018462,0.0236348284315686
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,23843,0.00620124174970306,0.00274337252880531,0.000824231593244654,0.0115782519061615,0.0238026520886518
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,23848,0.00822834861846362,0.00365974947917731,0.0010552396392761,0.0154014575976511,0.0245638351323425
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,24579,-0.00492422307080107,0.00220056278345003,-0.00923732612636313,-0.000611120015239007,0.0252488492659124
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24529,-0.00656060313360535,0.00294147996922371,-0.0123259038732838,-0.000795302393926877,0.0257315779886984
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,28467,-0.0108152530315812,0.00485642549433409,-0.020333847000476,-0.00129665906268636,0.0259551577453439
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,23942,0.0111536283566855,0.00503557435014445,0.00128390263040241,0.0210233540829687,0.0267717483745193
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24185,-0.0111334373418065,0.0050365405869945,-0.0210050568923158,-0.00126181779129734,0.0270775479555486
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29507,0.0043646385658155,0.00197464882904643,0.00049432686088449,0.0082349502707465,0.0270894585198834
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,23843,0.0117109709880921,0.00530643604532368,0.00131035633925772,0.0221115856369265,0.0273279466570888
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,23848,0.00520868002355992,0.00236137935819432,0.00058037648149905,0.00983698356562079,0.0274090133559802
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,23940,-0.00956564861351625,0.0043507159249091,-0.0180930518263381,-0.0010382454006944,0.0279132229355564
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,24529,-0.00554063114759917,0.00252367267622328,-0.0104870295929968,-0.00059423270220154,0.028139707279902
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,24185,0.00619770876063732,0.00282644522277388,0.000657876124000514,0.0117375413972741,0.028334356822009
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,28467,-0.00715090138312001,0.00326574660431399,-0.0135517647275754,-0.000750038038664591,0.0285564027814508
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,24683,-0.00414184476031718,0.00189201814818157,-0.00785020033075306,-0.000433489189881308,0.0285978413631862
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,23974,-0.00501076173143086,0.00229242932338608,-0.00950392320526758,-0.00051760025759415,0.0288408529813816
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28467,-0.0134251495203332,0.00614729810062793,-0.0254738537975639,-0.00137644524310243,0.0289769544679468
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,28908,-0.00557165622671135,0.00255978461690652,-0.0105888340758481,-0.000554478377574569,0.0295176476172609
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,23974,0.00523422673488512,0.00240836442199143,0.000513832467781913,0.00995462100198833,0.0297634991161873
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,23940,-0.00554114772278951,0.00255473126600621,-0.0105484210041617,-0.000533874441417348,0.0300944136205814
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24602,-0.00422721821756611,0.00194949778186427,-0.00804823387002008,-0.000406202565112139,0.0301406608316544
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,28908,0.0205188277529948,0.00947318781765295,0.00195137963039504,0.0390862758755946,0.0303201210882831
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,23756,0.00726829081645163,0.0033839205490622,0.000635806540289714,0.0139007750926135,0.0317325433369057
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24602,0.00586796110997002,0.00273225524354175,0.000512740832628176,0.0112231813873119,0.031750349422007
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,23843,0.00716244333936454,0.00334167555200175,0.000612759257441114,0.013712127421288,0.0320935842530964
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,23843,0.00913244151305761,0.00426634864865345,0.000770398161696852,0.0174944848644184,0.0323184028751765
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28612,-0.0129301218310333,0.00606491896306336,-0.0248173629986375,-0.00104288066342912,0.033019212335656
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,24602,0.00790914058291169,0.00372621703991992,0.000605755184668642,0.0152125259811547,0.0338002249966434
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29079,-0.00350711052114291,0.00165470053186542,-0.00675032356359914,-0.000263897478686689,0.0340580776990923
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,29381,0.0115073095036876,0.00545236186837366,0.000820680241675181,0.0221939387656999,0.0348221684073974
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,23756,0.00667646609644911,0.00316806044086048,0.000467067632362557,0.0128858645605357,0.0350907676358657
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,28823,-0.0102905597918759,0.00488704509015467,-0.0198691681685791,-0.000711951415172789,0.0352406702953018
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29271,0.00432128950314641,0.00205375677729886,0.000295926219640638,0.00834665278665219,0.0353790901298365
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,23974,-0.0116629604527507,0.00555424928055473,-0.022549289042638,-0.000776631862863428,0.0357545258996611
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",23756,-0.0140348978147969,0.00668881699934471,-0.0271449791335125,-0.000924816496081239,0.0358924505776293
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28631,0.0056405209068797,0.00269354238281093,0.00036117783657028,0.0109198639771891,0.0362607139160302
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,29507,-0.00394151110361667,0.00189135311184993,-0.00764856320284254,-0.0002344590043908,0.0371720612860424
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24602,-0.0102763744415126,0.00493471503093469,-0.0199484159021446,-0.000604332980880574,0.0373102707190297
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29226,-0.0133175635848772,0.00640432849714854,-0.0258700474392884,-0.000765079730466078,0.0375835239144893
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,29132,0.00859521255867607,0.00413438572305955,0.000491816541479355,0.0166986085758728,0.0376299814485696
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,23756,0.00510123630583908,0.00245949633100929,0.000280623497060863,0.00992184911461729,0.03808096672688
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,23848,0.0108711817011688,0.00526731291451358,0.00054724838872219,0.0211951150136154,0.03903845504876
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24145,0.0078799422916307,0.00382700329687872,0.000379015829748402,0.015380868753513,0.0395013782445976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,28860,0.00497821261230961,0.00241822252611528,0.000238496461123657,0.00971792876349556,0.039539164636651
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,24579,0.00587520718847977,0.00285620753157249,0.000277040426597688,0.0114733739503619,0.0396971544720717
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24669,0.00535431378026465,0.00260860782333428,0.000241442446529468,0.0104671851139998,0.0401261858108863
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24653,-0.0049858544423362,0.00243216204737191,-0.00975289205518514,-0.000218816829487268,0.0403781110812846
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,28344,-0.00447985553258554,0.00219745535511414,-0.00878686802860924,-0.000172843036561831,0.0414936369896085
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,23756,0.00619737874407138,0.00304020371381035,0.000238579465003099,0.0121561780231397,0.0415135258917517
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24185,-0.00781113822019102,0.00384302466308378,-0.0153434665598352,-0.000278809880546811,0.0421089570108676
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,29132,0.0116057366529583,0.00575856316863672,0.000318952842430314,0.0228925204634863,0.0438732256976602
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,23974,0.00389188309111655,0.00193147906153465,0.00010618413050864,0.00767758205172445,0.0439183583924023
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,23974,-0.00484241455892036,0.0024089352779798,-0.00956392770376077,-0.000120901414079948,0.0444224034300788
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,23974,-0.00425413852253397,0.00212041821184604,-0.00841015821775221,-9.81188273157267e-05,0.0448383105151571
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24185,-0.00772966859191896,0.00386682682755961,-0.0153086491739358,-0.00015068800990212,0.0456228391616388
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,23843,0.00903996740264631,0.00452234405100789,0.000176173062670846,0.0179037617426218,0.0456244370998232
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29034,-0.00813637544596916,0.00408881295269876,-0.0161504488332587,-0.00012230205867959,0.0466100657208957
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,24669,0.012745862006983,0.00641401236928224,0.000174397763189818,0.0253173262507762,0.0469123791256696
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24529,-0.00644240450841824,0.00324488165217821,-0.0128023725466875,-8.2436470148944e-05,0.047110544843082
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,23940,0.00537913087986011,0.00272211096971899,4.37933792108922e-05,0.0107144683805093,0.0481562775407809
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,23843,0.012999309488492,0.00658277885225953,9.70629380632679e-05,0.0259015560389206,0.0483086213706134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,23756,0.00789946313528422,0.00400967538248636,4.04993856109662e-05,0.0157584268849575,0.0488384666588949
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,24048,-0.0119371736179724,0.00606302335609707,-0.0238206993959227,-5.36478400221564e-05,0.0489819782355565
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23940,0.00448871517748381,0.00229423848273179,-7.99224867049919e-06,0.00898542260363812,0.0504159698400126
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,24579,-0.00973047754469473,0.00498505227080161,-0.0195011799954659,4.02249060764137e-05,0.0509577556061221
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24137,0.00713478802052299,0.00365586182422486,-3.07011549577308e-05,0.0143002771960037,0.0509970068143562
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,29381,-0.00377635603397521,0.00193544296668137,-0.00756982424867069,1.71121807202713e-05,0.0510476869790309
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,23843,0.010401375616844,0.00535650966611417,-9.73833287397727e-05,0.0209001345624278,0.0521707097110974
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,23756,-0.0111854606477056,0.00576688827556745,-0.0224885616678178,0.00011764037240663,0.0524400626177267
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,23756,0.00690260590005573,0.00356674206016848,-8.8208537874496e-05,0.0138934203379859,0.0529691354376339
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,23895,-0.00945734621555637,0.00490039813666887,-0.0190621265634274,0.000147434132314607,0.0536293426799972
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29507,0.00315853048484929,0.00163695962250715,-4.99103752647175e-05,0.0063669713449633,0.0536771207231367
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23843,0.00907308006111661,0.00470586269733575,-0.000150410825661456,0.0182965709478947,0.0538623219127151
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,29507,-0.00345638767016756,0.00179292791229184,-0.00697052637825957,5.7751037924457e-05,0.0538908999844702
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,28467,-0.00829702832237243,0.00430796860162794,-0.0167406467815632,0.000146590136818333,0.0541177805487679
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,23843,0.00573706717455908,0.00298444107034115,-0.000112437323309586,0.0115865716724277,0.0545767212976099
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,23756,0.0111265570463725,0.00579016307985638,-0.000222162590146013,0.022475276682891,0.054664157727366
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,24117,0.00296313240685309,0.00154229853584577,-5.97727234046149e-05,0.0059860375371108,0.0547126846332451
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,23940,0.00957867689046077,0.00501235773873322,-0.00024554427745635,0.0194028980583779,0.0560149476548347
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,23355,0.00965453571467326,0.0050563338573252,-0.000255878645684136,0.0195649500750306,0.0562234760205595
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,23756,0.00426807986218513,0.00224580046494128,-0.000133689049099769,0.00866984877347003,0.0573833673609074
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24683,-0.00548666666586464,0.00288737757103989,-0.0111459267051028,0.000172593373373549,0.057415263539843
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29470,0.00347419208256768,0.00183022674309711,-0.000113052333902657,0.00706143649903802,0.057675500239917
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,28467,-0.00612369605318979,0.00322754219433856,-0.0124496787540934,0.000202286647713779,0.0577951899446604
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29172,0.00350794534276026,0.00185058006255124,-0.000119191579840158,0.00713508226536069,0.0580238536667517
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23843,0.00436536219948149,0.00231048466896925,-0.000163187751698249,0.00889391215066122,0.0588542937963399
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,24602,-0.00848026121925401,0.00449222508694669,-0.0172850223896695,0.000324499951161503,0.0590693923528235
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,23843,0.0128481831212666,0.00681913438612076,-0.000517320275530088,0.0262136865180633,0.0595586149623765
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,24119,-0.00526487797839124,0.0028005399416316,-0.0107539362639892,0.000224180307206698,0.0601268005402359
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24650,-0.00336565758924551,0.00179544037704129,-0.00688472072824643,0.000153405549755419,0.0608653428515527
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24185,-0.00709059871350104,0.00378549343223319,-0.0145101658406781,0.000328968413676003,0.061066966149676
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,23940,-0.00729019095593311,0.00389752433637163,-0.0149293386552215,0.000348956743355283,0.0614311836663574
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,23756,-0.00974110191312439,0.0052272321288351,-0.0199864768856412,0.000504273059392407,0.0624001250946516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,29361,0.00579633560623138,0.003118081830915,-0.000315104782362016,0.0119077759948248,0.0630452565097376
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,29280,-0.00622080610602733,0.00334984504390546,-0.012786502392082,0.000344890180027375,0.0633150838919177
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,29409,0.00595898117293183,0.00321122999847083,-0.000335029624070995,0.0122529919699347,0.0635107001739023
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24529,-0.00815898223297053,0.0044024804494,-0.0167878439137945,0.000469879447853481,0.0638557638868319
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,28467,-0.00471089505791515,0.0025426507142729,-0.00969449045789003,0.000272700342059728,0.0639286068134683
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,23848,0.0050302972283081,0.00271615923498401,-0.000293374872260572,0.0103539693288768,0.0640397492411879
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,23843,0.0103304366091319,0.0055820291834446,-0.000610340590419509,0.0212712138086833,0.0642308890706684
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23848,0.00641127392203257,0.00346594907377852,-0.000381986262573331,0.0132045341066385,0.0643563601226712
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,23843,0.00946191645515136,0.00511896238995763,-0.000571249829165593,0.0194950827394683,0.0645561349943297
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23711,0.00699224147048253,0.00378930373930535,-0.000434793858555942,0.014419276799521,0.0650125455304031
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,23843,0.00935155950154185,0.0050790170960866,-0.000603314006787889,0.0193064330098716,0.0656025659364217
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23979,-0.0102560614516031,0.00557983145291359,-0.0211925310993137,0.000680408196107568,0.0660660280302576
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,23848,0.00448320677213926,0.00244010262177945,-0.00029939436654846,0.00926580791082697,0.0661776855575714
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,28631,-0.00791755697254981,0.00431006056103327,-0.016365275672175,0.000530161727075405,0.0662210909019209
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,23848,0.00677653967117332,0.00368890997549771,-0.000453723880802189,0.0140068032231488,0.0662218570656751
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29226,-0.00848326220486951,0.00464891672472022,-0.0175951389853211,0.000628614575582121,0.0680440552411463
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,23974,0.00748473384350903,0.00410712298868712,-0.000565227214317726,0.0155346949013358,0.0684099882662076
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",28823,-0.00532859516635334,0.00293818046496577,-0.0110874288776863,0.000430238544979568,0.0697543937044152
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,23974,-0.00386242775523131,0.00213131750170565,-0.00803981005857438,0.000314954548111774,0.0699638847802809
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28491,-0.00659629330865461,0.00364505417141061,-0.0137405994846194,0.000548012867310184,0.0703597242432159
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,23848,-0.0118145084643903,0.0065341507797242,-0.0246214439926498,0.000992427063869096,0.0706009075531747
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,28853,-0.00413228764703764,0.00229105807429665,-0.00862276147265906,0.000358186178583786,0.0712952032407903
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28491,-0.00718206895632891,0.00399674257160492,-0.0150156843966745,0.000651546484016728,0.07234928814304
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,24579,0.00343139628847451,0.00191773616081194,-0.000327366586716892,0.00719015916366591,0.0735795868026683
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,23756,0.00849279182592001,0.00476210825899459,-0.000840940361709386,0.0178265240135494,0.0745323454160102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,23843,0.00995695431396984,0.00559380083572431,-0.00100689532404981,0.0209208039519895,0.0750890271995378
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",23940,-0.0108670961120442,0.0061079516230049,-0.0228386812931339,0.00110448906904536,0.0752242696909846
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24539,0.0070230331610482,0.00395076663757057,-0.000720469448590124,0.0147665357706865,0.0754757064533588
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,23974,0.0132357787560991,0.00744701038357872,-0.00136036159571516,0.0278319191079134,0.0755270005994058
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,24602,-0.00635510311137013,0.00359653180344582,-0.0134043054461239,0.000694099223383681,0.0772391687208247
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,23756,0.0148915740662804,0.00843676580231747,-0.00164448690626188,0.0314276350388226,0.0775630260675102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,23974,-0.00628590775092811,0.00356242681515872,-0.0132682643086392,0.000696448806782985,0.0776603084846002
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,23974,-0.0135020416011934,0.00765659961822669,-0.0285089768529177,0.00150489365053095,0.0778371247381998
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,28612,-0.00616389284141469,0.00350734792735469,-0.0130382947790299,0.000710509096200509,0.0788564865136723
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24602,-0.0146260227337731,0.00834153822856666,-0.0309754376617638,0.00172339219421753,0.079546455658546
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,29409,-0.00370665610279994,0.00211985828708145,-0.00786157834547958,0.000448266139879696,0.0803810776914529
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,23756,0.00999978267678071,0.0057385012893978,-0.00124767985043898,0.0212472452040004,0.0814204074113762
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,28631,-0.00545674022364764,0.00313311783240012,-0.0115976511751519,0.000684170727856591,0.0815834942938207
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,23843,0.0070359782380922,0.00406012242998287,-0.000921861724674214,0.0149938182008586,0.0831179717533404
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,28491,0.0101530047102587,0.00587387885286699,-0.00135979784136056,0.0216658072618781,0.0839093045008837
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,29381,0.00287801865423544,0.00166562308664129,-0.000386602595581497,0.00614263990405237,0.0840179026484014
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,23974,0.00272482621507484,0.00157923191917994,-0.000370468346517848,0.00582012077666754,0.0844660860316246
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,29409,-0.00748516214506575,0.00433924958194886,-0.0159900913256855,0.00101976703555401,0.0845397855491768
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,23756,0.00552667697426253,0.00320748647939737,-0.000759996525356314,0.0118133504738814,0.0848915237661031
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,28631,-0.00737359293466027,0.00428383402335757,-0.0157699076204411,0.00102272175112058,0.0852144293323733
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,23848,0.0103517063511335,0.00603854399707623,-0.00148383988313596,0.0221872525854029,0.0864918006861481
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24185,0.00886206464585095,0.00517120686876774,-0.00127350081693383,0.0189976301086357,0.0865907092283087
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28631,-0.00459307967717824,0.00268228794290867,-0.00985036404527923,0.000664204690922755,0.0868386321947809
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24669,0.00367730081006009,0.0021512712018808,-0.000539190745626272,0.00789379236574645,0.0873965366881446
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,23940,0.00427359750630975,0.0025006591486985,-0.000627694425139313,0.00917488943775881,0.087466064788429
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29409,0.0031671946600178,0.00186347239010528,-0.000485211224588562,0.00681960054462415,0.0892130346192877
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,28467,-0.00366754975639236,0.00215801083545062,-0.00789725099387558,0.000562151481090859,0.0892350430493996
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,23756,0.00625583709533068,0.0036992000797112,-0.000994595060903276,0.0135062692515646,0.0908246438602405
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,24635,0.00437727603814838,0.00258858228613197,-0.000696345242670279,0.00945089731896703,0.0908506846409874
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29409,0.00397304156047795,0.00236601437252616,-0.000664346609673322,0.00861042973062922,0.0931212109215613
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,24185,0.00371878079928327,0.00221629710418193,-0.000625161524913311,0.00806272312347985,0.0933746271846692
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,23848,0.00733963701355995,0.00438242073484755,-0.00124990762674125,0.0159291816538611,0.0939884447501364
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23940,0.00572784218600114,0.00342429516999117,-0.000983776347181546,0.0124394607191838,0.0943980827238524
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,24185,0.00685952381205893,0.00411382054912584,-0.00120356446422771,0.0149226120883456,0.0954411137204338
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,23843,-0.00526713864265912,0.00316513480832222,-0.0114708028669707,0.000936525581652426,0.0961032087911558
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,23848,0.00850392432911623,0.005113643021402,-0.00151881599283169,0.0185266646510641,0.0963280897008309
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24539,-0.0122143912766545,0.007408043417998,-0.0267341563759305,0.00230537382262162,0.0992011661422323
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24529,0.00620239090573231,0.00376455215580292,-0.00117613131964141,0.013580913131106,0.0994522450568329
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23848,0.0103031653030773,0.00625434113560616,-0.00195534332271075,0.0225616739288654,0.0994967981753003
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,23756,0.00300725900598335,0.00183250662088489,-0.000584453970951039,0.00659897198291774,0.100797562195649
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,28491,0.0194473770507519,0.011907099885131,-0.00389053872410481,0.0427852928256086,0.102425608735355
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,23979,0.00448368407073342,0.00274645290153401,-0.000899363616273238,0.00986673175774009,0.102579694765382
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28612,-0.00571438081773407,0.00351401785321391,-0.0126018558100333,0.00117309417456519,0.103925094986271
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,23756,0.00545861549401815,0.00336096218016043,-0.00112887037909628,0.0120461013671326,0.104362865790225
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,28908,0.00685813050563159,0.00422402989781053,-0.00142096809407704,0.0151372291053402,0.104472338291966
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,23756,0.00484552274131307,0.00299404668802577,-0.00102280876721743,0.0107138542498436,0.105592756629896
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23843,-0.00718064800187788,0.00445809387884409,-0.0159185120044123,0.00155721600065654,0.107258556979893
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,23979,0.00209085123813642,0.00130160716129212,-0.000460298797996134,0.00464200127426897,0.108207746265154
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29122,0.00406819862019688,0.00253689020072032,-0.000904106173214953,0.00904050341360871,0.108809492759546
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29317,0.00397016812454132,0.00247605224693611,-0.000882894279453456,0.00882323052853609,0.108851271907997
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,23940,-0.0105997535440094,0.00663267372791966,-0.0235997940507319,0.00240028696271316,0.110031323408649
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,23940,0.00333632240750401,0.00209411751606559,-0.000768147923984558,0.00744079273899257,0.111131284453418
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24653,-0.00341649315848822,0.00214801135355179,-0.00762659541144973,0.000793609094473298,0.111726471552963
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,23711,0.00464724505831072,0.00295004811632891,-0.00113484924969394,0.0104293393663154,0.115197883824694
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,28908,0.0078714960774603,0.00502686281936856,-0.00198115504850208,0.0177241472034227,0.117386167480961
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,23940,-0.00879007578482889,0.00561496566600373,-0.0197954084901962,0.00221525692053842,0.117485325236075
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,23940,-0.00683393339302694,0.00437041212101937,-0.0153999411502249,0.00173207436417103,0.117905566246631
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,23843,-0.00539353903003786,0.00345911167477309,-0.0121733979125931,0.0013863198525174,0.118956030756804
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29122,-0.00272053945604409,0.00174884642932125,-0.00614827845751374,0.000707199545425571,0.119809491473462
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24185,0.00491167313068534,0.00315939778268905,-0.0012807465233852,0.0111040927847559,0.120048924546322
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,23940,0.00663392006128849,0.00427244810000235,-0.00174007821471612,0.0150079183372931,0.120503019828693
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,23843,0.00382510413631366,0.00246848034544044,-0.0010131173407496,0.00866332561337693,0.121255990452699
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,23843,0.00482066132055832,0.00311236871909572,-0.00127958136886929,0.0109209040099859,0.121425730070348
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29349,-0.00709635098353407,0.00458570950070619,-0.0160843416049182,0.00189163963785005,0.121755322972134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29381,-0.00789399059760953,0.00511753077093863,-0.0179243509086492,0.00213636971343019,0.12295345268462
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,29256,0.00331547093754616,0.00214976521098503,-0.000898068875984495,0.00752901075107681,0.123024178760619
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,23711,0.00889387075367908,0.00576727793080503,-0.00240999399069878,0.0201977354980569,0.123056267273157
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29507,0.00685272735022629,0.00445663312884764,-0.00188227358231509,0.0155877282827677,0.124145743081157
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24602,-0.00329142055094987,0.00214087982636407,-0.00748754501062345,0.000904703908723709,0.124204606699701
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,23756,0.00449561112819395,0.00292962192965776,-0.00124644785393525,0.0102376701103232,0.124911100712736
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24529,-0.0107553905310287,0.00701593008988165,-0.0245066135071967,0.00299583244513934,0.125289823009479
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,23843,0.00533423979842624,0.00348563284462843,-0.00149760057704549,0.012166080173898,0.125943280714926
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,23974,-0.003339620991849,0.0021830667394222,-0.00761843180111651,0.000939189817418505,0.126083356752437
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,24185,0.00407871262145109,0.00266665214355862,-0.00114792557992381,0.00930535082282599,0.126147292885692
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24185,0.00694765557254746,0.00454990101053384,-0.00197015040809886,0.0158654615531938,0.126776460880628
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,28612,0.0146870921395208,0.00964375661242742,-0.00421467082083693,0.0335888550998786,0.127778821378518
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23848,0.00535713136909015,0.00352509142442342,-0.00155204782277976,0.0122663105609601,0.128596094828432
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24653,-0.00329936110743041,0.00219493048468914,-0.00760142485742112,0.00100270264256031,0.132807152823257
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,23974,0.00588105824418443,0.00393371924647102,-0.00182903147889876,0.0135911479672676,0.134917795165271
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,23848,0.00676411609345982,0.00452686362609075,-0.00210853661367806,0.0156367688005977,0.13513217753974
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,23756,0.00650879256443577,0.00436222789327218,-0.0020411741063777,0.0150587592352492,0.135691486957023
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,23979,-0.00787344311068342,0.0052820417225828,-0.0182262448869457,0.00247935866557887,0.136078127942937
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_DRA,,29010,0.00387893283418606,0.00260269595943681,-0.00122235124631008,0.0089802169146822,0.136142613476594
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,23974,-0.00490581893454036,0.00330340814411969,-0.011380498897015,0.00156886102793422,0.137536304995503
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,23756,0.00327425618019023,0.00221205824655372,-0.00106137798305506,0.00760989034343553,0.138837061511802
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,23940,-0.00244395966579106,0.00165286043604293,-0.00568356612043519,0.000795646788853081,0.139253908997157
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29172,-0.00187390803124701,0.00126792296037626,-0.00435903703358449,0.00061122097109046,0.139435912699026
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,24651,0.0116244235780195,0.00787984467148396,-0.00382007197808901,0.0270689191341281,0.140168943547802
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23848,0.00651502277986107,0.00441749164217702,-0.00214326083880588,0.015173306398528,0.140273070496347
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,23645,-0.00464281328232841,0.00316847880456893,-0.0108530317392835,0.00156740517462669,0.142848837122195
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23940,0.00821908662982799,0.00562491596940652,-0.00280574867020878,0.0192439219298648,0.143975674682507
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,23940,-0.00663708495714917,0.00455486694862163,-0.0155646241764476,0.00229045426214921,0.145090490968873
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24185,0.00372360028107428,0.00255966976222759,-0.0012933524528918,0.00874055301504036,0.145760051057186
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29215,-0.00594526238862304,0.00412418604750231,-0.0140286670417276,0.0021381422644815,0.149437211794168
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",23974,-0.00302356811598542,0.00209818553095211,-0.00713601175665154,0.00108887552468071,0.149586606977453
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,24683,0.00271473222098351,0.00189033618660236,-0.00099032670475712,0.00641979114672413,0.150983494522998
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23843,0.00508762123482863,0.00355439767226218,-0.00187899820280524,0.0120542406724625,0.152340295019093
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,23843,0.00941802552815685,0.00660574962647853,-0.00352924373974107,0.0223652947960548,0.153958950427303
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29049,-0.00347485910342892,0.00243769538212768,-0.00825274205239917,0.00130302384554133,0.154032436047264
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,23974,0.00422157762929594,0.0029777893059014,-0.00161488941027081,0.0100580446688627,0.156294735657434
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,28976,-0.00391004799068459,0.00276076117580809,-0.00932113989526845,0.00150104391389926,0.156700357387245
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,23974,-0.00269843202272116,0.00190700409778864,-0.0064361600543869,0.00103929600894457,0.157078228921866
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,23974,-0.00347516544234565,0.00245851399149003,-0.00829385286566611,0.00134352198097482,0.157515070449809
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28491,0.00361158570165683,0.00255591204283816,-0.00139800190230595,0.00862117330561962,0.157657222392295
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24185,0.00702627847614043,0.00497699271100836,-0.00272862723743595,0.0167811841897168,0.158035924468044
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,24529,0.00584379864305688,0.0041709174253986,-0.00233119951072438,0.0140187967968381,0.1612021176646
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24185,0.00742731911261244,0.00531445914395541,-0.00298902080954017,0.0178436590347651,0.1622555992514
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,29034,-0.00191993755229586,0.00137448810806776,-0.00461393424410867,0.000774059139516946,0.162472900973024
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24185,0.00842027560876611,0.0060382436618585,-0.00341468196847656,0.0202552331860088,0.163182243229358
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,23756,0.00839547698464277,0.00604219732888113,-0.00344722977996423,0.0202381837492498,0.164701646642274
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,29409,-0.00455693118047705,0.00329009567210355,-0.0110055186978,0.0018916563368459,0.166049161145398
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24185,-0.00559026271149431,0.00403827022398023,-0.0135052723504956,0.00232474692750694,0.166272933428289
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,23979,0.006444337034271,0.00466472459534554,-0.00269852317260625,0.0155871972411483,0.167136839311343
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29271,-0.00278746818476585,0.00202836581549887,-0.00676306518314364,0.00118812881361193,0.169376681056662
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,24529,-0.0037512883387348,0.00273970962257778,-0.00912111919898725,0.00161854252151765,0.170940421507974
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,23974,0.00416959914468576,0.00305087145960832,-0.00181010891614655,0.0101493072055181,0.17173494438007
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24529,-0.00486710225637831,0.00356728788728355,-0.0118589865154541,0.00212478200269746,0.172463520765047
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,23979,-0.00473920569435677,0.00347526229724347,-0.011550719796954,0.00207230840824043,0.172675673641069
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,23756,0.00363764772664428,0.00267054832233817,-0.00159662698513853,0.00887192243842709,0.173168161261779
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,29187,-0.00321224380338082,0.00235991406511735,-0.00783767537101082,0.00141318776424918,0.173470542784934
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,23974,-0.00342260952799239,0.00253501758516489,-0.00839124399491558,0.0015460249389308,0.176986251360269
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,23848,0.0044789375447257,0.00332109163189132,-0.00203040205378129,0.0109882771432327,0.177467324546231
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,23940,-0.00489581776730793,0.0036363848124338,-0.0120231319996782,0.00223149646506231,0.178204986484274
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,23979,-0.00386596735924811,0.00287387168966146,-0.00949875587098457,0.00176682115248835,0.178569434856706
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,24653,0.0102689605289075,0.00764577561488548,-0.00471675967626807,0.025254680734083,0.179255383945105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,28612,-0.00586182903223603,0.00437763295983989,-0.0144419896335222,0.00271833156905016,0.180568041919693
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",23848,0.0049630580997144,0.00371795544618703,-0.00232413457481218,0.012250250774241,0.181925405093322
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23848,0.00668363824899247,0.00501226633408163,-0.00314040376580753,0.0165076802637925,0.182394842495319
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29470,-0.00564443726099228,0.00423482794109985,-0.013944700025548,0.00265582550356343,0.18258771233287
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29033,0.00328616946504259,0.00247188468416832,-0.00155872451592732,0.0081310634460125,0.183720356871032
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,23848,0.00475547151606812,0.00359287931291904,-0.0022865719372532,0.0117975149693894,0.185654497324806
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23974,0.00337526087304624,0.00255362981718345,-0.00162985356863332,0.0083803753147258,0.186263945993052
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,23974,0.00440649183861945,0.00333970514858035,-0.00213933025259802,0.0109523139298369,0.187039538790064
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,24529,0.00526505704381976,0.00399116645729727,-0.00255762921248289,0.0130877433001224,0.187122094994178
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,23756,0.00885487452381778,0.00674257171696842,-0.00436056604144033,0.0220703150890759,0.18910180958175
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24185,-0.00344176634434017,0.00262957309154622,-0.00859572960377076,0.00171219691509041,0.190591218827535
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24653,0.00250735449922742,0.00192423363419369,-0.00126414342379221,0.00627885242224706,0.192573086921032
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,23848,-0.0056071162786711,0.00430939596471831,-0.014053532369519,0.00283929981217679,0.193224004600723
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,23974,0.00389783930727333,0.0030104315162421,-0.00200260646456118,0.00979828507910784,0.195409436715313
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24579,-0.00365298610370796,0.00283076618130682,-0.00920128781906933,0.0018953156116534,0.196903679576875
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,29172,-0.00421022943019651,0.00326611614981648,-0.0106118170838368,0.00219135822344379,0.197386417230394
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,24185,0.015704593912942,0.0121937675767285,-0.00819519053744582,0.0396043783633298,0.197786234498698
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,24602,-0.00632366227540217,0.00496068713274917,-0.0160466090555905,0.0033992845047862,0.202407908358017
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,23848,0.00436593189858337,0.00343374153803899,-0.00236420151597305,0.0110960653131398,0.203570531113413
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,23756,-0.00382632653060767,0.00301005916469542,-0.0097260424934107,0.00207338943219536,0.203677130190016
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,29034,0.00295208460200707,0.00234415721612566,-0.00164246354159922,0.00754663274561336,0.20791865745059
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,24602,-0.00325001872513665,0.00258184697158565,-0.00831043878944451,0.00181040133917122,0.208115964848758
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28612,0.00302532714032343,0.00240942283730547,-0.0016971416207953,0.00774779590144215,0.209262885507698
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,23756,0.00574349142838844,0.00457822829103704,-0.00322983602204417,0.014716818878821,0.209664421240759
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,28467,-0.00344881362794044,0.00275242706577926,-0.00884357067686778,0.00194594342098691,0.21021302685425
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,23940,-0.00467186104590413,0.0037293914391387,-0.011981468266616,0.00263774617480773,0.210322035100087
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,23848,0.00337700583529161,0.00269788057367573,-0.00191084008911281,0.00866485175969604,0.210682199376828
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,29507,-0.00472136289264762,0.0037771769568097,-0.0121246297279946,0.0026819039426994,0.211319939930937
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,24067,0.00276038722681436,0.00220941141956421,-0.0015700591555315,0.00709083360916021,0.21153947091985
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,23974,0.00624043233157688,0.00500387615517628,-0.00356716493256863,0.0160480295957224,0.212365815219046
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,23974,-0.005622622123926,0.00451700471939284,-0.014475951373936,0.00323070712608396,0.213229282540145
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23974,0.00396542514648757,0.00320630908688419,-0.00231894066380545,0.0102497909567806,0.216189439419448
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,24285,0.00304991376346277,0.00246981952310196,-0.00179093250181706,0.00789076002874261,0.216889679659514
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,28367,-0.00399249269715147,0.00323344957132502,-0.0103300538569485,0.00234506846264556,0.21693484840438
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,29122,-0.00305297966941673,0.00249636723066043,-0.00794585944151118,0.00183990010267772,0.22135131640656
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29507,0.0030522072783949,0.00250300677686721,-0.00185368600426483,0.00795810056105464,0.222695975867333
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,24579,0.00327473865958365,0.00269717347107955,-0.00201172134373226,0.00856119866289956,0.224707006803244
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,28612,-0.00286033222781999,0.0023598582071027,-0.00748565431374129,0.0017649898581013,0.225492536099622
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,28631,0.00287138450243555,0.00237943800563925,-0.00179231398861738,0.00753508299348849,0.227538786317335
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28612,0.00266951129169043,0.00221830227313752,-0.0016783611636591,0.00701738374703996,0.228830424642214
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,24602,-0.00392321493980159,0.00326778147416913,-0.0103280666291731,0.0024816367495699,0.229927883766687
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,24119,0.00382209463742994,0.0031914061763764,-0.00243306146826781,0.0100772507431277,0.231076424290701
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,24669,-0.00758689313662927,0.00633886916305714,-0.0200110766962213,0.00483729042296272,0.231363153095915
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,23756,-0.00227523451503072,0.00191429420596107,-0.00602725115871441,0.00147678212865297,0.234628653395967
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24602,0.00647045986603296,0.005466291635996,-0.0042434717405192,0.0171843914725851,0.236542524959666
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28467,-0.00334117627469559,0.00282467885221635,-0.00887754682503963,0.00219519427564845,0.236877797296305
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,23843,0.0045523996655093,0.00385271663795245,-0.0029989249448775,0.0121037242758961,0.237373186699042
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,23848,-0.00427623489710101,0.00364176046727453,-0.0114140854129591,0.00286161561875707,0.240317888396786
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,29271,0.00177186414624786,0.00151107166742927,-0.00118983632191351,0.00473356461440923,0.240970706249651
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,23974,-0.00637452860936972,0.00544422541023935,-0.0170452104134388,0.0042961531946994,0.241659105827418
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23848,0.003453679006469,0.00295538598634453,-0.00233887752676628,0.00924623553970428,0.242574478457236
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23979,-0.00585966708392213,0.00504847158937414,-0.0157546713990954,0.00403533723125118,0.245783049380874
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28467,0.00460189622579095,0.00396947435958434,-0.00317827351899434,0.0123820659705762,0.246334966335832
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,28927,0.00413510776882325,0.00356898001459189,-0.00286009305977685,0.0111303085974233,0.246618837717393
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28467,-0.00567999675639367,0.00490485304348498,-0.0152935087216242,0.00393351520883688,0.246859036042876
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23715,0.00215435708016794,0.00186605126481261,-0.00150310339886477,0.00581181755920065,0.248306682353993
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23848,0.00281233750477118,0.002437286240978,-0.00196474352754569,0.00758941853708806,0.248560661348947
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,23843,-0.00515645528908127,0.00446999352825597,-0.013917642604463,0.00360473202630042,0.24868762836838
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29034,-0.00190198898073295,0.00165243491366999,-0.00514076141152613,0.00133678345006024,0.249732658061594
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",23756,-0.00475988509649085,0.00414059521538816,-0.0128754517186517,0.00335568152566995,0.250334485489048
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,23974,0.00235295912308328,0.00204842258267516,-0.00166194913896004,0.0063678673851266,0.250704040179997
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,23848,0.00420683352518626,0.00367454879340542,-0.00299528210988836,0.0114089491602609,0.252279825609556
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29145,0.00206838241154965,0.00180910601297712,-0.00147746537388551,0.00561423019698482,0.252916222178679
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,28814,0.00210533128712378,0.00184782708350108,-0.00151640979653834,0.0057270723707859,0.254564534369965
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,24490,-0.00425245081501385,0.00373408254299227,-0.0115712525992787,0.003066350969251,0.254789056339729
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23843,-0.00474528535744118,0.0041786821412821,-0.0129355023543541,0.00344493163947174,0.256138043743703
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24602,0.00341125246295117,0.00302648913096348,-0.00252066623373724,0.00934317115963958,0.259697714517056
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24185,-0.0031625897907463,0.0028074741118547,-0.00866523904998152,0.00234005946848892,0.259969614033815
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,24683,-0.00229689939762525,0.00204232001601711,-0.00629984662901879,0.00170604783376829,0.260747449744375
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,23848,-0.00386480461988666,0.00343723454329254,-0.01060178432474,0.00287217508496672,0.260857397674572
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,28612,0.0086218411684172,0.00772882295080234,-0.00652665181515538,0.0237703341519898,0.264626797867178
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24579,0.00323567716060962,0.0029015758482926,-0.00245141150204388,0.00892276582326312,0.264799293978841
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23940,0.00333954106821131,0.00299803893168947,-0.00253661523790005,0.00921569737432268,0.265329629588937
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,24160,-0.00307834592630182,0.00276955238274575,-0.0085066685964835,0.00234997674387986,0.266366050663158
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28467,0.00407198884507011,0.00367966053029834,-0.00314014579431464,0.0112841234844549,0.268467270373167
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,28908,0.000967204346478461,0.000875299000689622,-0.000748381694873199,0.00268279038783012,0.269169309705576
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,24529,0.00331295841585103,0.0030255778605737,-0.00261717419087343,0.00924309102257549,0.273534538803116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,23974,0.00803052685024425,0.00735353790433256,-0.00638240744224756,0.0224434611427361,0.274816380509475
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,24185,-0.00326688220704907,0.00299645328272954,-0.00913993064119898,0.00260616622710083,0.275614046902983
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,28612,0.00418577323545536,0.0038403637665845,-0.00334133974705026,0.011712886217961,0.275747938407638
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,23756,0.00532899322605953,0.00489033534541035,-0.00425606405094475,0.0149140505030638,0.275856844565761
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24529,-0.00488545589217531,0.00449709382566506,-0.0136997597904788,0.0039288480061282,0.277331116869615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,23974,0.00450646678937465,0.00417250395413387,-0.00367164096072773,0.012684574539477,0.28013570722649
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,23974,-0.00181905955241003,0.00168733851111483,-0.0051262430341951,0.00148812392937503,0.281015877852833
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,28631,-0.00248357570724253,0.0023037995830851,-0.00699902289008932,0.00203187147560426,0.281027393593324
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,23756,-0.00463438317523143,0.00430401695747373,-0.0130702564118799,0.00380149006141707,0.281599491480176
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,28467,-0.00252353007590936,0.00234625271742985,-0.00712218540207185,0.00207512525025314,0.282134253048807
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,28467,0.00507237383108379,0.00471982580727026,-0.00417848475116593,0.0143232324133335,0.282520356087511
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,23756,0.00725761040674882,0.00676243944275567,-0.00599677090105229,0.0205119917145499,0.28318165896048
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,23940,0.00530093868497683,0.00494267670023458,-0.00438670764748293,0.0149885850174366,0.283513785649511
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,23974,0.00701469690442881,0.00654471584714578,-0.00581294615597692,0.0198423399648345,0.283815832090132
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,24602,-0.0016940170410384,0.00158334785107434,-0.0047973788291441,0.00140934474706731,0.284676765992446
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,23711,-0.00274052642772278,0.00256693279501951,-0.00777171470596102,0.00229066185051546,0.285699733643571
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,23979,0.00442026212997028,0.00414676593847278,-0.00370739910943637,0.0125479233693769,0.286455132747893
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28491,-0.00946023711164798,0.00887601973081212,-0.0268572357840397,0.00793676156074378,0.286514168392651
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,28826,0.00261537609703834,0.00247063580913446,-0.0022270700888652,0.00745782228294188,0.289798048258364
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,23848,-0.00255271813633677,0.00242551440040268,-0.00730672636112602,0.00220129008845248,0.292606549120864
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,28631,0.00578494887321385,0.00549741583865179,-0.00498998617054366,0.0165598839169714,0.292669299693705
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,23848,0.00381931821370646,0.00364801249940981,-0.00333078628513677,0.0109694227125497,0.295129270342758
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,23756,0.00370826641595416,0.00354206969954761,-0.00323419019515916,0.0106507230270675,0.29514676918707
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,23940,0.00358998377870698,0.00343427471484117,-0.00314119466238172,0.0103211622197957,0.295876545440705
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,23756,0.00307591331934942,0.00295499369132364,-0.00271587431564492,0.00886770095434377,0.297923076237173
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,23848,0.005004676840633,0.00481456146898571,-0.00443186363857898,0.014441217319845,0.298588577061789
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,23756,-0.00475907505329533,0.00457908729712476,-0.0137340861556599,0.00421593604906921,0.298672810755116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,23940,-0.0051988289704434,0.00502575691813442,-0.0150493125299869,0.00465165458910008,0.300942364115437
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,28412,-0.00256957736108123,0.00248593567829018,-0.00744201129052999,0.00230285656836753,0.301310509079218
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,28569,-0.00416288172017705,0.00404752827118415,-0.012096037131698,0.00377027369134389,0.303723531090536
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,23756,0.0035463632274946,0.00345023570037114,-0.00321609874523282,0.010308825200222,0.304025619044196
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,29346,-0.00316676950771696,0.00309022422247317,-0.00922360898376437,0.00289006996833046,0.305480110069093
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,28371,-0.00347846379366171,0.00341029007933325,-0.0101626323491549,0.00320570476183145,0.307741624861182
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,23940,0.00270124419497995,0.00264988252273519,-0.00249252554958103,0.00789501393954093,0.308031660126957
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24529,0.00326005638939817,0.00322055756979065,-0.00305223644739151,0.00957234922618784,0.311421551070339
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,23940,0.00310209199488136,0.00306784899171612,-0.00291089202888224,0.00911507601864497,0.311949176459466
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,24185,0.00546090147596517,0.00540391448799426,-0.00513077092050359,0.0160525738724339,0.312244126790724
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,28631,0.00473980815384314,0.00469414744511258,-0.00446072083857752,0.0139403371462638,0.312634565036482
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,23974,-0.00198868242565795,0.00197032029863844,-0.00585051021098928,0.00187314535967339,0.312831690066608
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,29152,0.0136006763216486,0.0134909914674024,-0.0128416669544601,0.0400430195977574,0.313400318618105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23843,0.00390662386144209,0.00393661083515066,-0.0038091333754532,0.0116223810983374,0.321021029362424
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,28631,0.00204635130858882,0.00207619047171608,-0.00202298201597469,0.00611568463315234,0.32432406212761
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,23974,0.0021261124134869,0.00216754514869602,-0.0021222760779573,0.0063745009049311,0.326659384262565
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,28631,0.0100081816625173,0.0102115387131233,-0.0100064342152044,0.0300227975402389,0.327052170605533
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,23848,-0.00785642833382397,0.00802273577489175,-0.0235809904526118,0.00786813378496386,0.327456290684894
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,29507,-0.0013758340891895,0.00140664716593274,-0.00413286253441768,0.00138119435603867,0.328035528644619
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24539,-0.0039011371136102,0.00400602211237506,-0.0117529404538653,0.00395066622664491,0.330156435353091
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,23940,0.00547330958803366,0.0056539878439309,-0.0056085065860709,0.0165551257621382,0.333032129464929
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,23756,-0.00543479359981151,0.00567008838419255,-0.0165481668328289,0.00567857963320589,0.337819217736954
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28467,-0.0029268113597709,0.00305950091710099,-0.00892343315728885,0.00306981043774704,0.338762004305965
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28612,-0.00299470799975835,0.00313399644306246,-0.00913734102816077,0.00314792502864406,0.339304855614133
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,23756,-0.00426650548602627,0.00448899468512103,-0.0130649350688635,0.00453192409681094,0.341900056591345
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24529,0.00525135652255762,0.00553608849660068,-0.00559937693077972,0.016102089975895,0.342849711174293
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24653,0.00269837437381716,0.00284481365119669,-0.00287746038252835,0.00827420913016266,0.342872001021116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28491,-0.00312469810706441,0.00333529950281668,-0.0096618851325851,0.00341248891845628,0.348840154749901
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,23940,0.00450682942527846,0.00483554760145853,-0.00497084387358026,0.0139845027241372,0.351335342913533
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,29016,0.00286393195984338,0.00308071129341677,-0.00317426217525349,0.00890212609494025,0.35256869138933
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,29132,0.00271176240506177,0.00292547477249412,-0.00302216814902671,0.00844569295915025,0.353961320204074
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,23940,-0.00549484727598131,0.0059851206721111,-0.0172256837933191,0.00623598924135645,0.358583817378758
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29023,0.00171953868389995,0.00187750029966091,-0.00196036190343544,0.00539943927123534,0.359744796303371
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,24185,0.00234676765094868,0.00256467106474438,-0.00267998763595032,0.00737352293784767,0.36018159366361
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,24669,-0.00285229124460865,0.00313052175797088,-0.00898811389023157,0.00328353140101426,0.362239330635545
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,23848,-0.00298805041043796,0.00331094162217185,-0.00947749598989479,0.00350139516901888,0.366812373807039
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,24602,-0.00241807923831219,0.00270150983343036,-0.0077130385118357,0.00287688003521131,0.370750748268353
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23940,0.00330660827779355,0.00369807934986326,-0.00394162724793844,0.0105548438035255,0.371254883370442
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24529,0.00559623228419107,0.00627513455222391,-0.0067030314381678,0.0178954960065499,0.372503146019165
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,28324,0.00431641538870149,0.00484051571852692,-0.00517099541961128,0.0138038261970143,0.372547208028049
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,23940,0.00234224433727651,0.0026280466190651,-0.00280872703609109,0.0074932157106441,0.372804479719516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,28467,-0.00307984953302813,0.00346907939508903,-0.00987924514740263,0.00371954608134637,0.374655716263974
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28491,-0.00491601365598348,0.00556666375000949,-0.0158266746060021,0.00599464729403512,0.377180683291316
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,23756,0.00282361873397208,0.00320249872546636,-0.00345327876794197,0.00910051623588614,0.377952106856015
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,23940,0.0044280718785066,0.00502774641611137,-0.0054263110970717,0.0142824548540849,0.378474460901075
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,24683,0.00142487710635393,0.00162555263583603,-0.00176120605988469,0.00461096027259255,0.380739995781504
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,28491,-0.00547802669838672,0.00625710602641796,-0.0177419545101659,0.00678590111339248,0.381315346529726
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28612,-0.00489392605241028,0.00560730249180575,-0.0158842389363496,0.00609638683152899,0.382791829559846
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,24602,-0.00235982095279798,0.00270613957092025,-0.00766385451180167,0.00294421260620571,0.383203336023007
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,24185,-0.00378647026271281,0.00435570177472736,-0.0123236457411784,0.00475070521575282,0.38468432436627
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29507,0.00169678193950404,0.00195926835770657,-0.00214338404160085,0.00553694792060892,0.386481660906648
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29017,-0.001771805129947,0.00204597525131219,-0.0057819166225189,0.0022383063626249,0.386499854910551
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",23756,-0.00318143815088306,0.00369328683726602,-0.0104202803519245,0.00405740405015834,0.389020383061402
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,24561,0.00148263629727761,0.00172210613148975,-0.0018926917204423,0.00485796431499752,0.389277501625381
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29034,-0.00160756247926514,0.00188102433236477,-0.00529437017070009,0.00207924521216981,0.392768175663645
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,28807,0.00180567846129743,0.00212263374565864,-0.00235468368019351,0.00596604060278837,0.394955155986389
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23848,0.00306387761899912,0.0036086690626861,-0.00400911374386563,0.0101368689818639,0.395871688819335
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23242,0.00306655491498774,0.00361997240533597,-0.00402859099947076,0.0101617008294462,0.396936367228677
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,29384,-0.00195937707338276,0.00231478750427421,-0.00649636058176022,0.00257760643499469,0.397302583735542
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,23843,-0.00449630606704321,0.00531590821281027,-0.0149154861641513,0.00592287403006492,0.397661178662236
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,23756,-0.00877368542629311,0.0103816630287727,-0.0291217449626876,0.0115743741101014,0.398055888429727
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,28631,-0.00206320511501955,0.00244204827535033,-0.0068496197347062,0.0027232095046671,0.398192366808405
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24119,-0.00322192134291198,0.00382100584318757,-0.0107110927955596,0.00426725010973565,0.399117762941413
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,28631,-0.00236661333059156,0.00280731015654653,-0.00786894123742275,0.00313571457623963,0.399225355689198
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,23979,-0.00381290893964921,0.00453171878727961,-0.0126950777627172,0.00506925988341883,0.400142074304213
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24144,0.0032904195930335,0.00393019897127501,-0.00441277039066552,0.0109936095767325,0.402480296251978
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24529,-0.00336867335505503,0.00402539301606505,-0.0112584436665425,0.00452109695643248,0.402681804384627
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28631,-0.00291035384984455,0.00348046439224691,-0.00973206405864848,0.00391135635895939,0.403051073237019
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,29209,-0.00183542252043209,0.00219877200729624,-0.00614501565473271,0.00247417061386854,0.403865931531105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,23974,-0.00128711071470163,0.00156444440526271,-0.00435342174901653,0.00177920031961328,0.410671422666786
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,24491,-0.00348403988713518,0.00424731868760735,-0.0118087845148456,0.00484070474057523,0.41205787576239
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,23848,-0.00278058167336951,0.00343219876679274,-0.00950769125628328,0.00394652790954426,0.417864429301345
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24185,-0.00503031755125258,0.00624866461559441,-0.0172777001978176,0.00721706509531247,0.420814435182615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,28491,0.00527373317855963,0.00657676933173965,-0.00761673471165009,0.0181642010687694,0.422633167645834
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23979,-0.00190618779355595,0.00238285137897576,-0.00657657649634844,0.00276420090923655,0.423741414762948
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,28631,0.00276584546038986,0.00347018403230988,-0.0040357152429375,0.00956740616371721,0.425439437497355
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,24669,-0.00518618792603456,0.00659510601102272,-0.0181125957076391,0.00774021985556998,0.431658807784142
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24185,0.00233589210160175,0.00297264678070004,-0.00349049558857033,0.00816227979177383,0.431995077404722
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTN,Titin,23848,-0.00381046541005809,0.00485804890767341,-0.013332241269098,0.00571131044898178,0.432835952722022
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,29080,-0.00443249937206815,0.00566991517017301,-0.0155455331056072,0.00668053436147095,0.434363401291353
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,28631,-0.00312178687307753,0.00401264095213968,-0.0109865631392713,0.00474298939311624,0.436582466026452
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24185,-0.0047896905675294,0.00615757506713359,-0.0168585376991112,0.00727915656405244,0.436663069255816
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24185,-0.00245216048752141,0.00315509940271978,-0.00863615531685218,0.00373183434180935,0.437045166692814
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28631,-0.0065863161099401,0.0084914201156643,-0.0232294995366421,0.0100568673167619,0.437965828333394
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,23756,-0.00294822756120102,0.00382996653028774,-0.010454961960565,0.00455850683816296,0.441438695175184
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,29256,0.0017600825108756,0.00229788786139085,-0.00274377769745046,0.00626394271920166,0.443708273229206
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,23848,0.00269585601702522,0.00353950179001505,-0.00424156749140427,0.00963327952545472,0.446277391978441
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,23848,-0.00262946188767771,0.00347098581674185,-0.00943259408849173,0.00417367031313632,0.448725050946411
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,23843,0.00307812929064097,0.0040656766049509,-0.00489059685506281,0.0110468554363447,0.448996624631095
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,23848,-0.00216624286989096,0.00289396966383255,-0.00783842341100275,0.00350593767122083,0.454143806812296
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,28467,0.00256200030518444,0.00342270193814447,-0.00414649549357871,0.00927049610394759,0.454145803836032
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,29122,0.00329001094098891,0.00440722960769673,-0.00534815909009667,0.0119281809720745,0.455369537139106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,29445,0.00159746159380008,0.00215830599929192,-0.00263281816481207,0.00582774135241224,0.459217301815761
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,23843,0.00451247503674581,0.00612561005961693,-0.00749372068010336,0.016518670753595,0.461338064932053
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28631,-0.00240251909143454,0.0032654269501915,-0.00880275591380988,0.00399771773094079,0.461892387005342
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28491,0.00196188236389956,0.00272022858326746,-0.00336976565930467,0.00729353038710379,0.470780291769612
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,28491,0.00287290703307958,0.00398452262666223,-0.00493675731517839,0.0106825713813376,0.470905208704345
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23848,-0.00266461437157482,0.00371730161447254,-0.009950525535941,0.00462129679279135,0.473495807786408
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23843,-0.00306428686979886,0.00430810274765883,-0.0115081682552102,0.00537959451561245,0.476914893861384
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,23848,0.00291478828441334,0.00409813499167036,-0.00511755629926057,0.0109471328680873,0.476937836398536
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24529,-0.00189704183795505,0.00268562323610229,-0.00716086338071555,0.00336677970480544,0.47996521287344
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,23756,0.00209012977779904,0.00296189703773614,-0.00371518841616379,0.00789544797176187,0.480398647069356
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,28778,0.00297380316952119,0.0042739324166932,-0.00540310436719748,0.0113507107062399,0.486559565152371
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,23756,-0.00186049643992995,0.00267419452518323,-0.00710191770928909,0.00338092482942918,0.486609643339818
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,28467,-0.0028819889047261,0.00415024648690959,-0.0110164720190689,0.00525249420961669,0.487428340514904
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24602,0.00182193435725768,0.0026345460357393,-0.00334177587279135,0.00698564458730672,0.489223150893588
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,29268,-0.00750612390800986,0.0109727858810304,-0.0290127842348295,0.0140005364188098,0.493938094002948
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,23843,0.00183001004922865,0.00271840767347169,-0.00349806899077586,0.00715808908923316,0.500831737048221
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",23848,-0.00273903521605975,0.0040747838521381,-0.0107256115662504,0.00524754113413091,0.501468284622937
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,23940,0.00202386612091695,0.00301803367547744,-0.00389147988301884,0.00793921212485273,0.502487611293364
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24669,0.00122955954964181,0.00183369394998864,-0.00236448059233593,0.00482359969161955,0.502521840346299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23848,0.00317633856575729,0.00475826213239745,-0.00614985521374172,0.0125025323452563,0.50443262288037
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,23974,0.00260912341937672,0.00391813937779405,-0.00507042976109962,0.0102886765998531,0.505475817895891
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,23756,0.00288900178216289,0.00437006297876208,-0.00567632165621078,0.0114543252205366,0.508561475374665
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,23974,0.00262708957336141,0.00398091693632864,-0.00517550762184273,0.0104296867685655,0.509311049762907
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,23940,-0.00492349373072083,0.00746736560316633,-0.0195595303129268,0.00971254285148518,0.50968716967761
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,22789,-0.00252992183357517,0.00383835414054404,-0.0100530959490415,0.00499325228189115,0.509827744111873
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,28467,0.00251264193609419,0.00381609701108699,-0.00496690820563632,0.0099921920778247,0.510265645477002
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,23940,0.00311009936346404,0.00473084269933731,-0.00616235232723709,0.0123825510541652,0.510924182154615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,23974,-0.00124062129041618,0.00189059408105822,-0.00494618568929028,0.00246494310845793,0.51169717213954
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,23756,0.00149832165434911,0.00230511976050324,-0.00301971307623725,0.00601635638493547,0.515700245132104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,23974,-0.00407076469435957,0.00630786622610747,-0.0164341824975302,0.00829265310881107,0.518708300035142
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28491,0.00226676024267504,0.00352218786535438,-0.00463672797341955,0.00917024845876962,0.519862107084143
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,28491,-0.00478104861572244,0.0074399891462201,-0.0193634273423138,0.00980133011086896,0.520479121904532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,24529,-0.00185716752543935,0.00289258106095958,-0.00752662640492013,0.00381229135404142,0.520849897332769
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,23940,-0.0012587933329628,0.00197549459013431,-0.00513076272962605,0.00261317606370045,0.523997977774414
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29206,0.00225218383045139,0.00353552446686175,-0.00467744412459765,0.00918181178550042,0.524119753005188
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,23756,0.00255770809419726,0.00402348142452726,-0.00532831549787617,0.0104437316862707,0.524981189738358
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,23843,0.00297091370402347,0.00468591310564407,-0.0062134759830389,0.0121553033910858,0.526080669274209
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,23940,-0.00384131653472258,0.00606762685020928,-0.0157338651611328,0.00805123209168762,0.52668494228907
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,23940,0.00252839063252969,0.00401177827986138,-0.00533469479599862,0.010391476061058,0.52854237000642
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28491,0.00558765224346163,0.00900323023363212,-0.0120586790144573,0.0232339835013806,0.534849710352511
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24185,0.00356657895382644,0.0057570537596343,-0.00771724641505679,0.0148504043227097,0.535583235108556
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,29132,-0.00232037523793343,0.00375287524892944,-0.00967601072583512,0.00503526024996827,0.536387272432914
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,24185,0.00265236960852347,0.00429649090643737,-0.00576875256809379,0.0110734917851407,0.537020307838055
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28467,0.001776886505998,0.0028813415402665,-0.00387054291292434,0.00742431592492034,0.537445986101535
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28467,-0.0034846985911476,0.00566367491963906,-0.0145855014336402,0.00761610425134496,0.538380260092698
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,29172,0.00333631405680099,0.00554256591262701,-0.00752711513194794,0.0141997432455499,0.547216123406432
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,24653,-0.00128402658404775,0.00213377013897524,-0.00546621605643921,0.00289816288834371,0.547336613067906
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23848,0.00291243161795399,0.00485747698231075,-0.00660822326737508,0.0124330865032831,0.548793859417215
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,23974,0.00261821365401186,0.00437901085982935,-0.00596464763125367,0.0112010749392774,0.549911844479946
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,24443,0.003090105156434,0.00520446637055026,-0.0071106489298445,0.0132908592427125,0.552690842074598
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,23756,-0.00246821726125855,0.00417116152869117,-0.0106436938574932,0.00570725933497615,0.554034493427383
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,28860,0.00196019214021432,0.00332589882910853,-0.00455856956483839,0.00847895384526704,0.555616271039967
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,23974,-0.0019615947876005,0.0033808333975157,-0.00858802824673128,0.00466483867153027,0.561778179445024
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,23848,0.00202963410951268,0.00350824993338223,-0.00484653575991649,0.00890580397894184,0.562910608398271
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24683,-0.0010780703429877,0.00187291393599226,-0.00474898165753253,0.00259284097155714,0.564883221606309
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,23940,-0.00171223316270898,0.00299749719677386,-0.00758732766838574,0.00416286134296778,0.567855251674681
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,23974,0.00235793645540364,0.00416332445222406,-0.00580217947095551,0.0105180523817628,0.571155035129614
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24683,0.00176271692812013,0.00311808387604646,-0.00434872746893093,0.00787416132517119,0.571860886772139
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29349,-0.00165061644632181,0.00292990849662873,-0.00739323709971413,0.0040920042070705,0.573188685306485
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,23940,0.00167470393279067,0.00298128290998691,-0.00416861057078366,0.00751801843636501,0.57429887964482
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,23843,0.00310457430978926,0.00552926061959076,-0.00773277650460863,0.0139419251241872,0.574475017741835
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,29172,0.00105888833660088,0.0018937895770586,-0.00265293923443398,0.00477071590763574,0.576072334074275
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,23804,0.00137333578340708,0.00248658278220021,-0.00350036646970534,0.00624703803651949,0.580749089967697
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,24529,-0.00107339712293181,0.00195795764416555,-0.00491099410549629,0.00276419985963266,0.583543885003285
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,24529,-0.00306265553818272,0.00572497562207461,-0.0142836077574489,0.00815829668108351,0.592679642039222
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",23979,-0.00324562316917951,0.00613775586967471,-0.0152756246737419,0.00878437833538292,0.596951596972377
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24602,-0.00134505904393922,0.00254672600379536,-0.00633664201137813,0.00364652392349969,0.597398441395979
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,28491,0.00526446289644327,0.00997191626352668,-0.014280492980069,0.0248094187729556,0.597552790853294
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,24185,-0.00323099089729959,0.00620452672341217,-0.0153918632751875,0.00892988148058827,0.602547549319626
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,23940,-0.00225231904127937,0.00435322445971809,-0.0107846389823268,0.00628000089976808,0.6048880426181
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24539,-0.00549869737528535,0.0106423762115655,-0.0263577547499536,0.0153603599993829,0.60538458373293
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,28631,0.00174963932859675,0.00339525326149615,-0.00490505706393571,0.0084043357211292,0.606333937301737
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,29172,-0.00147865658413698,0.00289592088286777,-0.0071546615145578,0.00419734834628385,0.609635190974797
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,23940,0.00177529941269045,0.00349767564508023,-0.00508014485166681,0.00863074367704771,0.611762784057468
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,23974,0.00102368867189909,0.00201948507983789,-0.00293450208458317,0.00498187942838134,0.612225590525319
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,28631,0.00225949789061227,0.00449102679404961,-0.00654291462572497,0.0110619104069495,0.614888084623887
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,29381,0.00462746128668143,0.00922858991956576,-0.0134605749556675,0.0227154975290303,0.616074619290969
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,23940,0.00136786629800993,0.0027366351420561,-0.00399593858042002,0.00673167117643987,0.61719579045617
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,23843,-0.0042603999567367,0.00855425749444852,-0.0210267446458558,0.0125059447323824,0.618457351173028
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,23756,-0.00194326771101448,0.0039067041394808,-0.00960040782439685,0.00571387240236788,0.618898424785817
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,23940,-0.00150036632949056,0.00302501172326975,-0.00742938930709926,0.00442865664811815,0.619908176202733
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24185,0.00239514696599214,0.00484819169590568,-0.00710730875798299,0.0118976026899673,0.621290236149759
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,28631,0.00173093646386706,0.00350928148005633,-0.00514725523704334,0.00860912816477746,0.621843084857148
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,28915,-0.00143343900199017,0.00291267222351984,-0.00714227656008906,0.00427539855610872,0.622624965723991
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,23756,0.00226049350139326,0.00461329016467787,-0.00678155522137535,0.0113025422241619,0.624141291660371
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24699,-0.000659328215963558,0.00134762481677993,-0.00330067285685221,0.0019820164249251,0.624667604645462
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,23843,0.00223983454020628,0.00458437422918194,-0.00674553894899033,0.0112252080294029,0.625143420182877
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,23843,-0.00191778422468037,0.00393539980375782,-0.0096311678400457,0.00579559939068497,0.626038725503454
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,24185,-0.000811708692770803,0.00166623575394878,-0.00407753077051042,0.00245411338496881,0.626155625872793
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28631,0.00104114085261117,0.00215792668458688,-0.00318839544917911,0.00527067715440145,0.629473831949751
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23843,0.00197322450031899,0.00409352559138487,-0.00605008565879535,0.00999653465943333,0.629785182050194
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24648,0.000649424046211566,0.00135396635989105,-0.00200435001917489,0.00330319811159802,0.631483653620753
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,23848,0.00389848227778461,0.00819284044198499,-0.012159484988506,0.0199564495440752,0.634192637593548
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,24669,-0.0016249072113629,0.00341823096429198,-0.00832463990137518,0.00507482547864937,0.634531079429617
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,28631,-0.00139886585213254,0.00296490410447652,-0.00721007789690652,0.00441234619264144,0.637067346759639
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,24185,0.00140807979159227,0.00300791790845645,-0.00448743930898238,0.00730359889216691,0.639699846147577
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,23974,-0.00312134375184141,0.00668204668063906,-0.016218155245894,0.00997546774221114,0.640415478493836
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,23979,0.00891397917100248,0.0190840727764633,-0.0284908034708656,0.0463187618128705,0.640439749280523
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,29132,-0.00120003506566826,0.00258462874968142,-0.00626590741504384,0.00386583728370733,0.642438529895814
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,24185,0.00149192396783607,0.00323856780835455,-0.00485566893653886,0.00783951687221099,0.645036660086151
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,28631,-0.00146454215717256,0.00322273334702347,-0.00778109951733855,0.00485201520299344,0.649514896762531
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,29034,0.00273505221790093,0.00617934391441448,-0.00937646185435145,0.0148465662901533,0.658049649764762
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24669,0.00437533892158359,0.00995414098835885,-0.0151347774155997,0.0238854552587669,0.660267186356749
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,23974,-0.00207942479204682,0.0047373824948217,-0.0113646944818973,0.00720584489780371,0.660709257797112
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,23843,-0.00136822976557091,0.00318081343164708,-0.00760262409159918,0.00486616456045736,0.667089764736026
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,28612,-0.00186113007769161,0.00435859691998339,-0.0104039800408591,0.00668171988547584,0.669381006018632
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24579,-0.000826088198514388,0.00195060477563297,-0.00464927355875501,0.00299709716172623,0.671931560205994
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,23843,0.0015106337689844,0.00357061573029005,-0.0054877730623841,0.0085090406003529,0.672245275336947
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,23756,0.00192045520724748,0.00458229283520098,-0.00706083874974645,0.0109017491642414,0.675144245854786
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28467,-0.00150601055935488,0.00361657018953611,-0.00859448813084565,0.00558246701213588,0.677106160507552
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,23848,-0.00113456157016892,0.00274628046012585,-0.00651727127201559,0.00424814813167776,0.679517561875845
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24602,-0.000703567544169044,0.00172051810405386,-0.0040757830281146,0.00266864793977651,0.682596267756682
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24683,-0.000925991480261504,0.00232492455393199,-0.0054828436059682,0.0036308606454452,0.690420740137636
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29132,0.000886949047114512,0.00228195749748879,-0.00358568764796352,0.00535958574219254,0.697516431890224
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29423,-0.00128429776988372,0.00334097945003871,-0.00783261749195959,0.00526402195219216,0.700679175001289
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,23974,0.00103663384567267,0.00273102502120639,-0.00431617519589186,0.0063894428872372,0.704262919880511
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,28631,-0.00246942910872095,0.00660077270743064,-0.015406943615285,0.0104680853978431,0.708323669428709
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,28527,-0.00130602539658414,0.00351190709214931,-0.00818936329719679,0.00557731250402851,0.709981273844629
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24699,0.000449278569680618,0.00121069483265869,-0.00192368330233042,0.00282224044169166,0.710572561332899
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,23756,0.00183407329104975,0.00500182144377676,-0.0079694967387527,0.0116376433208522,0.71386018835319
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24579,0.000963640225397032,0.00264556447269847,-0.00422166614109198,0.00614894659188604,0.715676340487818
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,24087,-0.000943304051190199,0.00265500728633999,-0.00614711833241658,0.00426051023003618,0.722373621652207
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_A,,24602,0.000838165352166812,0.00236179153940962,-0.00379094606507604,0.00546727676940966,0.722678484990987
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,23848,-0.00154580760102851,0.00440884402634851,-0.0101871418926716,0.00709552669061457,0.725880172251955
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,28631,-0.00164197344019679,0.00469631411551889,-0.0108467491066138,0.00756280222622024,0.726618784715314
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,23848,-0.000997397932048943,0.00288341574097628,-0.00664889278436245,0.00465409692026457,0.729414554894188
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,29256,-0.00195230231484717,0.00570592723471444,-0.0131359196948875,0.00923131506519314,0.732237923093167
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24579,0.000634726699850407,0.00185638883595109,-0.00300379541861373,0.00427324881831454,0.732417983993306
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,24185,0.00130541003035497,0.00382058494974215,-0.00618293647113964,0.00879375653184958,0.732596159965918
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23919,-0.000944680201460437,0.00278258404106004,-0.00639854492193811,0.00450918451901724,0.734237996105867
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23940,0.00117675230530432,0.00355674071139327,-0.0057944594890265,0.00814796409963514,0.740759702694441
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,23848,-0.00234732939875672,0.0071052582794258,-0.0162736356264313,0.0115789768289179,0.741127008549597
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,23974,0.00216182552712979,0.00654517178273952,-0.0106667111670397,0.0149903622212992,0.741181342062653
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24185,-0.00128649964020028,0.00391086996581329,-0.00895180477319434,0.00637880549279378,0.742192665462088
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29122,-0.00141896144651397,0.00438109506292542,-0.0100059077698478,0.00716798487681985,0.746029074229828
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28436,0.000662885771671727,0.00206091769866633,-0.00337651291771428,0.00470228446105773,0.74772331622239
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,23974,-0.00142422728609791,0.00442842989570221,-0.0101039498816742,0.00725549530947842,0.747750981610017
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,23756,0.00122523490528841,0.00386544721942575,-0.00635104164478606,0.00880151145536289,0.751268348097912
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,23848,0.00102045073753283,0.00322278259607898,-0.00529620315078197,0.00733710462584763,0.751522177815746
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23979,-0.000596224021372103,0.00189019586204116,-0.00430100791097278,0.00310855986822857,0.752438122930023
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28491,-0.00128911165200964,0.00416014539253837,-0.00944299662138485,0.00686477331736556,0.756660732036676
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",23843,-0.00187680628793664,0.00607406791581515,-0.0137819794029343,0.0100283668270611,0.757334334445775
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24539,0.00381631748187102,0.0124418520148588,-0.0205697124672521,0.0282023474309942,0.759049770973656
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,24669,0.000969502163887992,0.00317565604986997,-0.00525478369385714,0.00719378802163313,0.760146399029457
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,23940,-0.000802636051144292,0.00262950920053547,-0.00595647408419381,0.00435120198190523,0.760184674357205
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29470,0.000774171509034631,0.00264105953424921,-0.00440230517809381,0.00595064819616307,0.769425509251703
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,23843,-0.00122067210673001,0.00417481477152971,-0.00940330905892824,0.00696196484546823,0.769991362190536
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,24529,-0.000931960180800766,0.00319567812490061,-0.00719548930560595,0.00533156894400442,0.770570909525574
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,23940,-0.00144389813493333,0.00515766800166079,-0.0115529274181885,0.00866513114832181,0.779516950437627
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,23654,-0.000699431321053228,0.00250120140126861,-0.0056017860675397,0.00420292342543324,0.77975758486709
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23843,0.00144919297439916,0.00532473854100182,-0.0089872945659644,0.0118856805147627,0.785499602718386
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24602,0.00150067433991947,0.00552969530486541,-0.00933752845761672,0.0123388771374557,0.786097496849452
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,23843,0.000983721461741535,0.00363670551449081,-0.00614422134666046,0.00811166427014353,0.786779520589438
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,24579,0.000438378218882065,0.0016312458298089,-0.00275886360754339,0.00363562004530752,0.788133339055458
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,29145,-0.000443942004775598,0.00167491859616617,-0.0037267824532613,0.0028388984437101,0.790970597832877
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29205,0.000673561835322123,0.00255776611218767,-0.00433965974456571,0.00568678341520996,0.792290478680705
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,23756,0.000631930187200736,0.00241671184821844,-0.00410482503530741,0.00536868540970889,0.793721967551386
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,28908,-0.000804354694536527,0.00308553682267818,-0.00685200686698577,0.00524329747791271,0.794336910307217
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,23843,-0.000651130049423837,0.00251293985408341,-0.00557649216342733,0.00427423206457965,0.795551930901439
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,24529,-0.00204105802539033,0.00794015441963423,-0.0176037606878734,0.0135216446370928,0.797138314024382
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,23974,-0.00139087746263946,0.00541955490309654,-0.0120132050727087,0.00923145014742975,0.797458484875545
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,28642,0.000762151702455079,0.00298141078291164,-0.00508141343205174,0.0066057168369619,0.798234848584403
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29409,0.000704956870254316,0.00275992201019434,-0.00470449026972659,0.00611440401023522,0.798395590186236
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24123,-0.00117018915106303,0.00462762346219917,-0.0102403311369734,0.00789995283484735,0.800370493625537
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,23940,-0.00118587805826024,0.00475691688565103,-0.0105094351541363,0.00813767903761579,0.803134338149596
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28415,0.000942282484078957,0.00386747297877398,-0.00663796455431805,0.00852252952247596,0.807509129243153
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,24579,0.00165548807136372,0.00683401880237194,-0.0117391887812853,0.0150501649240127,0.808594483478036
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23843,-0.00078108680568466,0.0033004738733052,-0.00725001559736285,0.00568784198599353,0.812923388484156
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,23848,-0.00111727823614982,0.00472669079746873,-0.0103815921991885,0.00814703572688889,0.813142625311709
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,24653,0.000835234476151776,0.00354978757065332,-0.00612234916232872,0.00779281811463227,0.813984527423225
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,24602,-0.00263939582548783,0.0114399794150358,-0.025061755478958,0.0197829638279823,0.817536714644514
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,23843,0.000981921888122592,0.00434112684086949,-0.00752668671998161,0.00949053049622679,0.821055156548138
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,23974,-0.00106999831654839,0.00479597983362567,-0.0104701187904547,0.00833012215735791,0.823457111101725
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,23940,0.000802187829685969,0.00363985725680338,-0.00633193239364865,0.00793630805302059,0.825569379777338
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,24579,0.00119776112600811,0.00545025430388037,-0.00948473730959741,0.0118802595616136,0.826058007443477
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",23756,0.000847308700686653,0.00398215350146923,-0.00695771216219303,0.00865232956356634,0.831503117901001
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,24185,-0.000893270117189725,0.00434163094391292,-0.00940286676725904,0.00761632653287959,0.836991611800187
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BSND,Barttin,23756,-0.000501249354964228,0.00244003988912918,-0.00528372753765742,0.00428122882772897,0.837240518623971
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24669,0.000369798132949816,0.00190698170633707,-0.00336788601147083,0.00410748227737046,0.846241664477387
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,24185,0.000750646749558296,0.00387621132235948,-0.00684672744226629,0.00834802094138288,0.846447849511282
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24529,0.000627448725444921,0.00328216600814149,-0.00580559665051239,0.00706049410140224,0.848394694023385
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,23848,0.000589591714294958,0.00310317752361182,-0.00549263623198422,0.00667181966057413,0.849313782633151
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,23848,-0.00054629988300929,0.00289449744622579,-0.00621951487761185,0.00512691511159327,0.850300254989873
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,28612,-0.000357439743207971,0.00197874180274017,-0.0042357736765787,0.00352089419016276,0.856651506725188
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,29213,0.000715866428977589,0.00396919896327921,-0.00706376353904966,0.00849549639700484,0.856874824846384
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,23848,0.000410855468036292,0.00234596992021727,-0.00418724557558956,0.00500895651166215,0.860977045775465
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29034,0.00048591176428064,0.00280804365141188,-0.00501785379248664,0.00598967732104792,0.862618984414762
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28612,0.000760612149617977,0.00440240681774414,-0.00786810521316054,0.00938932951239649,0.862831955363251
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23940,0.000609227963396647,0.00355176850816668,-0.00635223831261004,0.00757069423940333,0.863810018935011
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,29102,0.00155413302584383,0.0092119967220019,-0.0165013805492799,0.0196096466009676,0.866027884634735
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,28631,-0.000382933004339398,0.00227311789141161,-0.00483824407150615,0.00407237806282735,0.866221366337775
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29132,0.0014331009125362,0.00853557956335376,-0.0152966350316372,0.0181628368567096,0.866665226484632
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28467,-0.000766023962338396,0.00456338730530121,-0.00971026308072877,0.00817821515605198,0.86669223815249
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27688,-0.000347904023576654,0.00210483668049249,-0.00447338391734193,0.00377757587018863,0.868718593727449
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,29172,0.000414424567132176,0.00256386775235787,-0.00461075622748924,0.0054396053617536,0.871590173860312
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,28491,0.000453298439237965,0.00284261091791326,-0.00511821895987203,0.00602481583834796,0.873303249586903
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,24699,-0.000220079409032437,0.00141022337059559,-0.00298411721539979,0.00254395839733492,0.87598703154697
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,23974,0.00052723538464439,0.00344685483174726,-0.00622860008558023,0.00728307085486901,0.878430084859389
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24162,-0.00109285466217367,0.00727688910571338,-0.0153555573093719,0.0131698479850246,0.880622616866922
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",23848,0.000421826245755482,0.00283785136612918,-0.00514036243185771,0.00598401492336867,0.881836735938928
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,23843,0.000775974772033396,0.00541575967450725,-0.00983891419000082,0.0113908637340676,0.88606957291664
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,28612,-0.000721094685478129,0.00513886204141382,-0.0107932642866492,0.00935107491569295,0.888406680798467
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,28467,-0.000331281533346616,0.00241394885317776,-0.00506262128557503,0.0044000582188818,0.890844949408357
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",23756,0.000470785683391965,0.0035301535309414,-0.00644831523725317,0.0073898866040371,0.893908820845856
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,23848,0.000922385960061753,0.00712834960440641,-0.0130491792645748,0.0148939511846983,0.897044734670604
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,29122,-0.000521474663517087,0.00403015002496485,-0.0084205687124482,0.00737761938541402,0.89704729344104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,23756,0.000366437881623182,0.00294571567673739,-0.0054071648447821,0.00614004060802846,0.901002085376108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,23940,-0.00029788311572564,0.00242466342102983,-0.0050502234209441,0.00445445718949282,0.902222595914921
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,23979,0.000367008603274801,0.00303189252414368,-0.0055755007440468,0.00630951795059641,0.903652965938341
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24185,0.000678210670570775,0.00565751555147932,-0.0104105198103287,0.0117669411514703,0.904580925596234
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",23848,-0.000340993461884185,0.00287006602939271,-0.0059663228794939,0.00528433595572553,0.905426634118198
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23715,0.000409797155646603,0.00350608416346801,-0.00646212780475069,0.00728172211604389,0.906954772676245
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29361,0.00028660842985831,0.00248861267065299,-0.00459107240462154,0.00516428926433816,0.908312786473108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,24539,-0.00215128744207794,0.0187140887904088,-0.0388309014712793,0.0345283265871234,0.908481334733819
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,28631,-0.000420997250493143,0.003765271863703,-0.00780093010335102,0.00695893560236473,0.910974378569231
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,23756,-0.000500280331999982,0.00459716240117733,-0.00951071863830755,0.00851015797430759,0.91334322624788
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,23796,0.000663654833783545,0.00617690739930773,-0.0114430836688596,0.0127703933364267,0.914439814097979
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,23843,0.000547714222815239,0.00538777852116283,-0.0100123316786639,0.0111077601242944,0.919028489941089
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,24162,0.000717152128261805,0.007119170738934,-0.0132364225200488,0.0146707267765724,0.919761388250672
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,23940,-0.000247118423720547,0.00258355628018954,-0.00531088873289205,0.00481665188545096,0.923798964964293
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,23974,-0.000280692681328867,0.00294828124759753,-0.00605932392662003,0.00549793856396229,0.92415237311278
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,23843,0.000625041466066494,0.00699374754666789,-0.0130827037254026,0.0143327866575356,0.928787451199565
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,29004,0.000435344841581791,0.00500364622984796,-0.00937180176892021,0.0102424914520838,0.930667725417924
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28467,-0.000295894773704412,0.00342882317256167,-0.00701638819192528,0.00642459864451646,0.931231482133629
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23974,-0.000298255778670056,0.00353118926945123,-0.00721938674679446,0.00662287518945435,0.932688813565547
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24185,0.000358184250688348,0.00466730585155211,-0.00878973521835379,0.00950610371973049,0.938828427358798
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,23843,0.000263585061161437,0.00355497768135664,-0.00670417119429759,0.00723134131662046,0.940895353554977
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,23940,0.000308851533674163,0.00418206456309465,-0.00788799500999134,0.00850569807733967,0.941129204629324
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,23974,-0.000241215957278366,0.00338714149377427,-0.00688001328507594,0.00639758137051921,0.943227079037644
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24487,0.000204853615774994,0.00290503757623141,-0.00548902003363858,0.00589872726518856,0.943782998145489
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24185,0.000317513177163423,0.0045664936733405,-0.00863281442258396,0.00926784077691081,0.944567479848182
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,24529,-0.000237467756975598,0.00346925584389389,-0.00703720921100762,0.00656227369705643,0.945428622862596
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,24529,-0.000166043587698448,0.00248849658252257,-0.00504349688944268,0.00471140971404578,0.946801606510352
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,23843,-0.000190165914661893,0.00290264260968011,-0.0058793454296349,0.00549901360031112,0.947764709680613
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24185,-0.00018096273322452,0.00288876245952102,-0.00584293715388573,0.00548101168743668,0.950050757969333
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24539,0.000180023630341546,0.00314433071325225,-0.00598286456763287,0.00634291182831596,0.954343805666971
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,29277,-0.000167659373030729,0.00295957310752454,-0.00596842266377882,0.00563310391771736,0.954824510371811
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,24579,0.000193057738251331,0.00371902389891004,-0.00709622910361235,0.00748234458011501,0.958600141011522
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24119,-0.000139883677765153,0.00271935992085255,-0.00546982912263614,0.00519006176710584,0.958975395384216
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28631,0.000204410052479451,0.0040102788698459,-0.00765573653241851,0.00806455663737741,0.959348562018845
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,23756,-0.000244303040586031,0.00530279236065089,-0.0106377760674618,0.0101491699862897,0.963254334100673
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,29256,0.00011697462688144,0.00271583245041968,-0.00520605697594113,0.00544000622970401,0.965644934871315
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,23940,0.000154597215819288,0.00366822169348398,-0.00703511730340931,0.00734431173504788,0.966383456152029
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28612,-0.000101188609272501,0.00240583934246532,-0.00481663372050453,0.00461425650195952,0.966451490122734
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29381,0.000126251125367241,0.00337334163476925,-0.0064854984787805,0.00673800072951498,0.970145492259015
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,23756,0.000233343879066547,0.00630755732112087,-0.0121294684703304,0.0125961562284635,0.970489834889577
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24185,0.00012710019367937,0.00356877297076266,-0.00686769482901544,0.00712189521637418,0.97159001166401
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,27998,-9.59737973729035e-05,0.00271944988315037,-0.00542609556834764,0.00523414797360183,0.971847455547657
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,28491,-0.000220320461823729,0.00626136342767533,-0.0124925927800674,0.0120519518564199,0.971930637185104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24602,-7.46631042243712e-05,0.00244584111456035,-0.00486851168876266,0.00471918548031392,0.975647362881237
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24185,-0.00014418403287137,0.00479484066570465,-0.00954207173765249,0.00925370367190975,0.976010946768763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,23848,-9.88417359312632e-05,0.00339571540491116,-0.00675444392955715,0.00655676045769462,0.976778874834845
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24602,7.12606184337485e-05,0.00258567881694178,-0.00499666986277213,0.00513919109963963,0.978013521340648
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,28467,0.000101979536538999,0.00372239198837679,-0.0071939087606795,0.0073978678337575,0.978143890964068
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,23756,0.00010282527589559,0.00414878893170788,-0.00802880103025186,0.00823445158204304,0.980227136470282
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,23843,0.000190910083457597,0.00782908109295187,-0.0151540888587281,0.0155359090256433,0.980545926993601
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28491,5.09641224288667e-05,0.00229678830835894,-0.00445074096195466,0.00455266920681239,0.982297109146637
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29507,0.000105742724463812,0.00503872359271063,-0.00977015551724902,0.00998164096617665,0.983256954301637
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",24529,3.60149451079124e-05,0.00312393454525658,-0.00608689676359498,0.0061589266538108,0.990801715386657
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,23974,-2.00006977124384e-05,0.00310233530019908,-0.00610057788610263,0.00606057649067776,0.994856142451496
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,28187,6.71121435888526e-06,0.00189301584550109,-0.00370359984282326,0.00371702227154103,0.99717133081597
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,23843,-1.36217434603801e-05,0.00530510635733948,-0.0104116302038458,0.010384386716925,0.997951322349258
